000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||2|0|
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|31032|42523|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche Registration GmbH|Epóetín||31032||31032|42523||2|0|S
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|7688|12080|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7688||7688|12080||2|0|E
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|23605|33129|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23605||23605|33129||2|0|E
000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|30489|41836|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30489||30489|41836||2|0|
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|4815|8125|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4815||4815|8125||1|H|S
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4601|8900|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4601||4601|8900||1|0|
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|12802|19119|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||12802||12802|19119||1|H|S
000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|2985|5606|lyfalmen|V0942|5147|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||2985||2985|5606||2|0|G
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|4142|7199|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4142||4142|7199||1|0|
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2839|5406|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2839||2839|5406||1|0|G
000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|8261|12868|lyfalmen|V0942|12868|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||8261||8261|12868||2|0|G
000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|37338|50499|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||37338||37338|50499||1|H|S
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3388|6161|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3388||3388|6161||1|0|
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0|
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0|
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|93509|121544|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||93509||93509|121544||2|0|S
000985|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8731|13515|lyfalmen|V0095|10285|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||8731||8731|13515||1|0|E
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|15939|23436|lyfalmen|V0115|8242|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||15939||15939|23436||1|0|E
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|1840|4030|lyfalmen|V0050|2461|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1840||1840|4030||1|0|G
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5652|9277|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5652||5652|9277||1|0|G
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2828|5390|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2828||2828|5390||1|0|G
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19318|28087|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||19318||19318|28087||1|0|S
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|13416|19964|lyfalmen|V0637|19962|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||13416||13416|19964||1|0|G
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|26335|36582|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||26335||26335|36582||1|0|S
001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|139135|224286|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||139135||139135|224286||1|0|
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2413|4819|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2413||2413|4819||1|H|S
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|4641|7886|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4641||4641|7886||1|0|G
001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|521|2215|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||521||521|2215||1|0|G
001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1781|2621|lyfalmen|V0291|2461|2|60|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||816||816|2621||1|0|G
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3453|6251|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3453||3453|6251||2|0|E
001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3110|3908|lyfalmen|V0292|3494|2|60|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1751||1751|3908||1|0|G
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|GRH|0|0|1|100|DKK|1653|3773|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1653||1653|3773||1|0|E
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|GRH|0|0|1|100|DKK|3367|6132|lyfalmen|V0005|2806|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3367||3367|6132||1|0|E
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22431|31644|lyfsjukr|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||22431||22431|31644||2|0|S
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2964|5578|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2964||2964|5578||1|0|G
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12686|18959|lyfalmen|V0492|13909|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||12686||12686|18959||1|0|G
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1|0|
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1|0|
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|GPA|0|0|1|100|IKR|||lyfalmen|V0362|2728|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|25397|35396|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||25397||25397|35396||1|0|ES
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12073|15938|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||10491||10491|15938||1|0|G
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|8227|12822|lyfalmen|V0515|4432|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||8227||8227|12822||1|0|G
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11422|17219|lyfalmen|V0253|4190|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||11422||11422|17219||1|0|G
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|22167|31310|lyfalmen|V0516|5902|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||22167||22167|31310||1|0|G
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|8578|13305|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8578||8578|13305||1|0|G
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|12667|18933|lyfalmen|V0992|16319|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12667||12667|18933||1|0|G
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6112|9910|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6112||6112|9910||1|0|G
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5731|9386|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5731||5731|9386||1|0|G
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3109|5777|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3109||3109|5777||1|0|G
003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|1|SGB|0|0|0|100|XEU|34101|46405|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||34101||34101|46405||1|H|S
003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|2053|3016|lyfalmen|||2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1103||1103|3016||1|0|G
003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|25399|28602|lyfalmen|||2|500|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||20026||20026|28602||1|0|G
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1085|2741|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||903||903|2741||1|0|E
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2301|3439|lyfalmen|V0322|2858|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||1410||1410|3439||1|0|G
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|18988|27633|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||18988||18988|27633||1|H|S
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7940|12427|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7940||7940|12427||1|0|G
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4324|7449|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4324||4324|7449||1|0|G
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5812|9498|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5812||5812|9498||1|0|G
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PEU|0|0|0|100|DKK|17408|25458|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||17408||17408|25458||1|H|ES
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7719|14815|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||7719||7719|14815||1|0|
004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2073|4351|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2073||2073|4351||1|0|
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2866|2815|lyfalmen|V0494|2815|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||957||957|2815||1|0|G
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2867|4359|lyfalmen|V0318|4359|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2079||2079|4359||1|0|G
004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3061|5711|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||3061||3061|5711||1|0|
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4163|4520|lyfalmen|V0320|3975|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2196||2196|4520||1|0|G
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2012|3629|lyfalmen|V0317|3150|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||1548||1548|3629||1|0|G
004676|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0|
004687|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0|
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|8262|12870|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8262||8262|12870||1|0|G
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|843|2658|lyfalmen|||2|24|0|3,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||843||843|2658||1|0|
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|4224|7312|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4224||4224|7312||1|0|ES
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|358|1991|lyfalmen|||2|8|0|2,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||358||358|1991|30.6.2020|1|0|
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|926|2772|lyfalmen|||2|14|0|3,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||926||926|2772||1|0|
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|1585|3680|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||1585||1585|3680||1|0|
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2584|5055|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2584||2584|5055||1|0|
005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8796|7663|lyfalmen|V0148|4063|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4479||4479|7663||1|0|G
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2560|5022|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2560||2560|5022||1|0|E
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2624|4398|lyfalmen|V0337|4167|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2107||2107|4398||1|0|E
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18334|26733|lyfalmen|V0356|26731|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18334||18334|26733||1|0|G
005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0|
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|51449|66882|lyfalmen|V0451|56657|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||50291||50291|66882||1|0|G
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1795|3969|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1795||1795|3969||1|0|G
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4888|8226|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4888||4888|8226||1|0|G
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4931|8285|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4931||4931|8285||1|0|G
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1672|3799|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1672||1672|3799||2|0|G
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5899|9617|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5899||5899|9617||2|0|G
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4309|7429|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4309||4309|7429||2|0|G
005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MCE|0|0|0|100|SEK|4650|7898|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4650||4650|7898||2|0|G
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5459|9012|lyfalmen|V0324|4186|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5459||5459|9012||1|0|G
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8762|13558|lyfalmen|V0325|5254|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8762||8762|13558||1|0|E
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2754|5289|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2754||2754|5289||2|0|G
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14719|21647|lyfalmen|V0326|6569|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14639||14639|21647||1|0|E
005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RHA|0|0|1|100|IKR|1582|2532|lyfalmen|V0169|2530|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||751||751|2532||2|0|E
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5527|9105|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5527||5527|9105||1|0|G
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|100602|131632|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||100602||100602|131632||1|H|ES
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5278|8763|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5278||5278|8763||1|0|G
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|76858|100484|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||76858||76858|100484||1|H|ES
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3574|6951|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3574|6951||1|0|
006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|448965|564898|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||448965||448965|564898||1|H|L
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|13661|20301|lyfalmen|V0099|10279|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13661||13661|20301||1|0|G
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11829|17779|lyfalmen|V0117|5177|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11829||11829|17779||1|0|E
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16939|24813|lyfalmen|V0118|8414|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16939||16939|24813||1|0|E
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|20141|28748|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20141||20141|28748||1|0|E
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|84315|109915|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||84315||84315|109915||1|0|L
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|215565|274614|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||215565||215565|274614||1|0|L
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2292|4653|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2292||2292|4653||1|0|G
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7437|11734|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||7437||7437|11734||2|0|S
007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|SER|0|0|0|100|XEU|97656|126789|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||97656||97656|126789||3|H|S
007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|23146|32549|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||23146||23146|32549||1|H|S
007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6073|9857|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6073||6073|9857||1|0|G
007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|1|SHG|0|1|0|100|XEU|248219|315226|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||248219|315226||1|H|L
007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4933|8288|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4933||4933|8288||1|0|G
007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|15567|22924|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||15567||15567|22924||1|0|G
007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1703|2796|lyfalmen|V0290|2461|2|60|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||943||943|2796||1|0|G
007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|4013|6285|lyfalm11|V0983|5542|1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||4013||4013|6285||1|0|
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|1382|3400|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1382||1382|3400||1|0|
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|344|1971|lyfalmen|V0502|1060|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||344||344|1971||2|0|G
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|898|2548|lyfalmen|V0226|2255|2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||763||763|2548||1|0|G
008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1053|2947|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||1053||1053|2947||1|0|G
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|0|100|XEU|2863|5045|lyfalmen|V0227|4526|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2577||2577|5045||1|0|G
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4074|6544|lyfalmen|V0228|5352|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3666||3666|6544||1|0|G
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4774|7414|lyfalmen|V0224|6728|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||4298||4298|7414||1|0|G
008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|1|GEB|0|0|0|100|XEU|126940|164389|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||126940||126940|164389||1|H|S
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|7943|13691|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||7943||7943|13691||2|0|
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|11904|22755|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||11904||11904|22755||2|0|
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2756||2|0|G
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2810|5366|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2810||2810|5366||1|0|G
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0|
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|87392|113807|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||87392||87392|113807||2|0|S
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|107578|140308|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||107578||107578|140308||2|0|S
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|7084|11248|lyfalmen|V0145|2105|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||7084|11248||2|0|E
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|14047|20832|lyfalmen|V0145|4210|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||14047|20832||2|0|E
008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0|
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G
009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7859|12315|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7859||7859|12315||2|0|S
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4836|8154|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4836||4836|8154||2|0|G
009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7859|12315|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7859||7859|12315||2|0|S
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|11021|16667|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||11021||11021|16667||1|0|
009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6883|10972|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6883||6883|10972||2|0|S
009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0|
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PEU|0|0|1|100|DKK|21924|31003|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||21924||21924|31003||1|0|ES
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1144|3073|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1144||1144|3073||1|0|G
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1262|3235|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1262||1262|3235||1|0|G
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1459|3506|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1459||1459|3506||1|0|G
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1828|4014|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1828||1828|4014||1|0|G
009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|6442|10365|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6442||6442|10365||2|0|S
009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7583|11935|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7583||7583|11935||2|0|S
009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|6442|10365|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6442||6442|10365||2|0|S
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GII|0|0|0|100|DKK|56674|74955|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||56674||56674|74955||2|0|S
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9416|14458|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9416||9416|14458||1|0|
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10762|16311|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10762||10762|16311||1|0|
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8523|13229|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8523||8523|13229||1|0|
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10762|16311|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10762||10762|16311||1|0|
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8641|13391|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8641||8641|13391||1|0|
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9416|14458|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9416||9416|14458||1|0|
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|1|100|DKK|215323|274313|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||215323||215323|274313||2|0|S
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5952|9690|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5952||5952|9690||1|H|ES
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003|30.06.2020|R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|12529|18743|lyfalmen|||1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||12529||12529|18743||1|0|E
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|16010|23534|lyfalmen|V0605|2737|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||16010||16010|23534||1|0|G
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8071|12607|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8071||8071|12607||1|0|E
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|9239|14214|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||9239||9239|14214||1|H|S
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1219|3176|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1219||1219|3176||2|0|
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|253537|321840|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||253537||253537|321840||3|0|L
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|253537|321840|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||253537||253537|321840||3|0|L
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|710448|890110|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||710448||710448|890110||1|0|ES
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|42252|56714|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||42252||42252|56714||2|H|S
010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2779|2786|lyfalmen|V0058|2786|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||936||936|2786||2|0|G
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|20287|28933|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20287||20287|28933||1|0|E
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|13668|20311|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||13668||13668|20311||1|0|
010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|3820|3235|lyfalmen|V0059|3235|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1262||1262|3235||2|0|G
010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|31164|42690|lyfalmen|V0683|3026|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||31164||31164|42690||1|0|E
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|25180|35121|lyfalmen|V0684|3026|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25180||25180|35121||1|0|G
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3622|6483|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3622||3622|6483||1|0|G
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3749|6658|lyfalmen|V0826|2870|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3749||3749|6658||1|0|G
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16063|23607|lyfalmen|V0327|7213|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||16063||16063|23607||1|0|E
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1180|3122|lyfalmen|V0827|2159|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1180||1180|3122||1|0|G
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2236|2934|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1043||1043|2934|30.6.2020|1|0|G
011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|0|1|MEA|0|0|1|100|SEK|14773|21831|lyfsjukr|||1|10|0|1,6666|Icepharma hf|Meda AB|Ampicillín||14773||14773|21831||2|0|0
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6030|9798|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6030||6030|9798||1|0|G
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5432|8975|lyfalmen|V0691|5952|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5432||5432|8975||1|0|E
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|6948|8413|lyfalmen|V0624|5719|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5024||5024|8413||1|0|E
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1939|3811|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1939||1939|3811||2|0|
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|3819|6754|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3819||3819|6754||1|H|S
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|4492|8693|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4492||4492|8693||2|0|
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3663|5214|lyfalmen|V0323|4166|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||2700||2700|5214||1|0|G
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|3884|6844|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3884||3884|6844||2|H|S
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|2046|4314|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||2046||2046|4314||2|H|S
012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|28349|39129|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||28349||28349|39129||1|0|S
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|3732|6635|lyfalmen|V0909|3118|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3732||3732|6635||1|0|G
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6817|10881|lyfalmen|V0924|4170|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6817||6817|10881||2|0|E
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|9093|10801|lyfalmen|V0622|6564|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6759||6759|10801||1|0|E
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|957|2815|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||957||957|2815||1|0|E
012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4056|6338|lyfalm11|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4056||4056|6338||1|0|
012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|6003|9760|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||6003||6003|9760||1|0|G
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1974|2723|lyfalmen|V0250|2395|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||890||890|2723||2|0|G
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2743|3218|lyfalmen|V0251|3218|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1250||1250|3218||2|0|G
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|6652|9016|lyfalmen|V0959|4870|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5462||5462|9016||1|0|E
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|9582|13329|lyfalmen|V0996|7898|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8596||8596|13329||1|0|E
013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|6222|10062|lyfsjukr|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||6222||6222|10062||2|H|S
013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3018|5652|lyfalmen|V0042|5652|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxazósín||3018||3018|5652||1|0|G
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZE|0|1|0|100|SEK|313283|396148|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitiníb||313283||313283|396148||1|0|L
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|MUP|0|0|0|100|DKK|1281|3261|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1281||1281|3261||2|0|E
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|833|2486|lyfalmen|V0562|2349|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||718||718|2486||2|0|G
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|MUP|0|0|0|100|DKK|2460|4884|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2460||2460|4884||2|0|E
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|376|2015|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||376||376|2015||2|0|
013872|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|10341|15731|lyfalmen|V0215|9858|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10341||10341|15731||1|0|G
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6194|10023|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6194||6194|10023||1|0|G
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2285|4643|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2285||2285|4643||1|0|G
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4653|7902|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4653||4653|7902||1|0|G
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|101743|133051|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||101743||101743|133051||1|0|L
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|202557|258435|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||202557||202557|258435||1|0|L
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2415|4822|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2415||2415|4822||1|0|G
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|GRH|0|0|1|100|DKK|6533|10490|lyfsjukr|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||6533||6533|10490||1|0|ES
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|16339|23987|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16339||16339|23987||1|0|G
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|52018|69066|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||52018||52018|69066||2|0|E
014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1365|3377|lyfalmen|V0479|3064|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1365||1365|3377||1|0|E
014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1770|3934|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1770||1770|3934||1|0|E
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18092|26400|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18092||18092|26400||1|0|G
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|400|1852|lyfalmen|V0563|1759|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||257||257|1852||2|0|G
014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2546|5001|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2546||2546|5001||2|0|
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|77389|101155|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||77389|101155||2|0|S
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|1084|2332|lyfalmen|V0564|2113|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||606||606|2332||2|0|G
014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|944|2797|lyfalmen|V0596|2342|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||944||944|2797||2|0|G
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|19898|28886|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||19898||19898|28886||1|0|G
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0|
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|66521|87409|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||66521||66521|87409||1|0|G
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|44344|59360|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||44344||44344|59360||1|0|G
014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|727390|911181|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||727390||727390|911181||3|0|E
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2646|4161|lyfalmen|V0673|4030|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1935||1935|4161||1|0|G
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7645|12020|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7645||7645|12020||1|0|G
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1097|3008|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1097||1097|3008||1|0|G
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1829|2924|lyfalmen|V0234|1802|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1036||1036|2924||1|0|G
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2611|2924|lyfalmen|V0233|2303|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1036||1036|2924||1|0|G
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8895|13741|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8895||8895|13741||1|0|G
015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|299508|379015|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||299508||299508|379015||3|H|S
015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|79823|104234|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||79823|104234||3|H|S
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|12123|18184|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12123||12123|18184||1|0|G
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|12053|18088|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12053||12053|18088||1|0|G
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10531|15993|lyfalmen|V0829|13781|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10531||10531|15993||1|0|G
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|18445|26886|lyfalmen|V0470|23145|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||18445||18445|26886||1|0|G
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|36846|49876|lyfalmen|V1008|43511|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||36846||36846|49876||1|0|G
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3976|6853|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3976||3976|6853||2|0|
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6112|10535|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||6112||6112|10535||2|0|
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3306|5698|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3306||3306|5698||2|0|
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3355|5783|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3355||3355|5783||2|0|
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5867|10112|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5867||5867|10112||2|0|
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0|
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|ETH|0|0|1|100|GBP|1449|3492|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1449||1449|3492||2|0|E
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3226|5560|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3226||3226|5560||2|0|
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0|
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|1633|3746|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1633||1633|3746||1|0|E
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|1|100|GBP|1034|2921|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1034||1034|2921|31.7.2020|2|0|
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|2504|4944|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2504||2504|4944||1|0|E
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|5317|8816|lyfalmen|V0686|2033|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||5317||5317|8816||1|0|E
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|9377|14404|lyfalmen|V0687|2766|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||9377||9377|14404||1|0|E
016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|5157|8596|lyfalmen|||2|1000|0|1000,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||5157||5157|8596||1|0|G
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|1646|3763|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1646||1646|3763||1|0|E
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|11812|17756|lyfalmen|V0689|3059|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||11812||11812|17756||1|0|E
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PEU|0|0|1|100|DKK|94400|122671|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||94400||94400|122671||1|0|ES
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3292|6029|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3292||3292|6029||1|H|S
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|2410|4815|lyfalmen|V0685|2190|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2410||2410|4815||1|0|E
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|16628|24385|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||16628||16628|24385||1|0|E
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||8403||1|0|E
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|27459|38004|lyfalmen|V0682|3026|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||27459||27459|38004||1|0|E
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|7919|10694|lyfalmen|V0960|6040|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6681||6681|10694||1|0|E
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2998|5624|lyfalmen|V0240|5624|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2998||2998|5624||3|0|G
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5702|9346|lyfalmen|V0433|9346|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5702||5702|9346||3|0|G
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|51820|68816|lyfalmen|V0721|7689|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||51820||51820|68816||1|0|
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|76345|99835|lyfalmen|V0722|17168|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||76345||76345|99835||1|0|
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|28383|39172|lyfalmen|V0720|6743|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28383||28383|39172||1|0|
016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|65392|85981|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||65392||65392|85981||1|H|L
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1580|3673|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1580|3673||1|0|E
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GEI|0|0|0|100|DKK|32339|44176|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||32339||32339|44176||2|0|S
016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|2082|4364|lyfalmen|V0943|2957|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||2082||2082|4364||2|0|G
017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1048|2632|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1048||1048|2632||1|0|G
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|6536|10494|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||6536||6536|10494||1|0|
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|7183|11385|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||7183||7183|11385||1|0|
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|91212|118639|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||91212||91212|118639||2|0|S
017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|3734|6637|lyfalmen|V0944|3501|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3734||3734|6637||2|0|G
017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|6652|10654|lyfalmen|V0945|6262|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6652||6652|10654||2|0|G
017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|1|100|DKK|7731|12139|lyfsjukr|||1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7731||7731|12139||1|0|S
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2738|5267|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2738||2738|5267||2|0|G
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6771|13016|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6771||6771|13016||1|0|
017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0|
017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0|
017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0|
017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2007|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0|
017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0|
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8970|13844|lyfalmen|V0107|2461|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8970||8970|13844||1|0|0
018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1544|2461|lyfalmen|V0946|2461|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||700||700|2461||2|0|G
018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2107|3287|lyfalmen|V0947|3287|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1300||1300|3287||2|0|G
018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2975|3563|lyfalmen|V0948|3563|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|881|2340|lyfalmen|V0243|2134|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||612||612|2340||1|0|G
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6679|10691|lyfalmen|V0985|5792|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6679||6679|10691||1|0|G
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|18669|27194|lyfalmen|V0441|12497|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||18669||18669|27194||1|0|G
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MEC|0|0|1|100|SEK|1150|3081|lyfalmen|V0414|3081|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1150||1150|3081||2|0|G
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5569|9163|lyfalmen|V0438|3787|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5569||5569|9163||1|0|G
018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|4856|8182|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4856||4856|8182||1|0|E
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14084|20883|lyfalmen|V0440|9648|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14084||14084|20883||1|0|G
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|32345|44184|lyfalmen|V0111|6701|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||32345||32345|44184||1|0|E
018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|59063|77976|lyfsjukr|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||59063||59063|77976||2|H|S
018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|782|2574|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||782||782|2574||1|0|E
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TGH|0|0|0|100|NOK|80589|105203|lyfsjukr|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Glatíramer acetat||80589||80589|105203||1|0|ES
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|949|1865|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|Lídókaín í blöndum||949||949|1865||2|0|
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5738|9396|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5738||5738|9396||2|H|S
019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|180799|221895|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||173177||173177|221895||2|H|L
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17442|25505|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||17442||17442|25505||2|H|S
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20861|29659|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||20861||20861|29659||2|H|S
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18757|27315|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18757||18757|27315||2|H|S
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25243|35201|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||25243||25243|35201||2|H|S
019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|90399|112790|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||86588||86588|112790||2|H|L
019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|45199|58032|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||43294||43294|58032||2|H|L
019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|22600|30653|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||21647||21647|30653||2|H|L
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|6393|12299|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||6393||6393|12299||1|0|
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|491|2009|lyfalmen|V0633|2009|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||371||371|2009||1|0|G
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|32960|62702|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||32960||32960|62702||1|0|
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6666|10673|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6666||6666|10673||2|0|E
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|49603|66011|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||49603||49603|66011||2|H|L
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6226|10067|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6226||6226|10067||2|0|E
019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014|31.07.2020|R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|938|2658|lyfalmen|||2|100|0|200,0000|Alvogen|ratiopharm GmbH|Ramipríl||843||843|2658||2|0|G
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|187814|240099|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||187814||187814|240099||2|H|L
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|965|2490|lyfalmen|V0159|2369|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||721||721|2490||2|0|E
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|166537|213637|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||166537||166537|213637||2|H|L
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|13017|19415|lyfalmen|V0812|4224|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13017||13017|19415||2|0|E
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|13017|19415|lyfalmen|V0813|4224|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13017||13017|19415||2|0|E
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|12295|18421|lyfalmen|V0814|4224|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12295||12295|18421||2|0|E
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|12295|18421|lyfalmen|V0815|4224|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12295||12295|18421||2|0|E
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|12295|18421|lyfalmen|V0816|4224|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12295||12295|18421||2|0|E
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|0|1|0|1|VIC|0|0|0|100|DKK|61939|81614|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||61939||61939|81614||1|0|S
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1199|2914|lyfalmen|V0160|2914|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1029||1029|2914||2|0|E
019969|N06AB0405|Citalopram PCD|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|4359|2|100|0|100,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||2600||2600|5077||2|0|G
020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|4500|3975|lyfalmen|V0320|3975|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1800||1800|3975||2|0|G
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0|
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0|
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|31966|43704|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||31966||31966|43704||1|0|
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2025|4285|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2025||2025|4285|31.8.2020|3|0|E
020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|RPR|0|0|0|100|XEU|98152|127416|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||98152||98152|127416||0|0|S
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0|
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|49105|65382|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||49105||49105|65382||1|0|G
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|22754|32053|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||22754||22754|32053||1|0|G
020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|6632|4742|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||2357||2357|4742||2|0|G
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|BOA|0|0|0|100|XEU|2241|3863|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2241||2241|3863||1|0|
020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCC|0|0|0|100|DKK|50259|66841|lyfalmen|||1|180|0||Vistor hf|UCB Pharma S.A.|sodium oxybate||||50259|66841||1|0|E
020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2621|4518|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||2621||2621|4518||2|0|
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2531|4982|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2531||2531|4982||2|0|
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|2048|4317|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2048||2048|4317||2|0|
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|633|2369|lyfalmen|V0188|2048|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||633||633|2369||1|0|G
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|1424|2854|lyfalmen|V0189|2461|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||985||985|2854||1|0|G
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12905|19260|lyfalmen|V0490|9353|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||12905||12905|19260||1|0|G
021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0|
021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|33258|45338|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||33258||33258|45338||3|0|G
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005|30.06.2020|R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1578|3670|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1578||1578|3670||1|H|S
021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|60936|80345|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||60936||60936|80345||3|0|G
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3733|6636|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3733||3733|6636||1|0|G
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13479|20050|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13479||13479|20050||1|0|G
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12543|18762|lyfalmen|V0214|4543|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12543||12543|18762||1|0|E
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6730|10761|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6730||6730|10761||1|0|G
021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|14805|21876|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14805||14805|21876||1|0|G
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15938|23435|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||15938||15938|23435||1|H|S
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|18911|27527|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||18911||18911|27527||1|0|G
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005|31.08.2020|R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15129|22321|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||15129||15129|22321||1|H|S
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24533|34303|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24533||24533|34303||1|0|G
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|9164|14111|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||9164||9164|14111||1|H|S
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|4386|7535|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4386||4386|7535||1|0|S
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19641|28532|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19641||19641|28532||1|0|G
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|3422|6208|lyfalmen|V0692|2320|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3422||3422|6208||2|0|E
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4809|8117|lyfalmen|V0693|3261|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4809||4809|8117||2|0|E
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|12561|18787|lyfalmen|V0694|4076|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||12561||12561|18787||2|0|E
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SCL|0|0|0|100|DKK|26006|36166|lyfsjukr|||1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||26006||26006|36166||1|0|ES
022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|1|100|XEU|2787|5334|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2787||2787|5334||2|0|ES
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|107251|139901|lyfsjukr|||1|1200|0||Shire Sweden AB |Baxalta Innovations GmbH|albumin||107251||107251|139901||2|H|S
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|4492|7681|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4492||4492|7681||1|0|G
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|15750|23176|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||15750||15750|23176||1|0|
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2289|3945|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2289||2289|3945||2|0|
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3833|3261|lyfalmen|V0056|2393|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1281||1281|3261||1|0|G
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6796|4281|lyfalmen|V0057|2317|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2022||2022|4281||1|0|G
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2167|3735|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2167||2167|3735||2|0|
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1403|2418|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||1403||1403|2418||2|0|
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2020|4117|lyfalmen|V0321|4117|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1903||1903|4117||1|0|G
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4299||2|0|G
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|2200|4526|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2200||2200|4526||1|0|G
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|3401|5138|lyfalmen|V0125|3467|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2645||2645|5138||1|0|G
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|67411|88535|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||67411||67411|88535||2|0|S
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SCL|0|0|0|100|DKK|24188|33867|lyfalmen|||1|90|0|20,0000|Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||24188||24188|33867||1|0|
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SCL|0|0|0|100|DKK|37112|50213|lyfalmen|||1|90|0|30,0000|Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||37112||37112|50213||1|0|
023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|3000|4320|lyfalmen|V0125|3467|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||2050||2050|4320||2|0|G
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|13663|20304|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||13663||13663|20304||1|0|G
023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|5231|6935|lyfalmen|V0125|6935|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||3950||3950|6935||2|0|G
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|16180|23768|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||16180||16180|23768||1|0|G
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2360|3106|lyfalmen|V0250|2395|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1168||1168|3106||2|0|G
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3046|3575|lyfalmen|V0251|3218|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1509||1509|3575||2|0|G
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SGB|0|0|0|100|XEU|17371|25407|lyfalmen|V0029|6033|1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||17371||17371|25407||1|0|G
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2069|4346|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2069||2069|4346||2|0|G
023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|124819|161751|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||124819||124819|161751||2|H|S
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2737|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2361|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G
023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G
023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2327|4030|lyfalmen|V0673|4030|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1840||1840|4030||2|0|G
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|UPJ|0|0|0|100|DKK|27730|38347|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||27730||27730|38347||1|0|ES
023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|4251|lyfalmen|V0007|4251|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2000||2000|4251||2|0|G
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2452|4873|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2452||2452|4873||1|0|G
024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|62830|82741|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||62830||62830|82741||3|0|E
024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24533|34303|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24533||24533|34303||1|0|G
024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2916|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7723|12128|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7723||7723|12128||1|0|
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7723|12128|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7723||7723|12128||1|0|
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5569|9163|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5569||5569|9163||1|0|
024603|V04CL0001|Soluprick  Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1586|3681|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1586||1586|3681||1|0|
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5569|9163|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5569||5569|9163||1|0|
024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7723|12128|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7723||7723|12128||1|0|
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7723|12128|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7723||7723|12128||1|0|
024681|V04CL0002|Soluprick  Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1586|3681|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1586||1586|3681||1|0|
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19641|28532|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19641||19641|28532||1|0|G
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|57384|75853|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||57384||57384|75853||1|0|L
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9733|18636|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9733||9733|18636||1|0|
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|15259|22500|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15259||15259|22500||1|0|E
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATP|0|0|0|100|DKK|5329|8833|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||5329||5329|8833||2|0|E
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATP|0|0|0|100|DKK|14282|21156|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14282||14282|21156||2|0|E
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|44268|59264|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||44268||44268|59264||1|0|E
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|6301|10171|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||6301||6301|10171||2|H|S
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24533|34303|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24533||24533|34303||1|0|G
025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|1021|2815|lyfalmen|V0597|2815|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||957||957|2815||2|0|G
025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|3421|5584|lyfalmen|V0598|5560|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||2969||2969|5584||2|0|G
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|52412|69564|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||52412|69564||2|0|L
025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|28966|39910|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||28966||28966|39910||1|0|
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|BOA|0|0|0|100|XEU|3945|6800|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||3945||3945|6800||1|0|
025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|93401|98524|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||75309||75309|98524||2|0|S
025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0|
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2222|4367|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2222||2222|4367||1|0|
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|BOA|0|0|0|100|XEU|9413|16224|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||9413||9413|16224||1|0|
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|43739|58595|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||43739||43739|58595||1|0|G
026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010|31.08.2020|R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|36138|48981|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||36138||36138|48981||1|H|S
026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010|31.08.2020|R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|180692|231241|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||180692||180692|231241||1|H|S
026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|0|1|G|0|SHS|0|0|0|100|DKK|16932|24803|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||16932||16932|24803||1|0|G
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1846|4039|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1846|4039||1|0|G
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|7286|11526|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||7286|11526||1|0|G
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3646|6516|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3646|6516||1|0|G
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|14229|21083|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||14229|21083||1|0|G
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|21241|30139|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||21241|30139||1|0|G
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|28195|38935|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||28195|38935||1|0|G
026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0|
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|6532|10489|lyfalmen|V0099|10489|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||6532||6532|10489||2|0|G
027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E
027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|18049|26341|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18049||18049|26341||1|0|G
027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3563|lyfalmen|V0823|3539|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1500||1500|3563||2|0|G
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|752|2533|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||752||752|2533||2|0|
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1975|4216|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||1975||1975|4216||1|0|G
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|13418|11657|lyfalmen|||2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||7381||7381|11657||1|0|G
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|12919|11657|lyfalmen|V0342|11657|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||7381||7381|11657||1|0|G
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|2484|4917|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2484||2484|4917||2|0|S
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|6386|10288|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||6386||6386|10288||1|0|G
027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|4197|6262|lyfalmen|V0945|6262|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||3461||3461|6262||2|0|G
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|613|2342|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||613||613|2342||1|0|G
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|706|2470|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||706||706|2470||1|0|G
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|20828|29617|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20828||20828|29617||1|0|E
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|23950|33566|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||23950|33566||2|H|S
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|23620|33148|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||23620||23620|33148||1|0|E
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|29433|40500|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29433||29433|40500||2|H|S
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|40564|54579|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||40564|54579||2|H|S
028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4362|6715|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4362||4362|6715||2|0|
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|18002|26276|lyfalmen|V0387|26276|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||18002||18002|26276||1|0|G
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0|
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17507|25595|lyfalmen|V0386|25595|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||17507||17507|25595||1|0|G
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|50121|66667|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||50121||50121|66667||1|0|L
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2671|5174|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir  mótefnavakar||2671||2671|5174||1|0|
028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020||R|0|0|0|0|0|0|SPU|0|0|0|100|XEU|4291|7404|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||4291||4291|7404||1|0|
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|42913|57550|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||42913|57550||1|0|
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1649|3768|lyfalmen|V0202|3768|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1649||1649|3768||2|0|G
028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|632|2368|lyfalmen|V0266|2368|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||632||632|2368||2|0|G
028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|2582|3975|lyfalmen|V0267|3975|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||1800||1800|3975||2|0|G
028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|6182|5243|lyfalmen|V0245|4879|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2721||2721|5243||1|0|G
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|11646|11700|lyfalmen|V0232|10279|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||7412||7412|11700||1|0|G
028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|809|2602|lyfalmen|V0266|2368|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||802||802|2602||2|0|G
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|8077|15494|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||8077||8077|15494||2|0|
028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3031|4530|lyfalmen|V0267|3975|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2203||2203|4530||2|0|G
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GCA|0|0|1|100|DKK|1227|3057|lyfalmen|V0625|2079|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1133||1133|3057||1|0|G
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5664|9294|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5664||5664|9294||2|0|
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|16673|24447|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||16673||16673|24447||2|0|
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0
029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35827|48588|lyfalmen|V0802|48588|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35827||35827|48588||2|0|E
029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35827|48588|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35827||35827|48588||2|0|E
029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35827|48588|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35827||35827|48588||2|0|E
029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|11923|17909|lyfalmen|V0801|16171|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||11923||11923|17909||2|0|E
029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0|
029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35768|48513|lyfalmen|V0801|48513|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35768||35768|48513||2|0|E
029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|11943|17936|lyfalmen|V0802|16196|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||11943||11943|17936||2|0|E
029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35827|48588|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35827||35827|48588||2|0|E
029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KWA|0|0|0|100|DKK|35827|48588|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||35827||35827|48588||2|0|E
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|1|EIG|0|1|0|100|SEK|51034|67821|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||51034||51034|67821||1|H|L
029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|10879|16472|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||10879|16472||1|H|S
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|5895|9612|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5895||5895|9612||2|0|E
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0|
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2735|lyfalmen|V0168|2735|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||899||899|2735||2|0|E
030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PEU|0|0|0|100|DKK|8341|12978|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8341||8341|12978||1|0|
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|16720|28819|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||16720||16720|28819||2|0|
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2786|5333|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2786||2786|5333||2|0|G
031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2564|5027|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2564||2564|5027||2|0|G
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5830|9522|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5830||5830|9522||1|0|G
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19490|28324|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19490||19490|28324||1|H|S
032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|RET|0|0|0|100|IKR|8875|13713|lyfalmen|V0969|12927|2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||8875||8875|13713||2|0|
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OPC|0|0|0|100|DKK|21475|30435|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21475||21475|30435||1|0|G
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|BOA|1|0|0|100|XEU|14846|25589|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||14846||14846|25589||1|0|
032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013|30.06.2020|R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G
032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2806|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|22673|31950|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||22673||22673|31950||1|0|G
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|41396|55631|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||41396|55631||1|0|G
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|BRO|0|0|0|100|XEU|1246|2148|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1246||1246|2148||2|0|
033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|3137|5816|lyfalmen|V1004|4821|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||3137||3137|5816||2|0|E
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9329|17869|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9329|17869||2|0|
033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|10689|16210|lyfalmen|V1005|14155|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||10689||10689|16210||2|0|E
033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|6278|10139|lyfalmen|V1006|8493|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6278||6278|10139||2|0|E
033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|18529|27001|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||18529||18529|27001||2|0|E
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1438|3477|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1438||1438|3477||1|0|G
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1517|2883|lyfalmen|V0189|2461|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||1006||1006|2883||2|0|G
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|674|2426|lyfalmen|V0188|2048|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||674||674|2426||2|0|G
033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|9055|13961|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9055||9055|13961||2|0|G
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|16694|24476|lyfalmen|V0185|18732|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||16694||16694|24476||2|0|G
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|81644|106537|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||81644||81644|106537||1|0|S
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2525|4961|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2525|4961||2|0|
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|XEU|2146|3112|lyfalmen|V0098|2488|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||1173||1173|3112||2|0|G
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|24602|34390|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24602||24602|34390||2|H|L
034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|4235|4639|lyfalmen|V0323|4251|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2282||2282|4639||1|0|G
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|HEA|0|0|1|100|SEK|1115|3033|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1115||1115|3033||1|0|G
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|HEA|0|0|1|100|SEK|2606|5085|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2606||2606|5085||1|0|G
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|1|100|DKK|7202|11411|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7202||7202|11411||1|0|S
035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2066|4342|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||2066||2066|4342||1|H|S
035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|2543|4998|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||2543|4998||1|0|G
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|15882|23358|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15882||15882|23358||1|0|G
035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1119|2522|lyfalmen|V0050|2461|2|100|0|15,8333|Alvogen|ratiopharm GmbH|Metóprólól||744||744|2522||2|0|G
035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|652|2395|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||652||652|2395||1|0|E
035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1359|2854|lyfalmen|V0048|2737|2|100|0|31,6667|Alvogen|ratiopharm GmbH|Metóprólól||985||985|2854||2|0|G
035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2943|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G
035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|3975|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G
035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3017|3454|lyfalmen|V0233|3454|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1421||1421|3454||1|0|G
035802|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11886|17858|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11886|17858||1|0|E
035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GEB|0|0|0|100|XEU|24864|34722|lyfalmen|V0680|16914|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||24864||24864|34722||1|0|
036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|8461|13144|lyfalmen|V0806|9749|1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8461|13144||2|0|G
036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0
036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G
036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1527|3600|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1527|3600||1|0|G
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|756|2538|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||756||756|2538||2|0|E
036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|17201|25173|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17201||17201|25173||1|0|G
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1458|2513|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1458||1458|2513||1|0|
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0|
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|2625|5111|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2625||2625|5111||2|0|E
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|795|2592|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||795||795|2592||2|0|E
036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G
037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|6849|7816|lyfalmen|V0532|7251|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4590||4590|7816||1|0|G
037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|12808|10961|lyfalmen|||1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6875||6875|10961||1|0|G
037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|17706|20542|lyfalmen|||1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||13836||13836|20542||1|0|G
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2527|4976|lyfalmen|V0434|4876|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2527||2527|4976||2|0|G
037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3533|3975|lyfalmen|V0054|3975|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1800||1800|3975||2|0|G
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2804||2|0|G
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||4237||2|0|G
038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0|
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|3556|4421|lyfalmen|V0321|4117|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||2124||2124|4421||1|0|G
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1740|2856|lyfalmen|V0110|2730|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||987||987|2856||1|0|G
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|14635|21642|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||14635|21642||2|0|G
039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|1|PEU|0|1|0|100|DKK|231731|294720|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||231731||231731|294720||1|H|L
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|29206|40213|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||29206||29206|40213||2|0|S
039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|12608|17680|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||11757||11757|17680||1|0|G
039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1652|3772|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1652||1652|3772||2|0|G
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|5832|9525|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5832||5832|9525||1|0|
039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|3804|6734|lyfalmen|V0706|6734|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3804||3804|6734||3|0|G
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGB|0|0|0|100|XEU|19137|27838|lyfalmen|V1027|19253|1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||19137||19137|27838||1|0|E
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3091|5752|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3091||3091|5752||2|0|G
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1121|3041|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1121||1121|3041||2|0|G
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1123|2847|lyfalmen|V0542|2263|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||980||980|2847||2|0|G
039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|747|2526|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||747||747|2526||1|0|E
039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1573|3663|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1573||1573|3663||1|0|E
039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|765466|958537|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||765466||765466|958537||2|0|L
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0|
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2138|2675|lyfalmen|V0110|2675|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||855||855|2675||1|0|G
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|6752|4432|lyfalmen|V0182|4365|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||2132||2132|4432||1|0|G
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010|30.06.2020|R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|1748|2448|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||690||690|2448||1|0|G
040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|1|0|G|0|KAN|0|0|0|100|IKR|2200|4526|lyfalmen|V0227|4526|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2200||2200|4526||2|0|G
040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2885|5469|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2885||2885|5469||2|0|G
040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E
040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|237341|301697|lyfsjukr|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||237341||237341|301697||2|0|ES
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|8476|13164|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8476||8476|13164||2|0|E
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|8390|13046|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8390||8390|13046|30.6.2020|2|0|E
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4118|7098|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4118||4118|7098||1|0|
041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|5159|3026|lyfalmen|V0682|3026|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1381|3399|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1381||1381|3399||2|0|G
041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G
041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7161|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0|
042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|0|G|0|TEE|0|0|0|100|XEU|1250|3218|lyfalmen|V0449|2943|2|100|0|200,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Enalapríl||1250||1250|3218||1|0|G
042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|6000|9619|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5900||5900|9619||2|0|E
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2442|4859|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2442||2442|4859||1|0|S
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3609|6465|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3609||3609|6465||1|0|S
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2179|4497|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2179||2179|4497||1|0|S
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|2104|4394|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2104||2104|4394||1|0|S
042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|13501|19830|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||13319||13319|19830||1|0|G
042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2321|4693|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2321||2321|4693||1|0|
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2047|4315|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2047||2047|4315||1|0|S
042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7017|5604|lyfalmen|V0811|5604|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||2983||2983|5604||1|0|E
042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1430|3466|lyfalmen|V0560|3466|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1430||1430|3466||2|0|
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|535|2234|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||535||535|2234||1|0|
043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5436|5783|lyfalmen|V0624|5719|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3113||3113|5783||1|0|E
044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|0|BBB|0|0|1|100|DKK|744|2522|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||744||744|2522||1|0|
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|13415|19962|lyfalmen|V0637|19962|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||13415||13415|19962||3|0|G
044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|0|1|ZAA|0|0|0|100|DKK|14193|21033|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||14193||14193|21033||2|H|S
044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8866|8380|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||5000||5000|8380||2|0|
044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|5306|8801|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||5306||5306|8801||1|0|G
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|348070|439413|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||348070||348070|439413||1|0|L
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|487426|612733|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||487426||487426|612733||1|0|L
044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5418|8955|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5418||5418|8955||2|0|G
045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0|
045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|7480|11793|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7480||7480|11793||1|0|G
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1377|2457|lyfalmen|V0109|2355|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||697||697|2457||1|0|G
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1138|2383|lyfalmen|V0108|2213|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||643||643|2383||1|0|G
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|1|100|DKK|1782|3951|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1782|3951||2|0|ES
045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016|31.07.2020|R|0|0|0|0|0|1|VIN|0|0|1|100|DKK|2791|5339|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2791|5339||2|0|ES
045634|N02AJ0603|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AJ06|01.01.2011|31.08.2020|R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|384|2026|lyfalmen|||2|10|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Kódein og Paracetamól||384||384|2026||1|0|E
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|GRP|0|0|0|100|SEK|3961|4149|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||1926||1926|4149||1|0|G
046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|0|1|OBV|0|0|0|100|NOK|180538|231050|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||180538||180538|231050||2|H|S
046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|2075|3975|lyfalmen|V0429|3975|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||1800||1800|3975||2|0|G
046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|10582|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0|
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1442|3483|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1442|3483||1|0|G
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|915|2757|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||915||915|2757||1|0|G
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|528|2145|lyfalmen|V0021|2037|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||470||470|2145||1|0|G
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|812|2474|lyfalmen|V0022|2353|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||709||709|2474||1|0|G
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1041|2745|lyfalmen|V0023|2610|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||906||906|2745||1|0|G
046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSA|0|0|1|100|IKR|1264|2599|lyfalmen|V0625|2599|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||800||800|2599||2|0|G
046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G
047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0
047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|3199|4778|lyfalmen|V1010|3611|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2383||2383|4778||2|0|G
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|893|2727|lyfalmen|V1026|2727|2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||893||893|2727||2|0|G
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19925|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19925||5|H|S
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63421|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63421||5|H|S
047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|0|1|VAL|0|0|1|100|XEU|39949|53801|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||39949||39949|53801||2|0|S
048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|4517|7715|lyfsjukr|||1|250|0||Shire Sweden AB |Baxalta Innovations GmbH|albumin||4517||4517|7715||2|H|S
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|8174|12749|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||8174||8174|12749||1|0|S
048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|7327|11583|lyfsjukr|||1|100|0||Shire Sweden AB |Baxalta Innovations GmbH|albumin||7327||7327|11583||2|H|S
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1953|4186|lyfalmen|V0324|4186|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1953||1953|4186||1|0|G
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1148|3078|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1148||1148|3078||1|0|E
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2729|5254|lyfalmen|V0325|5254|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2729||2729|5254||1|0|G
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3684|6569|lyfalmen|V0326|6569|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3684||3684|6569||1|0|G
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5718|7213|lyfalmen|V0327|7213|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4152||4152|7213||1|0|G
048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|5628|7981|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4710||4710|7981||2|0|G
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1157|3090|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||1157||1157|3090||2|0|G
048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1821|3585|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1821||1821|3585||1|0|
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|1|GEB|0|1|0|100|XEU|873830|1093311|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||873830||873830|1093311||1|H|L
048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GCA|0|0|1|100|DKK|416|2071|lyfalmen|V0230|2071|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||416||416|2071||1|0|E
048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|3959|6947|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3959||3959|6947||2|H|S
048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|TMA|0|1|0|100|DKK|38549|52030|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||38549||38549|52030||3|0|L
048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4659|4226|lyfalmen|V0148|4063|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1982||1982|4226||2|0|G
049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4573|4263|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||2009||2009|4263||1|0|G
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|5384|8908|lyfalmen|V0376|5282|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5384|8908||1|0|G
049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|RRD|0|0|0|100|DKK|294806|373167|lyfsjukr|||1|1|0|16,6700|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||294806||294806|373167||1|0|ES
049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|928|2775|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||928||928|2775||1|0|G
049536|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8063|12596|lyfalmen|V0080|6487|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8063||8063|12596||1|0|G
049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|5401|8932|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5401||5401|8932||1|0|G
049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2470|2355|lyfalmen|V0109|2355|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||623||623|2355||2|0|G
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|946|2800|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||946||946|2800||1|0|G
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1849|4043|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1849||1849|4043||1|0|G
049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1938||1|0|E
049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|WPA|0|0|0|100|DKK|76490|100018|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||76490||76490|100018||1|0|E
049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0|
049942|B03BB0108|Folsyra Evolan|töflur|5|mg|100|stk|1|þpakki||B03BB01|01.10.2018||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|2000|4251|lyfalmen|||2|100|0|1250,0000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2000||2000|4251|31.8.2020|2|0|G
049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|0|1|0|1|MBV|0|1|0|100|DKK|1140764|1425302|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1140764||1140764|1425302||1|0|L
050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|6728|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E
050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4218||1|0|G
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|7610|11972|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||7610||7610|11972||2|0|G
050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|67211|88282|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||67211|88282||1|0|L
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1|0|
050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|11516|17349|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||11516||11516|17349||1|0|E
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5590|5768|lyfalmen|V0042|5652|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3102||3102|5768|||0|G
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|0|AGH|0|0|1|100|IKR|4615|6816|lyfalmen|V0002|6816|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3864||3864|6816||1|0|0
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||600||600|2324||1|0|G
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1000||1000|2874||1|0|G
051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0|
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1106|2792|lyfalmen|V0363|2792|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||940||940|2792||2|0|G
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3401|5177|lyfalmen|V0365|5177|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2673||2673|5177||2|0|G
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|17443|25506|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17443||17443|25506||1|H|S
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|187|1755|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||187||187|1755||2|0|
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|442|2106|lyfalmen|V0305|1178|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||442||442|2106||2|0|
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|280|1883|lyfalmen|V0439|1883|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||280||280|1883||2|0|0
052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0|
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|645|2386|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||645||645|2386||2|0|
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|623|2355|lyfalmen|V0305|2355|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||623||623|2355||2|0|
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|589133|739228|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||589133||589133|739228||1|0|L
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|AGC|0|0|0|100|XEU|3429|6218|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3429||3429|6218||1|0|G
052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|0|G|0|TIC|0|0|0|100|XEU|8260|12867|lyfalmen|||1|9|0|180,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||8260||8260|12867||1|0|G
052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4715|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|31186|42718|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||31186||31186|42718||1|0|S
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25354|35341|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||25354||25354|35341||1|0|S
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|26066|36242|lyfsjukr|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||26066||26066|36242||2|0|S
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22855|32181|lyfsjukr|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||22855||22855|32181||2|0|S
052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|1|0|G|0|POF|0|0|0|100|XEU|1825|4010|lyfalmen|V0222|4010|2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||1825||1825|4010||2|0|G
052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3026|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G
052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|11704|5528|lyfalmen|V0815|4224|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2928||2928|5528||1|0|0
052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|15235|22467|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||15235||15235|22467||1|0|E
053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983|31.08.2020|R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|4900|8242|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4900||4900|8242||1|0|G
053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|36728|49727|lyfalmen|V1007|44136|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||36728||36728|49727||2|0|E
053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|6149|9961|lyfalmen|V1003|8764|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6149||6149|9961||2|0|E
053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|MUP|0|0|0|100|DKK|1803|3969|lyfalmen|V1002|3334|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1795||1795|3969||2|0|E
053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|6489|8242|lyfalmen|V0115|8242|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4900||4900|8242||2|0|E
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDH|0|0|0|100|XEU|26941|37349|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||26941||26941|37349||1|0|G
053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|0|ATP|0|0|0|100|DKK|14404|21324|lyfalmen|V0957|16820|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14404||14404|21324||2|0|E
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|ETH|0|0|0|100|GBP|10864|16451|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||10864||10864|16451||2|0|
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|1520|3590|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1520||1520|3590||1|0|E
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0|
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|KAR|0|0|1|100|DKK|2040|4306|lyfalmen|||1|15|0|10,0000|Vistor hf|Karo Pharma AB|Pívmecillínam||2040||2040|4306||2|0|E
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|KAR|0|0|1|100|DKK|2727|5251|lyfalmen|||1|20|0|13,3300|Vistor hf|Karo Pharma AB|Pívmecillínam||2727||2727|5251||2|0|E
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0|
054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|1161|3096|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1161||1161|3096||1|0|
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|1|100|SEK|1142|3070|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1142||1142|3070||1|0|
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1554|3637|lyfalmen|V0061|3637|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1554||1554|3637||1|0|E
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|5736|11053|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5736||5736|11053||2|0|
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|11377|17157|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||11377||11377|17157||2|0|G
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|7059|5886|lyfalmen|V0187|5886|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||3188||3188|5886||2|0|G
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|2103|4392|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||2103|4392||1|0|
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|9487|14556|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9487||9487|14556||1|0|G
055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2861|lyfalmen|V0334|2861|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|1928|3736|lyfalmen|V0467|2772|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1626||1626|3736||1|0|E
055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G
055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2664|5165|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2664||2664|5165||1|0|G
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2685|3044|lyfalmen|V0112|2806|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1123||1123|3044||1|0|G
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4083|3320|lyfalmen|V0113|2806|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1324||1324|3320||1|0|G
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5931|3320|lyfalmen|V0114|2806|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1324||1324|3320||1|0|G
056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|1118292|1397353|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1118292||1118292|1397353||2|H|0
056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BNB|0|0|0|100|XEU|24369|34096|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||24369||24369|34096||2|0|E
056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0098|2737|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||900||900|2737||2|0|G
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|27756|47840|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27756||27756|47840||2|0|
056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|3466|6269|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3466||3466|6269||1|0|G
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1492|3552|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1492||1492|3552||2|0|E
056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|0|1|G|0|SHS|0|0|0|100|DKK|48645|64800|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||48645||48645|64800||1|0|G
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|1|BNB|0|1|0|100|XEU|221304|281751|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||221304||221304|281751||2|H|L
057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0|
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3499|6314|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3499||3499|6314||2|0|S
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3647|6518|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3647||3647|6518||1|0|S
057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2601|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G
057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2601|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2541|4995|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2541||2541|4995||1|0|S
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10773|2840|lyfalmen|V0607|2737|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||975||975|2840||2|0|G
057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|95243|123737|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||95243|123737||2|0|L
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|20753|29522|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||20753|29522||1|0|
058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|5008|8315|lyfalmen|V0585|8315|2|100|0|26,6666|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4953||4953|8315||1|0|G
058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|RRD|0|0|0|100|DKK|376692|475011|lyfsjukr|||1|1|0|33,3300|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||376692||376692|475011||1|0|ES
058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|166759|287426|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||166759|287426||2|0|
058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|253323|436628|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||253323|436628||2|0|
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|2203|4530|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2203||2203|4530||2|0|E
058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|33847|46083|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||33847||33847|46083||1|0|E
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5143|8577|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5143||5143|8577||2|0|S
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1231|3192|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1231||1231|3192||1|0|G
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1772|3937|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1772||1772|3937||1|0|G
059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|0|KWA|0|0|0|100|XEU|12422|18596|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||12422||12422|18596||2|0|0
059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||900||900|2737||1|0|G
059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|0|1|AZE|0|1|0|100|SEK|464824|584622|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||464824|584622||1|H|L
059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|1|HBP|0|0|0|100|DKK|11635|17512|lyfsjukr|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11635||11635|17512||3|H|
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|96833|125748|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||96833||96833|125748||1|0|G
059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|60712|80062|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||60712||60712|80062||1|H|ES
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|25593|35644|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||25593||25593|35644||1|0|G
059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4752|8039|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4752|8039||2|0|G
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|9195|14154|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||9195||9195|14154||1|0|E
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|45977|61425|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||45977||45977|61425||1|0|E
059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|3338|6092|lyfsjukr|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3338||3338|6092||2|0|ES
060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|2097|4384|lyfalmen|V0219|4007|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||2097||2097|4384||2|0|G
060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|3664|6372|lyfalmen|V0220|6372|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||3541||3541|6372||2|0|G
060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|5417|8713|lyfalmen|V0221|8712|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||5242||5242|8713||2|0|G
060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|5800|9319|lyfalmen|V0223|8639|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||5682||5682|9319||2|0|G
060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|22406|31613|lyfalmen|V0713|31613|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22406||22406|31613||1|0|G
060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E
061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGB|0|1|0|100|XEU|105205|137357|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||105205||105205|137357||1|0|L
061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2806|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0|
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|5243|8714|lyfalmen|V0133|7390|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||5243||5243|8714||1|0|G
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3945|6928|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3945||3945|6928||1|H|S
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|14504|21461|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||14504||14504|21461||1|0|ES
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|17732|25904|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||17732||17732|25904||1|0|ES
062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|15000|12509|lyfalmen|V0924|12509|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||8000||8000|12509||2|0|E
062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|0|G|0|PIX|0|0|1|100|DKK|5884|9597|lyfalmen|V0998|9597|1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5884||5884|9597||2|0|G
062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|0|1|0|1|GSE|0|1|0|100|XEU|2114506|2636365|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||2114506|2636365||1|0|L
062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3888|6849|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3888||3888|6849||1|0|G
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|952|2808|lyfalmen|V0308|2785|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||952||952|2808||1|0|
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|18515|31912|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||18515||18515|31912||2|0|
062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|80146|70881|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||53453||53453|70881||2|0|S
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|12128|16194|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||10677||10677|16194||1|0|
062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|122364|158698|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||122364||122364|158698||1|0|
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|PIX|0|0|1|100|DKK|5884|9597|lyfalmen|V0998|9597|1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5884||5884|9597||1|0|G
063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1881|3016|lyfalmen|V0276|3016|2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1103||1103|3016||1|0|G
063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5806|6774|lyfalmen|V0277|6774|2|100|0|33,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||3833||3833|6774||1|0|G
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3534||2|0|E
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2235|3728|lyfalmen|V0123|3728|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Terbínafín||1620||1620|3728||1|0|E
063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|148131|190745|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||148131||148131|190745||2|0|L
063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|0|SSE|0|0|1|100|DKK|13497|20075|lyfalmen|||2|2|0|0,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13497||13497|20075||1|0|E
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|993|2865|lyfalmen|V0310|2865|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||993||993|2865||1|0|
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|963492|1204826|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||963492|1204826||2|H|S
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|382027|481646|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||382027|481646||2|H|S
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|3302623|4114050|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3302623|4114050||2|H|S
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|1711464|2135093|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1711464|2135093||2|H|S
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2104|4394|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||2104||2104|4394||2|0|G
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6711|6033|lyfalmen|V0029|6033|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3295||3295|6033||2|0|G
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1217|2392|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1217||1217|2392||1|0|
064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|6944|11969|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6944|11969||1|0|
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|33393|45509|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||33393||33393|45509||1|H|S
064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|854|2673|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||854||854|2673||1|0|G
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|491|2174|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||491||491|2174||1|0|G
065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5124|9892|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||5124||5124|9892||2|0|
065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|571|2284|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||571||571|2284||2|0|ES
065276|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7166|11361|lyfalmen|V0081|6697|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7166||7166|11361||1|0|G
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0|
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0|
065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14709|21743|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||14709||14709|21743||1|0|G
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10097|15395|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||10097||10097|15395||2|H|S
065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G
065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|0|VAL|0|0|0|100|DKK|9473|8629|lyfalmen|V0954|7713|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||5181||5181|8629||2|0|0
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|51409|68296|lyfalmen|V0451|56657|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||51409||51409|68296||3|0|G
065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|DKK|2095|4381|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||2095||2095|4381||2|0|E
065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|2912|5506|lyfalmen|||2|200|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||2912||2912|5506||1|0|E
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3190|5889|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||3190||3190|5889||2|H|S
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|1626|2488|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||719||719|2488||1|0|G
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|2975|4843|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2430||2430|4843||1|0|G
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|5114|6580|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3692||3692|6580||1|0|G
066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|11082|16751|lyfalmen|||1|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||11082||11082|16751||3|0|E
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4619|8934|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4619||4619|8934||2|0|
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|901|2738|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||901||901|2738||2|0|
066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1|0|
066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|13025|19426|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||||13025|19426||1|H|S
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8421|13089|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||8421||8421|13089||1|0|S
067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GSU|0|0|0|100|DKK|111737|145481|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||111737|145481||2|0|S
067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|0|LVR|0|0|1|100|SEK|11758|17682|lyfalmen|V0012|5832|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||11758||11758|17682||3|0|0
067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|0|VEB|0|0|0|100|SEK|8701|16678|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|maropitant||||8701|16678||2|0|
067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2460|4884|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2460|4884||2|0|S
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|4744|8028|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4744||4744|8028||2|0|G
068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3123||2|0|G
068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|6823|4157|lyfalmen|V0182|4157|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1932||1932|4157||2|0|G
068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|8772|13572|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8772||8772|13572||1|0|G
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0|
068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|3178|5872|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3178||3178|5872||2|0|G
068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0|
068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2419|4827|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2419||2419|4827||2|H|S
068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2414|4821|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||2414||2414|4821||2|H|S
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0|
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0|
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0|
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0|
069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|0|G|0|LVR|0|0|0|100|XEU|16217|23819|lyfalmen|V0651|23819|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||16217||16217|23819||3|0|G
069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13422|19972|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13422||13422|19972||1|0|G
069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|37715|50976|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||37715||37715|50976||1|0|G
069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E
069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|398550|502196|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||398550||398550|502196||1|0|L
069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|0|1|G|0|AEE|0|0|0|100|XEU|15727|23145|lyfalmen|V0470|23145|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||15727||15727|23145||1|0|G
069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|G|0|KRK|0|0|1|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G
069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|68795|90286|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||68795|90286||2|0|S
070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|1792|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0|
070512|L01XE3501|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01XE35|01.07.2020||R|0|0|0|1|0|1|AZE|0|1|0|100|SEK|932979|1166876|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||932979||932979|1166876||1|0|L
070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|22170|31314|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||22170||22170|31314||2|0|L
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|10071|15360|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10071||10071|15360||1|0|G
070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|7189|12391|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7189||7189|12391||1|0|
071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|736|2511|lyfalmen|V0174|2461|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||736||736|2511||2|0|
071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|37616|50635|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||37446||37446|50635||1|0|G
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GEB|0|0|0|100|XEU|78084|102034|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||78084|102034||1|0|S
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7217|13863|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||7217||7217|13863||1|0|
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6711|6085|lyfalmen|V0029|6033|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3333||3333|6085||2|0|G
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S
072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|6000|9756|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||6000||6000|9756||2|0|G
072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3119|5791|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3119||3119|5791||2|0|G
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|PBV|0|0|0|100|SEK|540|2241|lyfsjukr|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||540||540|2241||1|0|S
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|56954|75309|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||56954||56954|75309||1|0|S
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|9110|6830|lyfalmen|V0286|5627|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3874||3874|6830||1|0|G
073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|476|2153|lyfalmen|V0500|2082|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||476||476|2153||1|0|G
073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|357670|451353|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||357670|451353||1|0|L
073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PEU|0|1|0|100|DKK|530514|666322|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||530514||530514|666322||1|0|L
073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|2932|5054|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2932||2932|5054||1|0|
073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|2246|3560|lyfalmen|V0944|3501|2|4|0|5,6000|Icepharma hf|Mylan AB|Búprenorfín||1498||1498|3560||2|0|G
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3211|5918|lyfalmen|V1010|3611|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3211||3211|5918||1|0|G
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|16694|18732|lyfalmen|V0185|18732|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||12521||12521|18732||1|0|G
073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|9505|14581|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||9505||9505|14581||1|H|S
073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|4388|lyfalmen|V0924|4170|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||2100||2100|4388||2|0|E
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|985|2854|lyfalmen|V0305|2355|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||985||985|2854||1|0|
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|530|2227|lyfalmen|V0439|1883|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||530||530|2227||1|0|
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1440|3480|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1440||1440|3480||1|0|
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|BRO|0|0|0|100|XEU|3607|6217|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3607||3607|6217||2|0|
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|948|2803|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||948||948|2803||2|0|G
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3061|5711|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3061||3061|5711||1|0|E
074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|21602|30596|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2760|lyfalmen|||2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||917||917|2760||2|0|E
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|1104|3017|lyfalmen|||2|25|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1104||1104|3017||1|0|
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0|
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|940|2792|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||940||940|2792||1|0|
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|1405|3432|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1405||1405|3432||1|0|
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|701|2463|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||701||701|2463||2|0|G
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|395|2042|lyfalmen|V1025|2042|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||395||395|2042||2|0|G
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|2292|4653|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2292||2292|4653||2|0|G
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|5395|8924|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5395||5395|8924||1|0|G
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|15815|23266|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15815||15815|23266||1|0|G
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|5687|9326|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5687||5687|9326||1|0|G
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1107|3022|lyfalmen|V0363|2792|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1107||1107|3022||1|0|G
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|16648|24412|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16648||16648|24412||1|0|G
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||4994||1|0|E
075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3637|3700|lyfalmen|V0445|3492|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1600||1600|3700||2|0|G
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1252|2461|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1252||1252|2461||1|0|
075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13121|11214|lyfalmen|V0440|9648|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||7059||7059|11214||2|0|G
075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5911|9634|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5911||5911|9634||2|0|S
075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5911|9634|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5911||5911|9634||2|0|S
075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6222|10062|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6222||6222|10062||2|0|S
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5064|8468|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||5064||5064|8468||1|0|G
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17603|25727|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||17603|25727||1|0|G
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|15639|23023|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||15639||15639|23023||1|0|G
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|15790|23231|lyfalmen|V0982|23229|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||15790||15790|23231||1|0|G
076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1201|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E
076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2403|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E
076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3604|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E
076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1394|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E
076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2788|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E
076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|4182|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1944|2461|lyfalmen|V0291|2461|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||700||700|2461||2|0|G
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3549||1|0|G
076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0290|2461|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G
076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|6400|6990|lyfalmen|V0273|6990|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||3990||3990|6990||2|0|0
076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|248228|315237|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||248228||248228|315237||1|0|L
076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|143901|185484|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||143901||143901|185484||1|0|L
076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|71950|94276|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||71950||71950|94276||1|0|L
076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|41372|55601|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||41372||41372|55601||1|0|L
076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2972|5589|lyfalmen|V0598|5560|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2972||2972|5589||1|0|G
076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|85745|111724|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||85745||85745|111724||2|0|L
076995|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4503|3340|lyfalmen|V0145|2105|2|4|0|8,0000|Alvogen|ratiopharm GmbH|Tadalafíl||1338||1338|3340||2|0|E
077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E
077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|54778|72557|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||54778||54778|72557||2|H|S
077555|N07BC0102|Buvidal|stl|8|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|14228|21081|lyfsjukr|||1|1|0|1,0000|Vistor hf|Camurus AB|Búprenorfín||14228||14228|21081||1|H|S
077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E
077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E
077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E
077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E
077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E
077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E
077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987|31.08.2020|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|720|2489|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||720||720|2489||1|0|G
077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G
078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|10398|15810|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10398||10398|15810||1|0|G
078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|40473|76956|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||40473||40473|76956||2|0|
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985|30.06.2020|R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|681|2435|lyfalmen|||1|20|0|2,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||681||681|2435||2|0|E
078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHE|0|0|0|100|DKK|13909|20642|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||13909||13909|20642||1|0|E
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|8675|6768|lyfalmen|V0069|2750|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3829||3829|6768||1|0|G
079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|5437|4192|lyfalmen|V0144|4182|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1957||1957|4192||2|0|E
079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|4135|7189|lyfalmen|V0315|7189|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||4135||4135|7189||1|0|G
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSA|0|0|0|100|XEU|11003|13296|lyfalmen|V0184|13296|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||8572||8572|13296||2|0|G
079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0|
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|515|2207|lyfalmen|||2|10|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||515||515|2207||1|0|E
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|837|2515|lyfalmen|V0418|2515|2|20|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||739||739|2515||1|0|E
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|849|2529|lyfalmen|V0177|2529|2|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||749||749|2529||1|0|E
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1478|3353|lyfalmen|V0411|3353|2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||1348||1348|3353||1|0|E
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0|
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|4105|7959|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4105|7959||2|0|
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||2|0|
080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|2874|lyfalmen|V0422|2874|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1000||1000|2874||2|0|G
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13375|23053|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||13375||13375|23053||2|0|
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|7120|7331|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||4238||4238|7331||1|0|G
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2342|4721|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2342||2342|4721||1|0|G
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|5640|9261|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5640||5640|9261||1|0|E
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2675|5180|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2675||2675|5180||1|0|E
080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|34663|47115|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||34663||34663|47115||1|0|G
080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|0|1|AMR|0|0|0|100|XEU|3213|5920|lyfsjukr|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3213||3213|5920||2|H|S
081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0
081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0815|4224|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PEU|0|1|0|100|DKK|663142|831274|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||663142||663142|831274||1|0|L
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0|
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0|
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2009|2486|lyfalmen|V0692|2486|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||718||718|2486||1|0|E
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4602|7832|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4602||4602|7832||1|0|G
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G
081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1594|3692|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1594||1594|3692||1|H|S
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|4883|8219|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4883||4883|8219||1|0|G
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|6877|10963|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6877||6877|10963||1|0|G
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|28418|39217|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||28418||28418|39217||2|H|S
082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|14027|24177|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||14027||14027|24177||1|0|
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|58898|101517|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||58898||58898|101517||1|0|
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|535|2234|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||535||535|2234||1|0|G
082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0|
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3101|5766|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3101||3101|5766||1|0|G
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2792|5341|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2792||2792|5341||1|0|G
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3955|6942|lyfalmen|V0080|6619|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3955||3955|6942||1|0|G
083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.04.2018||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|283322|320965|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||252833||252833|320965||2|0|L
083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|DKK|3805|6735|lyfalmen|V0706|6734|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)||3805||3805|6735||2|0|G
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3523|6347|lyfalmen|V0701|5558|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3523||3523|6347||1|0|G
083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5262|3666|lyfalmen|V0686|3631|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1575||1575|3666||1|0|E
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|6305|12132|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6305||6305|12132||2|0|
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GCA|0|0|1|100|DKK|910|2650|lyfalmen|V0231|2650|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||837||837|2650||1|0|E
083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5255|5719|lyfalmen|V0624|5719|2|30|0|36,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3067||3067|5719||1|0|E
084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|168436|215998|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||168436||168436|215998||1|0|
084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0|
084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G
084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|0|G|0|TVB|0|0|0|100|XEU|3022|4778|lyfalmen|V1010|3611|2|30|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Dútasteríð og tamsúlósínhýdroklóríð||2383||2383|4778||1|0|G
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|63082|83060|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||63082||63082|83060||1|0|L
084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|6074|9858|lyfalmen|V0215|9858|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||6074||6074|9858||2|0|G
084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1288|3271|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1288||1288|3271||1|0|E
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|38672|52186|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||38672||38672|52186||1|0|S
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|12974|19355|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||12974||12974|19355||1|0|G
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|37274|50418|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||37274||37274|50418||2|0|G
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2658|5156|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2658||2658|5156||2|0|
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|837|2650|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||837||837|2650||1|0|G
085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|12546|18766|lyfsjukr|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||12546||12546|18766||1|H|S
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|4438|7606|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4438||4438|7606||2|0|S
085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|3563|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|21062|29913|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21062||21062|29913||1|0|G
085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|17718|24576|lyfalmen|V0652|24357|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||16767||16767|24576||1|0|G
085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|9081|13997|lyfsjukr|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9081||9081|13997||2|0|S
085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|0|EXH|0|0|0|100|XEU|936|1915|lyfalm11|V0545|1915|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||466||466|1915||2|0|
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|78442|102487|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||78442||78442|102487||2|0|ES
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|22032|31140|lyfalmen|V0579|31140|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||22032||22032|31140||1|0|G
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|31646|43299|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||31646||31646|43299||1|0|E
085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|8673|13435|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||8673||8673|13435||1|H|S
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|TIC|0|0|0|100|XEU|2737|5265|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2737||2737|5265||1|0|G
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|TIC|0|0|0|100|XEU|6653|10655|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6653||6653|10655||1|0|G
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|388|2032|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||388||388|2032||1|0|
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1967|4205|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1967||1967|4205||1|0|G
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|3207|5912|lyfalmen|V0365|5177|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3207||3207|5912||1|0|G
086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BNB|0|0|0|100|XEU|42312|56790|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||42312||42312|56790||2|0|E
086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015|30.06.2020|R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|20581|29304|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai GmbH|Perampanel||20581||20581|29304||1|0|G
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|1|100|DKK|7899|12370|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7899||7899|12370||1|0|ES
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|1|100|DKK|8573|13298|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8573||8573|13298||1|0|ES
086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|GRH|0|0|1|100|DKK|11053|16711|lyfalmen|V0012|5832|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||11053||11053|16711||1|0|E
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|29030|39991|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||29030|39991||1|0|G
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|50743|67453|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||50743|67453||1|0|G
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|1|BSP|0|1|0|100|DKK|52381|69525|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||52381||52381|69525||1|H|L
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|17149|22470|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||17149|22470||2|0|E
086649|L01XX5001|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|854667|1069478|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||854667||854667|1069478||1|0|S
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|1|100|DKK|45943|61382|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||45943||45943|61382||2|0|S
087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0|
087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2434|lyfalmen|V0931|2434|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||680||680|2434||2|0|E
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0|
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|360|1993|lyfalmen|V0060|1940|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||360||360|1993||1|0|
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|243|1832|lyfalmen|V0312|597|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||243||243|1832||1|0|
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|214|1792|lyfalmen|V0312|1792|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||214||214|1792||1|0|
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1805|3982|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1805||1805|3982||1|0|
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|15928|23421|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||15928||15928|23421||1|0|G
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|15928|23421|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||15928||15928|23421||1|0|G
087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|0|G|0|ASP|0|0|0|100|XEU|5825|9515|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5825||5825|9515||1|0|G
087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1653|3773|lyfalmen|V0952|3378|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1653||1653|3773||1|0|G
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|35263|60779|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||35263||35263|60779||2|0|
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0|
087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5027|9708|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||5027||5027|9708||1|0|
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|24545|42306|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24545||24545|42306||2|0|
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3184|5264|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||3184||3184|5264||2|0|
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGP|0|0|1|100|DKK|1086|2993|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||1086||1086|2993||1|0|G
088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3285|6019|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3285||3285|6019||2|0|G
088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3026|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G
088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|8351|12992|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||8351||8351|12992||1|0|
088677|N07BC0102|Buvidal|stl|24|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|14228|21081|lyfsjukr|||1|1|0|3,0000|Vistor hf|Camurus AB|Búprenorfín||14228||14228|21081||1|H|S
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4815|8125|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4815||4815|8125||1|0|G
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|8321|12951|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8321||8321|12951||1|0|G
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12375|18531|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12375||12375|18531||1|0|G
088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|0|G|0|DSM|0|0|0|100|DKK|6239|10085|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6239||6239|10085||1|0|G
088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|446788|562190|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||446788||446788|562190||1|H|S
088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1503|3193|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1503|3193||1|0|
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|23781|33352|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||23781||23781|33352||1|0|0
089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|139346|179819|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||139346||139346|179819||1|0|L
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|1|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0|
089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|19843|28810|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||19843||19843|28810||1|0|L
089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|43161|57864|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||43161||43161|57864||1|0|L
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012|31.08.2020|L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2|0|
089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|1419|2737|lyfalmen|V0048|2737|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||900||900|2737||2|0|G
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|24164|33836|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24164||24164|33836||1|0|G
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|96658|125527|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||96658||96658|125527||1|0|G
090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|16281|18841|lyfalmen|V0261|11546|2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||12600||12600|18841||1|0|G
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2514|4958|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2514||2514|4958||2|0|E
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|5029|8420|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||5029||5029|8420||2|0|E
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|761|2545|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||761||761|2545||2|0|E
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|1|100|DKK|4494|7683|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||4494||4494|7683||2|0|ES
090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1925|4147|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1925||1925|4147||1|0|G
090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|825|2633|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||825||825|2633||1|0|G
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|1|AAS|0|0|0|100|XEU|13813|20510|lyfsjukr|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||13813||13813|20510||1|H|S
091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2655|5152|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2655||2655|5152||1|H|S
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4594|7821|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4594||4594|7821||1|H|S
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|13485|20059|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||13485||13485|20059||1|H|S
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|3607|6258|lyfalmen|V0958|6077|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3458||3458|6258||1|0|E
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6329|10209|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6329||6329|10209||1|0|G
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|TAE|0|0|1|100|SEK|3730|6632|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3730||3730|6632||2|0|G
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1052|2037|lyfalmen|V0021|2037|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||392||392|2037||1|0|G
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1819|2353|lyfalmen|V0022|2353|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||621||621|2353||1|0|G
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1182|3125|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||1182||1182|3125||1|0|G
092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|9300|17814|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||9300||9300|17814||2|0|
092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0|
092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E
092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2806|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E
092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|1|100|IKR|3453|4939|lyfalmen|V0011|4910|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2500||2500|4939||2|0|G
092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1510|2806|lyfalmen|V0005|2806|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||950||950|2806||2|0|E
092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3266|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E
092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5715|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2304|4669|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2304||2304|4669||1|0|G
092694|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar|H02AB04|01.01.2019||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|497|2182|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||497||497|2182||1|0|G
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|MUP|0|0|0|100|DKK|1010|2888|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1010||1010|2888||2|0|E
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|MUP|0|0|0|100|DKK|2320|4691|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2320||2320|4691||2|0|E
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|MUP|0|0|0|100|DKK|4510|7705|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4510||4510|7705||2|0|E
093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|342554|432553|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||342554||342554|432553||1|0|L
093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|456954|574834|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||456954||456954|574834||1|0|L
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4993|8370|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4993||4993|8370||1|0|G
093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5533|9114|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5533||5533|9114||1|0|G
093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|24980|32574|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||23166||23166|32574||2|0|ES
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1958|4193|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1958||1958|4193||1|0|G
093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|DKK|5556|9145|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5556||5556|9145||2|0|G
093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|DKK|4114|7160|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4114||4114|7160||2|0|G
093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2477|4907|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2477||2477|4907||2|0|
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|34241|46582|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||34241||34241|46582||2|0|G
093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|22397|31601|lyfalmen|V0588|21626|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||22397||22397|31601||2|0|G
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|421835|531156|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||421835||421835|531156||1|0|L
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|421835|531156|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||421835||421835|531156||1|0|L
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAC|0|0|0|100|DKK|5164|8606|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5164||5164|8606||2|0|G
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1805|3548|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1805||1805|3548||1|0|
094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|123099|159612|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||123099||123099|159612||1|0|L
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|1856|4053|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1856||1856|4053||2|0|G
094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|4102|2|98|0|49,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|76995|100657|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||76995||76995|100657||1|0|S
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|HAL|0|0|1|100|DKK|46217|61729|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||46217|61729||1|0|E
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6545|11281|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6545||6545|11281||2|0|
094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0|
095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|1|TAG|0|0|0|100|DKK|43775|58640|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||43775||43775|58640||1|H|S
095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|0|1|AIS|0|1|0|100|DKK|102834|134408|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||102834||102834|134408||1|0|L
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|8862|13696|lyfalmen|||1|50|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Dísúlfíram||8862||8862|13696||1|0|G
095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|15564|22920|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||15564||15564|22920||2|0|G
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15893|23373|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15893||15893|23373||1|0|E
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|16131|23701|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16131||16131|23701||1|0|E
095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|1|0|0|0|TVB|0|0|0|100|XEU|5320|4925|lyfalmen|V0959|4870|2|30|0|20,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Metýlfenídat||2490||2490|4925||1|0|E
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18779|27345|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18779||18779|27345||1|0|G
095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1955|4189|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1955|4189||2|H|ES
095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|3400|6178|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3400|6178||2|H|ES
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|0|100|XEU|930|2325|lyfalmen|||2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||601||601|2325|30.6.2020|1|0|G
095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5558|lyfalmen|V0701|5558|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2950||2950|5558||2|0|G
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4890|8334|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4303||4303|8334||2|0|0
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6745|11630|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||6040||6040|11630||2|0|0
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|11217|19936|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||10418||10418|19936||2|0|0
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008|31.07.2020|R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|123417|160007|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||123417||123417|160007||1|0|L
096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|742308|929735|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||742308||742308|929735||2|H|L
096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2190|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|9577|14680|lyfalmen|V0347|14678|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9577||9577|14680||1|0|G
096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2048|lyfalmen|V0930|2048|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||400||400|2048||2|0|E
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|708035|887109|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||708035||708035|887109||2|0|L
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|649890|814792|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||649890||649890|814792||2|0|L
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|684082|857318|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||684082||684082|857318||2|0|L
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|752468|942371|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||752468||752468|942371||2|0|L
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|8478|13167|lyfalmen|V0349|12054|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8478||8478|13167||1|0|G
096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|0|1|GRP|0|0|0|100|GBP|9691|14837|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Epírúbicín||||9691|14837||1|H|S
096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNP|0|0|0|100|XEU|12530|18744|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||12530||12530|18744||1|0|G
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELC|0|0|0|100|DKK|74247|127972|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||74247||74247|127972||2|0|
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|VMD|1|0|0|100|XEU|8177|15684|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||8177|15684||2|0|
097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11229|16954|lyfalmen|V0334|2549|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11229||11229|16954||1|0|E
097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|20890|29695|lyfalmen|V0335|2549|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||20890|29695||1|0|E
097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|35316|47941|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||35316||35316|47941||1|0|E
097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6259|12045|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||6259||6259|12045||2|0|
097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|1|0|0|0|0|DSM|0|0|0|100|DKK|17896|23391|lyfalm11|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||17896||17896|23391||1|0|
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2611|2610|lyfalmen|V0023|2610|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||808||808|2610||1|0|G
097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|1|100|DKK|3062|5712|lyfsjukr|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||3062|5712||2|0|ES
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1622|3730|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1622||1622|3730||1|0|E
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1500||1500|3563|||0|G
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|596|2318|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||596||596|2318||2|0|G
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|596|2318|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||596||596|2318||2|0|G
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0|
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|DKK|978|2541|lyfalmen|V0243|2541|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||758||758|2541||2|0|G
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|DKK|1695|3020|lyfalmen|V0244|2804|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1106||1106|3020||2|0|G
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|DKK|4516|4979|lyfalmen|V0245|4979|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2529||2529|4979||2|0|G
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|DKK|7867|10489|lyfalmen|V0232|10489|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||6532||6532|10489||2|0|G
098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|2729|5035|lyfalmen|V0381|5035|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2570||2570|5035||1|0|G
099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2991|2461|lyfalmen|V0107|2461|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||700||700|2461||2|0|
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|86369|112513|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||86369||86369|112513||1|0|S
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2472|2481|lyfalmen|V0284|2365|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||714||714|2481||2|0|G
099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|11180|13613|lyfalmen|V0272|8917|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8802||8802|13613||1|0|G
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4620|4369|lyfalmen|V0285|3287|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2086||2086|4369||2|0|G
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8268|7478|lyfalmen|V0286|5627|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4345||4345|7478||2|0|G
099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0|
099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2953|4790|lyfalmen|V0685|3910|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2392||2392|4790||1|0|E
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0|
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1684|2295|lyfalmen|V0247|2295|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||579||579|2295||1|0|G
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2789|3941|lyfalmen|V0248|3941|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1775||1775|3941||1|0|G
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5807|4500|lyfalmen|V0249|4500|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2181||2181|4500||1|0|G
099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|170725|218845|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||170725||170725|218845||1|0|L
099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|340689|430233|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||340689||340689|430233||1|0|L
099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|681354|853925|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||681354||681354|853925||1|0|L
099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|1|CLU|0|1|0|100|XEU|149944|193000|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||149944||149944|193000||1|H|L
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|11725|17636|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||11725|17636||2|0|E
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2271|3539|lyfalmen|V0823|3539|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1483||1483|3539||1|0|G
100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|PIL|0|0|1|100|IKR|322|1759|lyfalmen|V0563|1759|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||190||190|1759||2|0|G
100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2190|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E
100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E
100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E
100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3483|6292|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3483||3483|6292||1|0|E
101021|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|3393|5673|lyfalmen|V0598|5673|2|100|0|13,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||3033||3033|5673||1|0|G
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|10117|14027|lyfalmen|V0254|12388|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9103||9103|14027||1|0|G
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|14441|21375|lyfalmen|V0256|18571|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||14441||14441|21375||1|0|G
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|59528|88263|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||54754||54754|88263||1|0|
101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0|
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1938|4165|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||||1938|4165||1|0|
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|3343|6099|lyfalmen|||2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||||3343|6099||1|0|G
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|12579|24035|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12579||12579|24035||1|0|
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|6235|10080|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6235||6235|10080||2|0|E
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|18496|26956|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||18496||18496|26956||2|0|E
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1084|2990|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1084||1084|2990||1|0|G
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1635|3748|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1635||1635|3748||1|0|G
102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5846|9544|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5846||5846|9544||2|H|S
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|422|2079|lyfalmen|V0230|2071|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||422||422|2079||1|0|E
102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0|
102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|8487|3026|lyfalmen|V0684|3026|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1110||1110|3026||2|0|G
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|TOG|0|0|0|100|SEK|3253|5975|lyfalmen|V0041|4002|1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3253||3253|5975||1|0|G
102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|16126|14548|lyfalmen|V0441|12497|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||9481||9481|14548||2|0|G
103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|V0060|1940|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940||2|0|
103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2665|5166|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2665||2665|5166||2|0|G
103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|0|1|0|0|PMA|0|0|0|100|DKK|7557|9844|lyfalmen|V0657|7829|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||6064||6064|9844||1|0|E
103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|TBB|0|0|0|100|NOK|96410|125213|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||96410||96410|125213||1|0|S
103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|0|1|0|1|FKA|0|0|0|100|DKK|36575|49534|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||36575||36575|49534||1|0|0
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2750|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G
103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G
103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1825|4010|lyfalmen|V0222|4010|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1825||1825|4010||2|0|G
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|300234|379918|lyfsjukr|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||300234||300234|379918||2|H|S
103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|107030|139627|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||107030||107030|139627||1|0|L
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|4020|7797|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||4020||4020|7797||1|0|
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2444||1|0|E
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8629|13375|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8629||8629|13375||2|H|S
104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3689|6575|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||3689||3689|6575||2|0|G
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2867|5444|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2867||2867|5444||1|0|G
104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|0|1|G|0|ALE|0|0|0|100|SEK|12063|16319|lyfalmen|V0992|16319|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||10768||10768|16319||2|0|G
104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5632|9250|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5632||5632|9250||1|0|G
104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|10742|16283|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||10742||10742|16283||1|0|E
104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G
104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6684|10698|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6684||6684|10698||1|0|G
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3768|6684|lyfalmen|V0017|5922|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3768||3768|6684||1|0|G
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|6049|9824|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6049||6049|9824||1|0|G
104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|4602|7832|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4602||4602|7832||2|0|G
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|104197|136103|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||104197|136103||1|0|S
105363|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|3386|3273|lyfalmen|V0107|2461|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1290||1290|3273||1|0|E
105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2111|4404|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2111||2111|4404||2|0|G
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2250|4595|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2250||2250|4595||2|0|
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2660|5159|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2660||2660|5159||2|0|
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|1863|4062|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1863||1863|4062||2|0|
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|2884|4065|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1865||1865|4065||2|0|
106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|462285|581464|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||462285||462285|581464||1|0|L
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|17795|25991|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||17795||17795|25991||1|H|S
106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3664|2635|lyfalmen|V0107|2461|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||826||826|2635||2|0|E
107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|126998|164461|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||126998||126998|164461||1|H|S
107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|3275|5645|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3275||3275|5645||1|0|
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1590|3686|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1590||1590|3686||1|0|G
107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4711|5557|lyfalmen|V0438|3787|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||2949||2949|5557||2|0|G
107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PBV|0|0|0|100|XEU|20292|27779|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||19094||19094|27779||2|H|S
107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|12998|5514|lyfalmen|V0814|4224|2|28|0|8,7500|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2918||2918|5514||1|0|E
107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3026|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G
107785|L01XE4201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|303060|383433|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||303060||303060|383433||1|0|L
107918|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|6040|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E
107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0|
108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013|31.08.2020|R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2093|4379|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2093||2093|4379||2|0|G
108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0|
108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|74156|97066|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||74156||74156|97066||1|0|E
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9380|14409|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9380||9380|14409||1|0|G
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|75247|98446|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||75247||75247|98446||3|0|E
109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|776|2159|lyfalmen|V0827|2159|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||480||480|2159||2|0|G
109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|1710|3706|lyfalmen|V0584|3702|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1604||1604|3706||2|0|G
109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|5824|8178|lyfalmen|V0585|8149|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4853||4853|8178||2|0|G
109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|3825|6763|lyfalmen|||2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||3825||3825|6763||2|0|G
109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|10639|14572|lyfalmen|V0587|13889|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||9499||9499|14572||2|0|G
109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|20541|21626|lyfalmen|V0588|21626|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||14624||14624|21626||2|0|G
110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|9494|14565|lyfalmen|V0686|3631|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||9494||9494|14565||3|0|E
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0|
110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1881|4087|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1881||1881|4087||1|0|G
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2461|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G
110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|19868|28844|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||19868||19868|28844||1|0|
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G
110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1556|3258|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1556||1556|3258||1|0|
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4338|7469|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4338||4338|7469||1|0|G
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MBV|0|0|0|100|DKK|93209|121164|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||93209||93209|121164||1|0|S
110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|CLU|0|1|0|100|XEU|8831|13653|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8831||8831|13653||1|0|L
111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|0|GED|0|0|0|100|XEU|14731|18216|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||13696||13696|18216||1|0|E
111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|4869|5103|lyfalmen|V0373|4920|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2619||2619|5103||2|0|G
111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|0|EXH|0|0|0|100|DKK|2690|4655|lyfalm11|V0993|4655|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2690||2690|4655||2|0|
111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GCA|0|0|1|100|DKK|709|2474|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||709||709|2474||1|0|E
112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|0|1|SEB|0|0|0|100|XEU|137499|177521|lyfsjukr|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||137499||137499|177521||3|H|0
112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|199276|254355|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||199276||199276|254355||1|0|L
112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|1500|3012|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1100||1100|3012||2|0|E
112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2365|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G
112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3287|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G
112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5627|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G
112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E
113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|54809|72596|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||54809||54809|72596||1|0|E
113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|0|1|NEP|0|0|0|100|DKK|120402|156258|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||120402||120402|156258||1|H|0
113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|4844|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6981|11107|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6981||6981|11107||1|0|G
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5563|9155|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5563||5563|9155||1|0|G
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|2342|4721|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2342||2342|4721||2|H|S
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|2926|5525|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2926||2926|5525||1|0|G
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|5026|8416|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5026||5026|8416||1|0|G
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|516082|648373|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||516082||516082|648373||1|0|L
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|613|2342|lyfalmen|V0930|2048|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||613||613|2342||2|0|E
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|891|2724|lyfalmen|V0931|2434|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||891||891|2724||2|0|E
114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5000|3590|lyfalmen|V0145|2105|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1520||1520|3590||2|0|E
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0|
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|35718|48450|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||35718|48450||2|0|L
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3843|6787|lyfalmen|V0824|2876|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3843||3843|6787||1|0|G
114461|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|16097|6315|lyfalmen|V0145|6315|2|12|0|24,0000|Alvogen|ratiopharm GmbH|Tadalafíl||3500||3500|6315||2|0|E
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|10855|16439|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||10855||10855|16439||2|0|G
114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|DKK|9001|12727|lyfalmen|V0973|12727|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||8158||8158|12727||2|0|G
114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|18015|lyfalmen|V0420|13886|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||12000||12000|18015||2|0|G
114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|6130|10566|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6130||6130|10566||2|0|
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2125|3927|lyfalmen|V0278|3927|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1765||1765|3927||2|0|G
114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|0|1|CLU|0|1|0|100|XEU|52741|69980|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||52741||52741|69980||1|H|L
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2865|3858|lyfalmen|V0279|3858|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1715||1715|3858||2|0|G
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8523|7198|lyfalmen|V0280|7198|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4141||4141|7198||2|0|G
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11779|7198|lyfalmen|V0282|7198|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4141||4141|7198||2|0|G
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G
115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|89357|116292|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||89357||89357|116292||1|H|S
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|1|100|XEU|7882|12347|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7882||7882|12347||2|0|S
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1164|3024|lyfalmen|V0158|2829|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1109||1109|3024||2|0|E
115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1741|3081|lyfalmen|V0276|3016|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1150||1150|3081||2|0|G
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11511|17342|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11511||11511|17342||1|0|G
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9911|15139|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9911||9911|15139||1|0|G
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|46020|61480|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||46020||46020|61480||1|0|G
115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|0|STE|0|0|0|100|DKK|3674|6555|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3674||3674|6555||1|0|0
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|1|100|DKK|3550|6384|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3550||3550|6384||1|0|ES
116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|1|100|DKK|1856|4053|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1856||1856|4053||1|0|ES
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1|0|
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1|0|
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|863|2555|lyfalmen|V0562|2349|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||768||768|2555||1|0|G
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|439|2021|lyfalmen|V0563|1759|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||380||380|2021||1|0|G
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|918|2738|lyfalmen|V0564|2113|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||901||901|2738||1|0|G
116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|15039|22198|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15039||15039|22198||1|0|G
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4519|7098|lyfalmen|V0081|6834|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||4069||4069|7098||1|0|G
116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|5862|9566|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5862||5862|9566||1|0|G
116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|6382|10282|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||6382||6382|10282||1|0|G
116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|16381|24045|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||16381||16381|24045||1|0|G
116907|N02AE0104|Buprenorphine ratiopharm|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR|1916|3501|lyfalmen|V0944|3501|2|4|0|5,6000|Alvogen|ratiopharm GmbH|Búprenorfín||1455||1455|3501||2|0|G
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|9881|18917|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9881||9881|18917||2|0|
117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1583|3677|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1583||1583|3677||1|0|G
117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|11772|16926|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11209||11209|16926||1|0|E
117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|21685|28777|lyfalmen|V0273|6990|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||19819||19819|28777||1|0|G
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1496|3557|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1496||1496|3557||2|0|G
117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|31123|42638|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||31123||31123|42638||1|0|G
117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|57478|75972|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||57478||57478|75972||1|H|L
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|5371|10360|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5371||5371|10360||2|0|
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|14334|27365|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||14334||14334|27365||2|0|
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1848|4042|lyfalmen|V0278|3927|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1848||1848|4042||1|0|G
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2780|4130|lyfalmen|V0279|3858|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1912||1912|4130||1|0|G
118046|N07BC0102|Buvidal|stl|96|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|60848|80234|lyfsjukr|||1|1|0|12,0000|Vistor hf|Camurus AB|Búprenorfín||60848||60848|80234||1|H|S
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|8342|9030|lyfalmen|V0282|7198|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5472||5472|9030||1|0|G
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1768|3931|lyfalmen|V0283|3931|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1768||1768|3931||1|0|G
118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|438717|552152|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||438717||438717|552152||1|0|L
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14590|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14590||5|H|S
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|8523|8716|lyfalmen|V0280|7198|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5244||5244|8716||1|0|G
118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5443|10497|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5443||5443|10497||2|0|
118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|21146|30019|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||21146||21146|30019||1|0|G
118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1278|3257|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1278||1278|3257||2|H|S
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|494|2178|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||494||494|2178||2|0|G
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|1315|3308|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1315||1315|3308||2|0|G
119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2326|2993|lyfalmen|V0824|2876|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1086||1086|2993||2|0|G
119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3141|5821|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3141||3141|5821||2|0|E
119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E
119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0|
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGP|0|1|0|100|DKK|342076|431958|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||342076||342076|431958||1|0|L
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGP|0|1|0|100|DKK|317580|401492|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||317580||317580|401492||1|0|L
120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|39492|53223|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||39492||39492|53223||2|H|L
120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|1|HSS|0|1|0|100|DKK|55809|73861|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||55809||55809|73861||1|H|L
120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7679|8586|lyfalmen|V0118|8586|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5150||5150|8586||2|0|E
121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|427136|537749|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||427136||427136|537749||2|H|L
121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8586|lyfalmen|V0118|8586|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||5150||5150|8586||2|0|E
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|GRH|0|0|1|100|DKK|3963|6953|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3963||3963|6953||1|0|E
121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0|
121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3267|5995|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3267||3267|5995||2|0|G
122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|3416|6200|lyfalmen|V0145|2105|2|4|0|8,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||3416||3416|6200||2|0|E
122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0|
122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9347|16110|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9347||9347|16110||1|0|
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|33279|57360|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||33279||33279|57360||2|0|
123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|0|1|0|1|KAN|0|0|0|100|IKR|18000|26273|lyfsjukr|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|S
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|668|2417|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||668||668|2417||1|0|G
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|SMA|0|0|0|100|XEU|23932|33543|lyfalmen|V0579|31140|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||23932||23932|33543||1|0|G
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1841|3618|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1841|3618||2|0|
124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|32872|44850|lyfalmen|||1|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||32872||32872|44850||3|0|E
124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|737|2512|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||737||737|2512||1|0|G
124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8377|13028|lyfalmen|V0995|7004|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||8377||8377|13028||1|0|G
124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G
125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|12045|18077|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||12045||12045|18077||2|0|G
125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|0|G|0|LNA|0|0|1|100|XEU|6224|8337|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||4969||4969|8337||2|0|G
125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|4399|3356|lyfalmen|V0285|3287|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G
125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|1711464|2135093|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1711464||1711464|2135093||2|H|S
126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|0|G|0|AZE|0|0|0|100|SEK|5688|9327|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5688||5688|9327||1|0|G
126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2359|2676|lyfalmen|V0057|2317|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||856||856|2676||1|0|G
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|49201|65503|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||49201||49201|65503||2|H|L
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|98399|127729|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||98399||98399|127729||2|H|L
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|196833|251316|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||196833||196833|251316||2|H|L
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|1|FIN|0|1|0|100|DKK|129140|167125|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||129140||129140|167125||2|H|L
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|32575|44474|lyfalmen|V0976|44474|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||32575|44474||2|0|G
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|3575|6419|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3575|6419||1|0|G
126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|7635|12007|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7635||7635|12007||2|0|G
127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|1|100|XEU|3372|5010|lyfalmen|V0011|5010|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2552||2552|5010||1|0|G
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0|
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|6356|10246|lyfalmen|V0279|3858|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6356||6356|10246||2|0|E
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|KAR|0|0|0|100|DKK|1330|3329|lyfalmen|||1|100|0|50,0000|Vistor hf|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1330||1330|3329||2|0|G
128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|246199|312714|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||246199||246199|312714||1|0|L
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|24425|34166|lyfalmen|V0282|7198|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||24425||24425|34166||2|0|G
129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4530|7733|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4530||4530|7733||1|0|G
129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|19080|17884|lyfalmen|V0680|16914|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||11905||11905|17884||2|0|
129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3556||2|0|
129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3214|5922|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3214||3214|5922||1|0|G
129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0812|4224|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E
130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4332|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2059||2059|4332||2|0|G
130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|1|0|100|SEK|328739|415371|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||328739||328739|415371||2|0|L
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|DKK|5610|5178|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2674||2674|5178||2|0|
130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|1|PFM|0|0|0|100|SEK|324488|410083|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||324488||324488|410083||1|H|S
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|20849|39725|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||20849||20849|39725||1|0|
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1584|3678|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1584||1584|3678||2|0|
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|10404|15818|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||10404|15818||1|0|
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|42377|68312|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||42377|68312||1|0|
131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|7148|13732|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||7148||7148|13732||2|0|
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2905|5496|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2905|5496||2|0|
131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1685|3817|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Fenemal||1685||1685|3817||2|0|G
131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1909|4125|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Fenemal||1909||1909|4125||2|0|G
131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2317|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G
132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|0|VAL|0|0|1|100|XEU|1213|2282|lyfalmen|V0003|2276|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||570||570|2282||2|0|
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|5076|6597|lyfalmen|V0581|6597|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3705||3705|6597|||0|G
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G
132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|1|TPA|0|1|0|100|DKK|421888|531222|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||421888||421888|531222||1|H|L
132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016|31.08.2020|L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2|0|
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AGC|0|0|0|100|XEU|9387|14418|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||9387||9387|14418||1|0|G
132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|0|1|0|1|SGB|0|1|0|100|XEU|190295|243185|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||190295||190295|243185||1|0|L
132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G
132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5074|8482|lyfalmen|V0681|7860|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5074||5074|8482||1|0|E
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|6666|12817|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6666|12817||2|0|
132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|4780|4165|lyfalmen|V0335|2601|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1938||1938|4165||1|0|G
132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0|
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|CLA|0|0|0|100|XEU|456|2126|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||456||456|2126||1|0|
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0|
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|0|1|SLP|0|0|0|100|SEK|23558|33070|lyfsjukr|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||23558||23558|33070||1|H|S
133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|1323|2599|lyfalmen|V0037|2599|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||800||800|2599||2|0|G
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|0|1|SLP|0|0|0|100|SEK|31323|42891|lyfsjukr|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||31323||31323|42891||1|H|S
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|0|1|SLP|0|0|0|100|SEK|42593|57145|lyfsjukr|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||42593|57145||1|H|S
133227|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2019||R|0|0|0|0|G|0|GLZ|0|0|0|100|DKK|5403|8334|lyfalmen|V0981|8334|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||4967||4967|8334||2|0|G
133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|4330|7458|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4330||4330|7458||2|H|S
133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|11704|5528|lyfalmen|V0814|4224|2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||2928||2928|5528||1|0|E
133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|1400|3425|lyfalmen|V0333|3204|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1400||1400|3425||1|0|E
134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|51449|66882|lyfalmen|V0451|56657|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||50291||50291|66882||1|0|G
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3014|5646|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3014||3014|5646||2|0|G
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7240|11463|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7240||7240|11463||2|0|G
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|60592|79910|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||60592||60592|79910||1|0|S
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GAD|0|0|0|100|DKK|110669|144152|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||110669||110669|144152||2|0|S
135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G
135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G
135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|10283|15651|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10283||10283|15651||1|0|G
135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G
135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G
135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4545|7754|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4545||4545|7754||1|0|G
135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1290|3273|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1290||1290|3273||1|0|G
135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|DKK|2386|3118|lyfalmen|V0909|3118|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||1177||1177|3118||2|0|G
135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2950|5558|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2950||2950|5558||1|0|G
136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|0|1|0|1|SSE|0|1|0|100|DKK|210361|268141|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||210361||210361|268141||1|0|L
136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|6336|10219|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6336||6336|10219||1|H|S
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PEU|0|0|0|100|DKK|37870|51172|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||37870||37870|51172||1|0|G
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MEA|0|0|0|100|DKK|6334|10216|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||6334||6334|10216||2|0|
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|63082|83060|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||63082||63082|83060||1|0|L
136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|2957|5568|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2957||2957|5568||1|0|
136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0|
136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0|
137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11546|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G
137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|1756|3572|lyfalmen|V1002|3572|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1507||1507|3572||2|0|E
137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|0|G|0|MEC|0|0|0|100|SEK|668|2417|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||668||668|2417||2|0|G
137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|1|0|100|SEK|1972438|2459672|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||1972438||1972438|2459672||2|0|L
137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|6990|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G
138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4824|4939|lyfalmen|V0689|3059|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2500||2500|4939||2|0|E
138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2817|5375|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2817||2817|5375||2|0|G
138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|2499299|3114939|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2499299|3114939||2|0|ES
138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2806|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17310|25323|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||17310||17310|25323||1|0|
138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3671|6551|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3671||3671|6551||2|0|G
138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5196|5952|lyfalmen|V0691|5952|2|30|0|18,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3236||3236|5952||1|0|E
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2804|4920|lyfalmen|V0373|4920|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2486||2486|4920||1|0|G
139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|AEB|0|1|0|100|XEU|110272|143659|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||110272||110272|143659||1|0|L
139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G
140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|556|2263|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||556||556|2263||1|0|G
140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2393|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G
140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0|
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1052|2946|lyfalmen|V0266|2368|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||1052||1052|2946||1|0|G
140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|16249|21626|lyfalmen|V0588|21626|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||14624||14624|21626||1|0|G
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|9735|14897|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9735||9735|14897||1|0|S
140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|1|0|0|0|ARO|0|0|0|100|DKK|7209|11420|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||7209||7209|11420||2|0|E
140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|1|0|0|0|TVB|0|0|0|100|XEU|3327|6077|lyfalmen|V0958|6077|2|30|0|10,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Metýlfenídat||3327||3327|6077||1|0|E
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|74730|141948|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||74730||74730|141948||1|0|
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|53889|71432|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||53889||53889|71432||1|0|S
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1222|3180|lyfalmen|V0413|2931|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1222||1222|3180||1|0|G
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|3204|5908|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||3204||3204|5908||1|0|G
141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0|
141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|3700|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1600||1600|3700||2|0|0
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|3639|6507|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3639||3639|6507||1|0|S
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MRP|0|0|0|100|SEK|15069|22239|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||15069|22239||2|0|G
141783|R02AX0101|Strefen|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0|
141805|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|3|dropaí||A07DA02|01.06.2018||R|0|0|1|0|0|0|ARO|0|0|0|100|DKK|19323|28094|lyfalmen|||2|30|0|3,0000|Pharmanovia A/S|Pharmanovia A/S|opium||19323||19323|28094|31.7.2020|2|0|E
141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|36728|45037|lyfalmen|V1007|45037|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||33020||33020|45037||2|0|E
141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3744||1|0|
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6377|10275|lyfalmen|V0267|3975|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||6377||6377|10275||1|0|G
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1708|3849|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1708||1708|3849||2|0|G
142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|23419|32894|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||23419|32894||5|H|S
142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|2723|4693|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2723||2723|4693||1|0|
142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|4289|4906|lyfalmen|V0384|3813|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2476||2476|4906||1|0|G
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|870|2695|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||870||870|2695||1|0|G
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|3202|5905|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||3202||3202|5905||2|0|E
142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|458767|577089|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||458767||458767|577089||1|0|ES
142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1056|2951|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||1056||1056|2951||2|0|G
142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2461|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G
142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2043|2943|lyfalmen|V0049|2943|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1050||1050|2943||2|0|G
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0|
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2280|4636|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2280||2280|4636||1|H|S
143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8856|4994|lyfalmen|V0687|4939|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2540||2540|4994||1|0|E
143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4362|7502|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4362||4362|7502||1|0|
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|589|2309|lyfalmen|V0542|2309|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||589||589|2309||1|0|G
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|CLA|0|0|0|100|XEU|1105|3019|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1105||1105|3019||1|0|
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1374|3389|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1374||1374|3389||1|0|E
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5084|8496|lyfalmen|V0387|7507|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5084||5084|8496||1|0|G
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|4981|8354|lyfalmen|V0386|7313|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4981||4981|8354||1|0|G
143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|GRP|0|0|0|100|DKK|2950|5558|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Litíum||2950||2950|5558||1|0|G
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1735|3886|lyfalmen|V0174|2461|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1735||1735|3886||1|0|E
144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3475|6281|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3475||3475|6281||1|0|G
144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|9728|14572|lyfalmen|V0587|13889|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9499||9499|14572||1|0|G
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1461|2655|lyfalmen|||2|24|0|8,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||841||841|2655||1|0|
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|0|1|JAN|0|1|0|100|DKK|81658|106555|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||81658||81658|106555||1|H|L
145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4805|8112|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4805|8112||1|0|G
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4751|9184|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4751||4751|9184||1|0|
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|6423|12356|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||6423||6423|12356||1|0|
145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|695899|872015|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||695899||695899|872015||2|0|L
145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|514|2205|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||514||514|2205||1|0|G
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0|
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|7812|14991|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7812||7812|14991||1|0|
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|9352|17913|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||9352||9352|17913||1|0|
145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|7183|11385|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7183||7183|11385||2|0|S
145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|0|1|0|1|CLU|0|0|0|100|XEU|115659|150359|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||115659||115659|150359||1|0|S
145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|5311|8808|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5311||5311|8808||1|0|G
145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|26836|37216|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||26836||26836|37216||1|0|G
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGP|0|1|0|100|DKK|25842|35959|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||25842||25842|35959||1|H|L
146102|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|0|G|0|MYL|0|0|0|100|DKK|5889|6062|lyfalmen|V0985|5792|2|30|0|60,0000|Icepharma hf|Mylan AB|Sólífenacín||3316||3316|6062||2|0|G
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|17957|26214|lyfalmen|V0817|4560|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17957||17957|26214||2|0|E
146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|0|G|0|MYL|0|0|0|100|DKK|14972|13375|lyfalmen|V0441|12497|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||8629||8629|13375||2|0|G
146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|0|1|0|1|HPI|0|0|0|100|DKK|259912|329769|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||259912||259912|329769||1|0|ES
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|337|1962|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||337||337|1962||1|0|
146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0815|4224|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9192|14150|lyfalmen|V0608|14150|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||9192||9192|14150||1|0|G
147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2916|lyfalmen|V0322|2916|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1030||1030|2916||2|0|G
147578|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0|
147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|1771|3936|lyfalmen|||2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1771||1771|3936||1|0|E
147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4939|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E
147902|L01XE2901|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|0|1|0|1|SIE|0|0|0|100|SEK|246583|313191|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||246583||246583|313191||1|0|S
147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|16484|24186|lyfalmen|V1009|24186|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16484||16484|24186||1|0|E
148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|161007|206759|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||161007|206759||2|0|ES
148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|0|1|0|1|VAL|0|0|0|100|XEU|51655|68607|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||51655||51655|68607||2|0|S
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|100676|131724|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||100676||100676|131724||2|0|
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1215|2874|lyfalmen|V0577|2874|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||1000||1000|2874||1|0|E
148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1809|3988|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1809||1809|3988||1|0|E
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|6217|9643|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||5918||5918|9643||1|0|E
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|STG|0|0|0|100|DKK|62293|82062|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||62293||62293|82062||1|0|E
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|STG|0|0|0|100|DKK|62293|82062|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||62293||62293|82062||1|0|E
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|569|2281|lyfalmen|V0601|2168|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||569||569|2281||1|0|G
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|1001|2876|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1001||1001|2876||1|0|G
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81814||5|H|S
148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|1|WEH|0|0|1|100|XEU|14341|16396|lyfsjukr|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||10824||10824|16396||2|0|S
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3661|7116|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3661||3661|7116||2|0|
149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|473|2149|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||473||473|2149||1|0|G
149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0|
149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|283008|358494|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||283008||283008|358494||1|H|L
149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|2475|4905|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2475||2475|4905||1|0|S
149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|1|WEH|0|0|0|100|XEU|15449|22762|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||15449||15449|22762||2|H|ES
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7792||1|0|G
150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4613|5627|lyfalmen|V0253|4190|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3000||3000|5627||2|0|G
150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|170396|218436|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||170396||170396|218436||1|H|L
150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0805|10445|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|42180|56623|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||42180|56623||1|0|S
151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4300|2737|lyfalmen|V0607|2737|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G
151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|46241|58380|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||43569||43569|58380||2|0|ES
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6101|9895|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6101||6101|9895||1|0|G
151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0|
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|1469|3520|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1469||1469|3520||1|0|G
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|30841|42281|lyfalmen|V0607|2737|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||30841||30841|42281||1|0|G
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|427|2086|lyfalmen|V0633|2009|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||427||427|2086||1|0|G
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MCE|0|0|0|100|SEK|4354|7491|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4354|7491||2|0|G
151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|5295|3026|lyfalmen|V0682|3026|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|1141|3068|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1141||1141|3068||1|0|
151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0|
151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1930|2844|lyfalmen|V0234|1802|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||978||978|2844||1|0|G
151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|118118|113483|lyfsjukr|||2|12|0|24,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||87136||87136|113483||2|0|S
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1783|3952|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1783||1783|3952||1|H|S
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0|
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2824|5385|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2824||2824|5385||1|0|G
152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4533|7737|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4533||4533|7737||1|0|G
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8288|12906|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8288||8288|12906||1|0|G
152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|6238|4251|lyfalmen|||2|42|0|7,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||2000||2000|4251|31.7.2020|1|0|G
152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|6763|9498|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||5812||5812|9498||1|0|G
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1|0|
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1560|3645|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1560||1560|3645||2|0|
153179|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2019||R|0|0|0|0|G|0|GLZ|0|0|0|100|DKK|3630|5905|lyfalmen|V0436|5905|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||3202||3202|5905||2|0|G
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1|0|
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|31767|43453|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||31767|43453||1|0|S
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín||||||31.8.2020|1|0|G
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSE|0|0|0|100|DKK|181145|231805|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||181145||181145|231805||2|H|ES
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|727|2499|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||727||727|2499||1|0|G
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|39646|43231|lyfalmen|V0452|43231|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||31592||31592|43231||1|0|G
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3733|6636|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3733||3733|6636||1|0|E
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1211|3165|lyfalmen|||2|24|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1211||1211|3165||1|0|
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G
154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|ALE|0|0|0|100|SEK|22317|20664|lyfalmen|V0183|20664|2|1|0|27,9070|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||13925||13925|20664||2|0|G
154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|7004|lyfalmen|V0995|7004|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||4000||4000|7004||2|0|G
154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|0|G|0|GSD|0|0|0|100|DKK|8890|13734|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||8890||8890|13734||1|0|G
154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2301|4665|lyfalmen|||1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2301||2301|4665||1|0|G
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||13372||1|0|G
154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|21602|30596|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17986|26254|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||17986||17986|26254||1|0|S
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20551|29267|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||20551||20551|29267||1|0|S
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25708|35789|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||25708||25708|35789||1|0|S
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23454|32938|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||23454||23454|32938||1|0|S
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23518|33019|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||23518||23518|33019||1|0|S
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28503|39324|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||28503||28503|39324||1|0|S
154697|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|0|G|0|MYL|0|0|0|100|DKK|4742|3787|lyfalmen|V0438|3787|2|30|0|30,0000|Icepharma hf|Mylan AB|Sólífenacín||1663||1663|3787||2|0|G
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15334|22604|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||15334||15334|22604||1|0|S
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3070|5723|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3070||3070|5723||1|0|G
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22660|31934|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||22660||22660|31934||1|0|S
154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3537|3240|lyfalmen|V0334|2549|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1266||1266|3240||1|0|G
154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6200|3240|lyfalmen|V0335|2549|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1266||1266|3240||1|0|G
155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013|31.07.2020|R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2339|3975|lyfalmen|||2|30|0|15,0000|Alvogen|ratiopharm GmbH|Memantín||1800||1800|3975||2|0|G
155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|1|0|100|SEK|1314959|1641952|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1314959||1314959|1641952||2|0|L
155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1684|2295|lyfalmen|V0247|2295|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||579||579|2295||2|0|G
155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|3148|3941|lyfalmen|V0248|3941|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1775||1775|3941||2|0|G
155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|5951|4500|lyfalmen|V0249|4500|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||2181||2181|4500||2|0|G
155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|17868|26091|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||17868||17868|26091||1|0|
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1567|3655|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1567||1567|3655||1|0|G
155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5818|7273|lyfalmen|V0253|4190|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4196||4196|7273||1|0|G
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|675|2427|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||675||675|2427||1|0|G
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1425|3097|lyfalm11|V0590|3057|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1425||1425|3097||1|0|
155485|L01XX4601|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|0|1|0|1|AZA|0|1|0|100|SEK|384680|484945|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||384680||384680|484945||1|0|L
155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0|
155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|G|0|SSE|0|0|1|100|DKK|38604|52100|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||38604||38604|52100||1|0|G
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5290|8779|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5290||5290|8779||1|0|E
156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|0|1|0|1|KAN|0|0|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|S
156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|20669|29416|lyfalmen|V0383|21088|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||20669||20669|29416||1|0|G
156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|5252|8727|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5252||5252|8727||2|0|G
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|6096|9888|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6096||6096|9888||2|0|G
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|397|2044|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||397||397|2044||2|0|0
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|650|2393|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||650||650|2393||1|0|
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|DKK|8081|13348|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6946||6946|13348||2|0|0
157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E
157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0|
157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0|
157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64824|85263|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||64824||64824|85263||2|H|S
157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39826|48608|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||35843||35843|48608||1|0|S
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1483|3539|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1483||1483|3539||1|0|G
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6522|10475|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6522||6522|10475||1|0|
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|1033|2920|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1033||1033|2920||1|H|S
158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|20172|28787|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||20172|28787||1|0|
158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|45957|61400|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||45957|61400||1|H|ES
158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|70486|92424|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||70486||70486|92424||1|H|ES
158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4060|3710|lyfalmen|V0143|3604|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1607||1607|3710||1|0|E
158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|256100|325028|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||256100||256100|325028||2|0|L
158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|14688|4560|lyfalmen|V0817|4560|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2225||2225|4560||2|0|E
158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|1724|2599|lyfalmen|V0967|2599|2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||800||800|2599||2|0|
159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1823|4007|lyfalmen|V0219|4007|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1823||1823|4007||1|0|G
159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|3630|6494|lyfalmen|V0220|6372|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3630||3630|6494||1|0|G
159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|5241|8712|lyfalmen|V0221|8712|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5241||5241|8712||1|0|G
159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0|
159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|5188|8639|lyfalmen|V0223|8639|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5188||5188|8639||1|0|G
159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|4800|4526|lyfalmen|V0814|4526|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E
159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|10818|16161|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10653||10653|16161||1|0|G
159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|0|0|1|IPC|0|1|0|100|SEK|131871|155561|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||119842||119842|155561||2|H|L
159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0|
159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|44871|60026|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||44871||44871|60026||2|H|S
159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|459|2130|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||459||459|2130||2|0|G
159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1391|3412|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1391||1391|3412||2|0|G
159751|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|512|2101|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||438||438|2101||2|0|ES
159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G
159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|0|LVR|0|0|0|100|DKK|44329|59341|lyfalmen|V0980|59341|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||44329||44329|59341||3|0|E
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|138486|178749|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||138486||138486|178749||1|H|S
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NIL|1|0|0|100|XEU|4246|8226|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||4246||4246|8226||2|0|
160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SUG|0|1|0|100|XEU|63309|83347|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||63309||63309|83347||2|0|L
160195|C09CA0307|Valsartan Jubilant|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|IKR|2000|3838|lyfalmen|V0678|3563|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1700||1700|3838||2|0|G
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|GRP|0|0|1|100|XEU|5785|3093|lyfalmen|V0010|2193|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1159||1159|3093||1|0|E
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|829|2639|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||829||829|2639||1|0|G
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|931|2779|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||931||931|2779||1|H|S
161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1486|3543|lyfalmen|V0169|2530|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1486||1486|3543||1|0|E
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2566|5030|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2566||2566|5030||1|0|G
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|613|2342|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||613||613|2342||1|0|G
161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1709|2512|lyfalmen|V0143|1201|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||737||737|2512||1|0|E
161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|4210|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|57934|76549|lyfalmen|V0452|43231|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||57934||57934|76549||1|0|G
161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|1|100|DKK|6577|10551|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||6577|10551||2|0|ES
161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2715|5235|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2715||2715|5235||1|0|G
161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AGC|0|0|0|100|XEU|28393|39185|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||28393||28393|39185||1|0|G
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|RRD|0|0|0|100|DKK|551810|692808|lyfalmen|||1|60|0|30,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||551810||551810|692808||1|0|E
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1967|4205|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1967||1967|4205||1|0|G
162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|13997|7761|lyfalmen|V0145|6315|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4550||4550|7761||2|0|E
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5718|11019|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5718||5718|11019||2|0|
162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2506|4084|lyfalmen|V0041|4084|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1879||1879|4084||2|0|G
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|500|2101|lyfalmen|V0500|2082|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||438||438|2101||1|0|G
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|723|2493|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||723||723|2493||1|0|G
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|452|2120|lyfalmen|V0502|2120|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||452||452|2120||1|0|G
162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|0|1|0|1|CLU|0|1|0|100|XEU|26243|36466|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||26243||26243|36466||1|0|L
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1207|3159|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1207||1207|3159||1|0|G
163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|9788|14970|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9788||9788|14970||1|0|G
163082|N02BA5103|Triplo|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2018||L|0|0|0|0|0|0|OEC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|Orifarm Generics A/S|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1|0|
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|1240|3205|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1240||1240|3205||1|0|E
163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0|
163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|4139|7195|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||4139||4139|7195||2|0|G
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|1148|3078|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1148||1148|3078||1|0|
163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3339|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G
163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|6387|10289|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6387||6387|10289||1|0|
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11066|16729|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11066||11066|16729||2|H|S
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2456|4878|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2456||2456|4878||1|0|G
163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|490560|616631|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||490560||490560|616631||2|0|L
163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1790|3962|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1790||1790|3962||1|0|G
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHG|0|0|1|100|XEU|616|2346|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||616||616|2346||2|0|G
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|1847|4040|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1847||1847|4040||2|0|G
163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3734|6637|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3734||3734|6637||1|0|S
164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|NRO|0|0|0|100|DKK|39957|53811|lyfsjukr|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||39957||39957|53811||2|0|S
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9722|18615|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9722||9722|18615||1|0|
164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|346565|437541|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||346565||346565|437541||1|0|L
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1022|2905|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1022||1022|2905||2|0|G
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1256|3227|lyfalmen|V0314|3227|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1256||1256|3227||2|0|G
164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|DKK|5357|8871|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5357||5357|8871||2|0|G
164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0|
165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0|
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1540|3618|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1540||1540|3618||1|0|
165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|21602|30596|lyfalmen|V0667|30596|1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6995|13441|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6995||6995|13441||2|0|
165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2018||R|0|0|0|0|0|1|EHF|0|0|0|100|XEU|8673|13435|lyfsjukr|||2|25|0||Actavis Group PTC hf|Actavis ehf|Írinótekan||8673||8673|13435||1|H|S
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|168201|215706|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||168201||168201|215706||2|0|L
165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|4359|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||||||||0|0
165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|199276|254355|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||199276||199276|254355||1|0|L
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4234|7326|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4234||4234|7326||1|0|S
165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|6053|11654|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||6053|11654||2|0|
166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8916|6040|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3300||3300|6040||2|0|E
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1547|3627|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1547||1547|3627||1|0|G
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|14578|21563|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14578||14578|21563||1|0|G
166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|0|MYL|0|0|0|100|DKK|8815|13631|lyfalmen|||1|5|0||Icepharma hf|Mylan AB|Inflúensa, hreinsaðir  mótefnavakar||||8815|13631||2|0|
166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2806|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G
166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABD|0|1|0|100|DKK|124321|161132|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||124321||124321|161132||1|0|L
167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|8346|11312|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||7130||7130|11312||2|0|E
167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|43706|58553|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||43706||43706|58553||2|0|L
167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2548|3081|lyfalmen|V0826|3075|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G
167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|1220|2461|lyfalmen|V0189|2461|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||700||700|2461||2|0|G
167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1814|3052|lyfalmen|V0005|2806|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1129||1129|3052||1|0|E
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|140824|181657|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||140824||140824|181657||2|0|S
168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|13886|lyfalmen|V0420|13886|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||9000||9000|13886||2|0|G
168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|103438|135159|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||103438||103438|135159||2|0|L
168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|5105|5996|lyfalmen|V0007|4251|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3268||3268|5996||1|0|E
168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|152209|195817|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly Nederland B.V.|Ixekizumab||152209||152209|195817||2|0|L
168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2537|4990|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2537||2537|4990||2|0|G
168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|3021|5656|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3021||3021|5656||2|0|G
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3000|5627|lyfalmen|V0240|5624|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3000||3000|5627||1|0|G
168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5703|9348|lyfalmen|V0433|9346|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5703||5703|9348||1|0|G
169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E
169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|0|1|CLU|0|0|0|100|XEU|536636|673936|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||536636||536636|673936||1|H|0
169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2874|lyfalmen|V0994|2874|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||1000||1000|2874||2|0|G
169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|1353|3353|lyfalmen|V0411|3353|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1348||1348|3353||2|0|E
169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|1088|2529|lyfalmen|V0177|2529|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||749||749|2529||2|0|E
169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|1074|2516|lyfalmen|V0418|2515|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||740||740|2516||2|0|E
169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|0|ZBE|0|0|0|100|IKR|6255|12037|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||6255||6255|12037||2|0|0
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2738|5267|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2738||2738|5267||2|0|
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2948|5556|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2948||2948|5556||2|0|
169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2|0|
170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|21342|30267|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||21342||21342|30267||2|H|L
170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|53076|70404|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||53076||53076|70404||2|H|L
170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|5345|8855|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5345||5345|8855||1|0|
170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|106292|138709|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||106292||106292|138709||2|H|L
170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|268946|341005|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||268946||268946|341005||1|0|L
170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|960|2258|lyfalmen|V0108|2258|2|100|0|33,3400|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||552||552|2258||1|0|G
170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|1|0|G|0|KAN|0|0|1|100|IKR|550|2255|lyfalmen|V0226|2255|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||550||550|2255||2|0|G
170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|194226|248074|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||194226||194226|248074||1|0|E
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|11790|17726|lyfalmen|||1|100|0|50,0000|Artasan ehf|Sandoz GmbH|Rífampicín||11790||11790|17726||1|0|G
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2241|4582|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2241||2241|4582||2|0|
170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|31455|39079|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||28309||28309|39079||1|0|S
170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|958|2817|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||958||958|2817||1|0|G
170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2|0|
170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|1|CPV|0|1|0|100|XEU|53042|70361|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||53042||53042|70361||2|H|L
171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|13886|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G
171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||3049||1|0|G
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2773|5431|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|Prednisolonum og sýkingalyf||2773||2773|5431||1|0|
171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|0|1|HUN|0|1|0|100|DKK|48034|64027|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||48034||48034|64027||1|H|L
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|3395|6171|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3395|6171||2|0|
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|3428|6216|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3428||3428|6216||2|0|
171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|MYL|0|0|0|100|DKK|1283|3264|lyfalmen|||1|30|0|20,0000|Icepharma hf|Mylan AB|Mebeverín||1283||1283|3264||2|0|G
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2735|5262|lyfalmen|V0247|2295|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2735||2735|5262||1|0|G
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4753|8040|lyfalmen|V0248|3941|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4753||4753|8040||1|0|G
172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|5000|8380|lyfalmen|V0253|8380|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||5000||5000|8380||2|0|G
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8798|13607|lyfalmen|V0249|4500|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8798||8798|13607||1|0|G
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|16012|23537|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||16012||16012|23537||1|0|G
172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|16466|24162|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||16466||16466|24162||1|0|
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|9309|14311|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||9309||9309|14311||1|0|G
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2754|2450|lyfalmen|V0284|2365|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||692||692|2450||1|0|G
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|7715|8951|lyfalmen|V0118|8414|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||5415||5415|8951||1|0|E
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||4142||1|0|E
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|12666|18931|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12666||12666|18931||1|0|S
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|GRP|0|0|1|100|DKK|3726|4892|lyfsjukr|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2466||2466|4892||1|0|S
174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|587|2306|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||587||587|2306||2|0|E
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1452|3496|lyfalmen|||1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1452||1452|3496||1|0|G
174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G
174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|10684|16203|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||10684||10684|16203||1|0|G
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3800|6728|lyfalmen|V0368|4738|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3800||3800|6728||1|0|G
174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|54248|49196|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||36308||36308|49196||2|0|S
174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0|
174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHE|0|0|0|100|DKK|16639|24400|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||16639||16639|24400||1|0|E
175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|24030|33667|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||24030|33667||3|0|S
175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|7258|9321|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5684||5684|9321||1|0|G
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5407|10429|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5407||5407|10429||2|0|
175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|1|CTH|0|1|0|100|DKK|187612|239848|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||187612||187612|239848||1|H|L
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|2253|2680|lyfalmen|||1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||859||859|2680||1|0|G
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|4723|7999|lyfalmen|V0278|3927|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4723||4723|7999||2|0|E
176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|0|G|0|KPA|0|0|1|100|DKK|1395|3418|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1395||1395|3418||2|0|G
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2686|4940|lyfalmen|V0429|3975|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2501||2501|4940||2|0|G
176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RNE|0|0|1|100|DKK|2787|5334|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2787||2787|5334||1|0|0
176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G
176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6678|12840|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6678||6678|12840||2|0|
176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2431|4844|lyfalmen|V0655|4844|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||2431|4844||2|0|E
177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|436135|548941|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||436135||436135|548941||1|H|S
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7910|12385|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7910||7910|12385||2|0|S
177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|358099|451886|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||358099||358099|451886||1|0|L
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1028|2913|lyfalmen|V0231|2650|2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||1028|2913||1|0|0
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4642|8977|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4642||4642|8977||2|0|
177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|367197|463201|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||367197|463201||2|0|E
177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|9493|12603|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||8068||8068|12603||1|0|G
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|34421|46809|lyfalmen|V0975|46067|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||34421||34421|46809||2|0|G
178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|836478|1046856|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||836478||836478|1046856||1|0|L
178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|96124|124851|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||96124|124851||3|0|S
178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|0|1|G|0|SHS|0|0|0|100|DKK|10265|15627|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||10265||10265|15627||1|0|G
178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0
179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|139944|163158|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||125950||125950|163158||1|0|L
179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0|
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|9246|14224|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9246|14224||2|0|G
179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|18116|26433|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18116||18116|26433||1|0|
179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8025|12544|lyfalmen|V0818|12544|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||8025||8025|12544||2|0|E
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|118332|153683|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||118332||118332|153683||2|0|L
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|4514|lyfalmen|V0148|4514|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2191||2191|4514||2|0|G
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|721|2490|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||721||721|2490||1|0|G
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0|
181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|9907|15134|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9907||9907|15134||1|H|S
181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0|
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|6201|10033|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||6201||6201|10033||1|0|
182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6796||2|0|G
182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E
182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|9810|15000|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9810||9810|15000||1|0|G
182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1413|3188|lyfalmen|V0048|2737|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1228||1228|3188||1|0|G
182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|15238|22472|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15238||15238|22472||2|H|S
182561|L01XE0303|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|0|1|0|1|WEH|0|1|0|100|XEU|322634|320965|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||252833||252833|320965||2|0|L
182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|8390|5772|lyfalmen|V0817|4560|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3105||3105|5772||1|0|E
182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|16710|31873|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||16710||16710|31873||1|0|
182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|20919|39858|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||20919|39858||2|0|
182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016|30.06.2020|R|0|1|0|0|0|1|CLU|0|0|0|100|XEU|11464|5799|lyfsjukr|||2|5|0|1,0000|Artasan ehf|Accord Healthcare S.L.U.|Zoledronsýra||3125||3125|5799||1|H|S
183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|1|PIP|0|0|1|100|DKK|180134|230547|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||180134||180134|230547||1|0|ES
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5463|10535|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5463||5463|10535||1|0|
183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|0|1|G|0|SHS|0|0|0|100|DKK|6145|9956|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||6145||6145|9956||1|0|G
183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E
183485|L01XE4201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|153160|196999|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||153160||153160|196999||1|0|L
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|5865|9571|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5865|9571||1|0|G
183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|0|G|0|LVR|0|0|0|100|DKK|29765|40920|lyfalmen|V0652|40920|3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||29765||29765|40920||3|0|G
183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7055|13555|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||7055||7055|13555||2|0|
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1204|3155|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Flúdrókortisón||1204||1204|3155||2|0|G
183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|4500|4526|lyfalmen|V0815|4526|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E
184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|358327|452170|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||358327||358327|452170||1|H|L
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|DKK|3214|5922|lyfalmen|V0017|5922|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3214||3214|5922||2|0|G
184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|44593|59675|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||44593|59675||2|H|S
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|47541|63403|lyfalmen|V0185|18732|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||47541||47541|63403||1|0|G
184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|0|PHM|0|0|0|100|XEU|12964|24766|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||12964||12964|24766||2|0|
184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E
185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0|
185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1915|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0|
186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|288373|365167|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||288373|365167||3|0|S
186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|18038|11731|lyfalmen|V0419|11338|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||7435||7435|11731||1|0|E
186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|16472|20006|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||13447||13447|20006||2|0|G
186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0|
186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1011|2818|lyfalmen|V0597|2815|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||959||959|2818||1|0|G
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|10028|3081|lyfalmen|V0607|2793|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3081||2|0|G
186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|6313|10187|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6313||6313|10187||1|0|
187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|0|1|SUG|0|1|0|100|XEU|42700|57281|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||42700||42700|57281||2|H|L
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G
187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5914|10193|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5914||5914|10193||2|0|
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|3934|6913|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3934||3934|6913||2|0|G
187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|923|2768|lyfalmen|V0066|2737|2|100|0|100,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Enalapríl||923||923|2768||1|0|G
188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3264||2|0|G
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|71702|93962|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||71702||71702|93962||1|H|ES
188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2163|4475|lyfalmen|V0621|2667|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||2163||2163|4475||2|0|G
188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016|31.08.2020|R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|13309|19816|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||13309||13309|19816||1|0|G
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2967|5582|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2967||2967|5582||1|0|G
188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|5643|9265|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5643||5643|9265||1|0|G
188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G
188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|2874|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G
189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|9780|14203|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||9231||9231|14203||2|H|S
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|42102|56524|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||42102||42102|56524||1|0|S
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6900|10995|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6900||6900|10995||1|H|S
189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|0|1|0|0|NEL|0|0|0|100|DKK|78238|102229|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||78238||78238|102229||1|0|E
189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|5466|9021|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5466||5466|9021||2|0|G
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2722|5244|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2722||2722|5244||1|0|G
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1041|2931|lyfalmen|V0413|2931|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1041||1041|2931||1|0|G
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|504|2192|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||504||504|2192||1|0|G
190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1730|3879|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1730||1730|3879||2|0|G
190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2737|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E
190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|23994|33621|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||23994||23994|33621||1|0|G
191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4201||1|0|G
191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3594|6445|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3594||3594|6445||1|0|S
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5499|5477|lyfalmen|V0117|5177|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||2891||2891|5477||1|0|E
191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|893|2727|lyfalmen|V1026|2727|2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||893||893|2727||2|0|G
191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3687|6573|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3687||3687|6573||1|0|S
191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3847|6793|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3847||3847|6793||1|0|S
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0|
191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3516|6337|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3516||3516|6337||2|0|G
191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|18936|6077|lyfalmen|V0689|5463|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3327||3327|6077||1|0|
192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|1159|2278|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1159||1159|2278||1|0|
192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||2|0|
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|5321|8406|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5019||5019|8406||1|0|G
192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2937|4364|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||2082||2082|4364|31.8.2020|1|0|G
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|KAR|0|0|0|100|DKK|2273|4626|lyfalmen|||1|100|0|100,0000|Vistor hf|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2273||2273|4626||2|0|G
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|6658|10662|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6658||6658|10662||2|0|S
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|1|TIC|0|1|0|100|XEU|150757|194011|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||150757||150757|194011||1|H|L
193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2757|2843|lyfalmen|V0233|2303|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||977||977|2843||1|0|G
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|864|2687|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||864||864|2687||1|0|G
193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|IKR|21696|7689|lyfalmen|V0721|7689|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||4498||4498|7689||2|0|
193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|21602|30596|lyfalmen|V0667|30596|1|28|0|35,0000|Vistor hf|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E
193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|0|1|0|1|ZEN|0|1|0|100|SEK|356670|450109|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||356670||356670|450109||1|0|L
194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3754|3622|lyfalmen|V0143|3604|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1543||1543|3622||2|0|E
194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|2538|2333|lyfalmen|V0556|2186|2|4|0|3,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||607||607|2333||1|0|E
194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5540|10681|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5540||5540|10681||2|0|
194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|1|100|XEU|5726|5832|lyfalmen|V0012|5832|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3149||3149|5832||1|0|G
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2955|5565|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||2955||2955|5565||2|0|G
195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0|
195449|A02BC0403|Rabeprazol Krka|sþ-hylki|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0||LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0|
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0|
195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|56067|74187|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||56067||56067|74187||2|0|L
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|154064|198124|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||154064||154064|198124||1|0|L
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|831|2642|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||831||831|2642||1|0|G
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|635|2372|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||635||635|2372||1|0|E
195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|3299|5445|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2868||2868|5445||2|0|G
196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2485|4918|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2485||2485|4918||2|0|G
196518|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.04.2019||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|56745|75045|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||56745||56745|75045||1|H|0
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|6256|10109|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||6256||6256|10109||2|0|G
196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|626|2360|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||626||626|2360||1|0|G
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|21195|30081|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||21195|30081||1|0|S
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|800|2599|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||800||800|2599||2|0|G
197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|0|1|PEU|0|1|0|100|DKK|42925|57565|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||42925||42925|57565||1|H|L
197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1697|3834|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1697||1697|3834||2|0|
197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|259367|329091|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||259367||259367|329091||1|0|E
198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0|
198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|2872|3425|lyfalmen|V0116|3063|2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1400||1400|3425||2|0|
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3429|2806|lyfalmen|V0069|2806|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||950||950|2806||2|0|G
198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4072|7103|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4072||4072|7103||1|0|G
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|36455|49382|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||36455||36455|49382||1|0|G
199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|8461|13144|lyfalmen|V0805|9749|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8461|13144||2|0|G
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|637|2375|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||637||637|2375||1|0|
199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0|
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|75927|99306|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||75927|99306||1|0|S
199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6009|9769|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||6009||6009|9769||1|0|G
199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|2293935|2859524|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2293935||2293935|2859524||1|H|L
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|39511|75131|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||39511||39511|75131||1|0|
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1912|4130|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1912||1912|4130||2|0|E
370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|258407|304350|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||239474||239474|304350||2|0|L
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0|
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0|
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||10553||1|0|E
371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|782806|980103|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib hydrochloride||782806||782806|980103||2|0|L
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|3752|6662|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3752||3752|6662||1|0|G
372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|0|1|0|1|AOP|0|0|0|100|XEU|32823|44788|lyfsjukr|||1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||32823|44788||2|0|0
372121|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.11.2018||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0|
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3301|6041|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3301||3301|6041||2|0|G
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|7192|11397|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||7192||7192|11397||2|H|L
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|1|0|0|0|TVB|0|0|0|100|XEU|8422|8001|lyfalmen|V0996|7898|2|30|0|40,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Metýlfenídat||4725||4725|8001||1|0|E
372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2953||2|0|G
373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3105|5627|lyfalmen|V0934|5627|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3000||3000|5627||2|0|
373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|83701|109139|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||83701|109139||3|H|S
373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G
373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|5509|7981|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4710||4710|7981||2|0|G
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|12791|19103|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||12791||12791|19103||1|0|G
373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|86519|112703|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||86519||86519|112703||2|0|S
373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3848|6794|lyfalmen|V0436|5905|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3848||3848|6794||1|0|G
373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4699|7966|lyfalmen|V0437|6658|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4699||4699|7966||1|0|G
373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5953|9692|lyfalmen|V0981|8334|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5953||5953|9692||1|0|G
373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|4272|7378|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||4272||4272|7378||1|0|
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|6061|5150|lyfalmen|||2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||2653||2653|5150|31.7.2020|2|0|G
373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|1|ILT|0|0|0|100|XEU|421175|530335|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||421175||421175|530335||2|0|S
374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|8540|13252|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8540||8540|13252||3|H|ES
374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|365424|450660|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||357113||357113|450660||1|0|S
374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|240259|305326|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||240259||240259|305326||1|0|L
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|492|2175|lyfalmen|V0500|2082|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||492||492|2175||2|0|G
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5543|9127|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5543||5543|9127||1|0|S
374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3860|6811|lyfalmen|V0926|3940|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3860||3860|6811||1|0|G
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|10913|16519|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10913||10913|16519||1|0|G
374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|358099|451886|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||358099||358099|451886||1|0|L
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||2|0|
374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|5452|9002|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5452||5452|9002||1|0|
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|7044|11193|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7044||7044|11193||1|0|G
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|8314|12941|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8314||8314|12941||1|0|G
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|9737|14900|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9737||9737|14900||1|0|G
374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|6572|10544|lyfalmen|V0383|10544|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||6572||6572|10544||1|0|G
374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0
375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|3302623|4114047|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3302621||3302621|4114047||2|H|S
375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G
375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ACC|0|0|1|100|XEU|11486|17307|lyfsjukr|||2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||11486|17307||1|0|ES
375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4000|2737|lyfalmen|V0605|2737|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G
375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2610|5090|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2610||2610|5090||2|0|G
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|27015|37442|lyfalmen|V0459|37442|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||27015||27015|37442||1|0|G
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGP|0|0|0|100|DKK|5869|9576|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5869||5869|9576||1|0|G
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|17085|25014|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||17085||17085|25014||1|0|G
376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0|
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|89457|116419|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||89457||89457|116419||1|0|G
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|BRO|1|0|0|100|XEU|12825|22105|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||12825||12825|22105||2|0|
377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|216842|276202|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||216842||216842|276202||1|0|E
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|9240|8118|lyfalmen|V0182|4365|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4810||4810|8118||1|0|G
377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018||R|1|0|0|0|G|0|TVA|0|0|0|100|DKK|2317|3118|lyfalmen|V0909|3118|2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||1177||1177|3118||2|0|G
377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|0|1|G|0|GRI|0|0|0|100|IKR|4291|7404|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||4291||4291|7404||3|0|G
377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|27989|35135|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||25191||25191|35135||1|0|L
378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|574051|720470|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||574051||574051|720470||2|0|S
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1376|3392|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1376||1376|3392||1|0|G
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|16484|24186|lyfalmen|V1009|24186|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16484||16484|24186||1|0|E
378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|15788|23229|lyfalmen|V0982|23229|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||15788||15788|23229||3|0|G
378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1776|3942|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1776||1776|3942||1|0|G
379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1401|3426|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1401||1401|3426||1|0|G
379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G
379351|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|9208|14172|lyfalmen|V0587|14172|2|100|0|53,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9208||9208|14172||1|0|G
379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|192249|245615|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||192249|245615||3|0|S
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|125227|162259|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||125227||125227|162259||1|0|L
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|117883|121969|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||93845||93845|121969||1|0|S
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|129032|134895|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||103226||103226|134895||1|0|S
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|164625|170309|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||131700||131700|170309||1|0|S
379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5876|7251|lyfalmen|V0532|7251|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||4180||4180|7251||2|0|G
379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|2328|4702|lyfalmen|||2|12,5|0|2,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2328||2328|4702||1|0|
379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|3086|5745|lyfalmen|||2|12,5|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||3086||3086|5745||1|0|
379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2348|3273|lyfalmen|V0322|2916|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1290||1290|3273||1|0|G
380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0|
380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2766|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E
380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|29713|40855|lyfalmen|V0653|40853|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||29713|40855||1|0|G
380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|605|2331|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||605||605|2331||1|0|G
380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|8937|10833|lyfalmen|V1010|10833|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||6782||6782|10833||2|0|G
380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E
380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|581|2298|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||581||581|2298||1|0|G
381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3194|5505|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3194||3194|5505||2|0|
381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|0|G|0|AZE|0|0|0|100|SEK|20160|28772|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||20160||20160|28772||1|0|G
381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|318225|402294|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||318225||318225|402294||1|0|
382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|0|1|0|0|OHA|0|0|0|100|XEU|172141|220606|lyfalmen|||1|5|0||Orphan Europe Nordic AB|Orphan Europe SARL|mercaptamine ||172141||172141|220606||3|0|
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0|
382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0|
382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|144186|185838|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||144186|185838||3|0|S
382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|5082|8493|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5082||5082|8493||1|0|G
382940|N06BA0702|Modafinil Bluefish|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.12.2019|31.07.2020|R|1|0|0|1|0|0|BFP|0|0|0|100|XEU|13377|19910|lyfalmen|||2|90|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Modafinil||13377||13377|19910||1|0|E
383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|0|1|0|0|TGH|0|0|0|100|XEU|75497|98762|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||75497||75497|98762||1|0|E
383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|12297|18424|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||12297||12297|18424||1|0|L
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1296|2201|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||1277||1277|2201||2|0|
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1|0|
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1|0|
383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1725|3872|lyfalmen|V0314|3227|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1725||1725|3872||1|0|G
383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|0|1|WEH|0|1|0|100|XEU|166838|214011|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||166838||166838|214011||2|H|L
384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|3250|2117|lyfalmen|V0006|1224|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||450||450|2117||2|0|G
384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|7217|11431|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7217||7217|11431||1|0|G
384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0|
384837|N07BC0102|Buvidal|stl|32|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|14228|21081|lyfsjukr|||1|1|0|4,0000|Vistor hf|Camurus AB|Búprenorfín||14228||14228|21081||1|H|S
384858|L01XE0105|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|0|1|0|1|RTH|0|1|0|100|XEU|170595|111826|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatiníb||85826||85826|111826||2|0|L
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|7645|12020|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7645||7645|12020||1|0|
386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|RRD|0|0|0|100|DKK|376692|475011|lyfsjukr|||1|1|0|50,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||376692||376692|475011||1|0|ES
386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|0|1|0|1|FKA|0|0|0|100|DKK|36575|49534|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||36575||36575|49534||1|0|0
386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6701|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E
387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7839|12288|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7839||7839|12288||1|0|G
387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|1|WEH|0|1|0|100|XEU|149945|193001|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||149945||149945|193001||2|H|L
387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|935|2785|lyfalmen|V0308|2785|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||935||935|2785||2|0|
387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5808|11189|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5808||5808|11189||2|0|
387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10732|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|S
388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0||Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0|
388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0|
388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|133276|172269|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Temsirolímus||133276||133276|172269||1|H|S
388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2642|5134|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2642||2642|5134||2|0|
388264|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|3151|5835|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3151||3151|5835||2|0|
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0|
388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017|31.08.2020|R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|11367|17143|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||11367||11367|17143||1|H|S
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.04.1994||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|5672|9305|lyfalmen|V1024|9305|1|20|0||Icepharma hf|Aspen Pharma|Blöndur||5672||5672|9305||2|0|
388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|68057|23339|lyfalmen|V0722|17168|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||15868||15868|23339||2|0|
388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|9206|14169|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||9206||9206|14169||2|0|G
389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|0|0|1|WEH|0|0|0|100|XEU|6896|10990|lyfsjukr|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6896||6896|10990||2|H|S
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|531|2229|lyfalmen|||1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||531||531|2229|31.7.2020|2|0|G
389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|331281|418532|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||331281|418532||2|0|L
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|HEA|0|0|1|100|SEK|803|2603|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||803||803|2603||1|0|G
389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G
389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821||2|0|0
389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|450|2117|lyfalmen|||2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||450||450|2117||2|0|E
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MRP|0|0|0|100|SEK|43363|58119|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||43363|58119||2|0|G
389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|16063|23607|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||16063||16063|23607||1|0|G
390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G
390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|1|TVB|0|1|0|100|NOK|69797|91553|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||69797||69797|91553||1|H|L
390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|COR|0|0|0|100|DKK|79251|103510|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||79251||79251|103510||1|H|S
390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|3462|6263|lyfalmen|V0381|5035|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3462||3462|6263||1|0|G
390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|5959|9700|lyfalmen|V0429|3975|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||5959||5959|9700||1|0|G
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2795|5345|lyfalmen|V0037|2599|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2795||2795|5345||1|0|G
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|10224|15570|lyfalmen|V0196|5627|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||10224||10224|15570||1|0|G
391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|278691|353125|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||278691||278691|353125||1|0|L
392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|496|1952|lyfalm11|V0545|1915|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||496||496|1952||1|0|
392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|31099|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|ES
392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|1031|2917|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||1031||1031|2917||2|0|G
392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|12557|18781|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12557||12557|18781||2|0|E
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|9498|10896|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||6828||6828|10896||1|0|G
392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|0|1|0|1|BNB|0|1|0|100|XEU|24402|34137|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||24402||24402|34137||2|0|L
393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2874|lyfalmen|V0109|2403|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||1000||1000|2874||2|0|G
393642|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0|
393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2308|4108|lyfalmen|V0669|4108|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1896||1896|4108||2|0|G
394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|2104|3728|lyfalmen|V0123|3728|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1620||1620|3728||2|0|E
394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|53183|70539|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||53183||53183|70539||2|0|ES
394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5281|7968|lyfalmen|V0681|7860|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4701||4701|7968||1|0|E
395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|83542|108938|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||83542||83542|108938||1|0|
395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|36908|49955|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||36908||36908|49955||1|0|
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|145382|187326|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||145382||145382|187326||1|0|S
395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|6469|10402|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6469||6469|10402||1|0|
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|18333|26731|lyfalmen|V0356|26731|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||18333||18333|26731||3|0|G
396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|5007|8390|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5007||5007|8390||1|0|G
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5506||1|0|G
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|21542|41040|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||21542||21542|41040||2|0|
396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|54518|72228|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||54518||54518|72228||1|0|0
396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5690|10966|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5690||5690|10966||1|0|
396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|3386|6158|lyfalmen|||2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||3386||3386|6158||1|0|0
397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3631|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E
397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2333|2877|lyfalmen|V0250|2395|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||1002||1002|2877||1|0|G
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|1|MCE|0|1|0|100|SEK|33193|45256|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||33193||33193|45256||2|H|L
397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3484|6293|lyfsjukr|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3484||3484|6293||1|H|S
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002|30.06.2020|R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|30158|41417|lyfsjukr|||1|120|0||Icepharma hf|Roche Registration GmbH|Capecitabín||30158||30158|41417||2|0|S
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E
397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|0|1|G|0|AEE|0|0|0|100|XEU|31813|43511|lyfalmen|V1008|43511|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||31813||31813|43511||1|0|G
398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|895|2730|lyfsjukr|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||895||895|2730||1|H|S
398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|673|2424|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||673||673|2424||2|0|G
398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|22398|31603|lyfsjukr|||2|2|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22398||22398|31603||1|H|S
399034|C09CA0307|Valsartan Jubilant|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|IKR|3500|4113|lyfalmen|V0679|3904|2|98|0|196,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1900||1900|4113||2|0|G
399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|178070|227980|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||178070||178070|227980||1|0|L
399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0|
399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|81251|106040|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||81251||81251|106040||1|H|S
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|0|100|DKK|506|2194|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||506||506|2194||1|0|G
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2732|3141|lyfalmen|V0244|3141|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1194||1194|3141||1|0|G
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9126|14059|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9126||9126|14059||1|0|G
399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|358099|451886|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||358099||358099|451886||1|0|L
399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2326|2902|lyfalmen|V0824|2876|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1020||1020|2902||2|0|G
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1244|3210|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1244||1244|3210||1|0|G
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur||||||||0|0
400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|123353|159928|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||123353||123353|159928||1|0|S
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2632|5121|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2632||2632|5121||1|0|E
400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|59622|78684|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||59622||59622|78684||1|0|G
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|503|2190|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||503||503|2190||1|0|
400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|556|2263|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||556||556|2263||1|0|G
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1595|3693|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1595||1595|3693||1|0|
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|445|2110|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||445||445|2110||1|0|
400508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR|1060|2957|lyfalmen|V0943|2957|2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||1060||1060|2957||2|0|G
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|5453|9003|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5453||5453|9003||1|0|E
400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|0|1|0|1|BNB|0|1|0|100|XEU|155787|200267|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||155787||155787|200267||2|0|L
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2360|4523|lyfalmen|V0037|2599|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2198||2198|4523||2|0|G
401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|0|0|1|PEU|0|0|1|100|DKK|21924|31003|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||21924||21924|31003||1|0|ES
401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|9334|14345|lyfalmen|V0459|12481|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9334||9334|14345||1|0|G
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|834|2646|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||834||834|2646||1|0|G
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1224|3183|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1224||1224|3183||1|0|G
402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G
402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|0|1|0|1|VAL|0|0|0|100|XEU|36128|48968|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||36128||36128|48968||2|0|S
402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1366|3378|lyfalmen|V0952|3378|2|100|0||Vistor hf|Galenica AB|Mómetasón||1366||1366|3378||1|0|G
402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|779886|976471|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||779886||779886|976471||1|0|ES
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2010|3950|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||2010||2010|3950||1|0|
402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|328079|414550|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||328079||328079|414550||1|0|L
402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|0|G|0|LVR|0|0|0|100|DKK|8679|12054|lyfalmen|V0349|12054|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7669||7669|12054||3|0|G
402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|5235|3060|lyfalmen|V0552|2737|2|30|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||1135||1135|3060||1|0|E
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|6619|12728|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6619||6619|12728||1|0|
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|1070|2971|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||1070|2971||1|0|G
403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|18754|27311|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||18754||18754|27311||2|0|G
404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|0|1|SNP|0|0|1|100|XEU|21933|31014|lyfsjukr|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||21933||21933|31014||1|0|ES
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2797||2|0|G
404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|39935|53783|lyfsjukr|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||39935||39935|53783||1|H|0
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|66782|87739|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||66782||66782|87739||1|H|S
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1039|2928|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1039||1039|2928||1|0|G
404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
404997|A10BJ0301|Lyxumia|stl|||3|ml|2|áfpen|10 mcg/sk og 20 mcg/sk|A10BJ03|01.10.2013|30.06.2020|R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|10443|15872|lyfalmen|||1|6|0|21,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||10443||10443|15872||1|0|E
405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013|30.06.2020|R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G
405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|3200|5516|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3200||3200|5516||2|0|
405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2649||1|0|
405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|1|ILT|0|0|0|100|XEU|421175|530335|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||421175||421175|530335||2|0|S
405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G
405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|33444|45574|lyfsjukr|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||33444|45574||2|H|S
405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|1|100|DKK|3691|6578|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3691||3691|6578||2|0|ES
405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|18564|27049|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18564||18564|27049||1|0|
405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|430|2090|lyfalmen|||2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||430||430|2090|31.7.2020|1|0|G
406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|194226|248074|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||194226||194226|248074||1|0|E
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18589|27084|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18589||18589|27084||1|0|E
406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|1|AZA|0|1|0|100|SEK|759029|950531|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||759029||759029|950531||1|0|L
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|56080|74204|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||56080||56080|74204||1|0|E
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|65288|85850|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||65288||65288|85850||1|0|E
407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|GRP|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4698||1|0|G
407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|0|1|0|1|NED|0|1|0|100|XEU|126684|164071|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||126684||126684|164071||2|0|L
407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|18693|35635|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||18693|35635||2|0|
407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|7000|4939|lyfalmen|V0817|4886|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||2500||2500|4939||2|0|E
407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|2872|4950|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2872||2872|4950||1|0|
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|372|2010|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||372||372|2010||1|0|
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|668|2417|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||668||668|2417||1|0|
408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|31650|43305|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||31650||31650|43305||1|0|G
408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|17213|25190|lyfalmen|V0974|21151|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||17213||17213|25190||2|0|G
408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|13382|19270|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||12912||12912|19270||1|0|G
408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1976|4218|lyfalmen|V0310|2865|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1976||1976|4218||2|0|
408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0|
408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|4673|7930|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4673||4673|7930||2|0|
408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0813|4224|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3318|5719|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3318||3318|5719||2|0|
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|3895|6859|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3895||3895|6859||1|0|E
409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0|
409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|11333|17097|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||11333||11333|17097||2|0|E
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8571|13295|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||8571||8571|13295||1|0|E
409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|64454|84795|lyfalmen|V0728|84795|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||64454||64454|84795||1|0|E
409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3235|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G
409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|16027|23557|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||16027||16027|23557||1|0|G
409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|60485|79775|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||60485||60485|79775||1|0|E
409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|0|G|0|TOG|0|0|0|100|SEK|2121|4417|lyfalmen|||1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||2121||2121|4417||1|0|G
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6950|11064|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6950||6950|11064||1|0|E
409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3475|6281|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3475||3475|6281||1|0|
409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16219|23822|lyfalmen|V0651|23819|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16219||16219|23822||1|0|G
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3926|6902|lyfalmen|V0196|5627|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3926||3926|6902||2|0|G
410223|L01XE2701|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|499529|627785|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||499529||499529|627785||1|0|L
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3748|5942|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||3229||3229|5942||1|0|G
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|592|2313|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||592||592|2313||2|0|G
411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|893|2727|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||893||893|2727||2|0|G
411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1540|3618|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1540||1540|3618||1|0|G
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|441|2073|lyfalmen|V0230|2071|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||418||418|2073||2|0|E
411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|ASD|0|0|0|100|SEK|1629|2698|lyfalmen|V0692|2320|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||872||872|2698||2|0|E
411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|11810|17753|lyfalmen|V0689|3059|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||11810||11810|17753||3|0|E
411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13781|lyfalmen|V0829|13781|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13781||2|0|G
411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|0|1|0|0|MOL|0|0|0|100|IKR|12650|16638|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||11000||11000|16638||2|0|E
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|24071|33719|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||24071||24071|33719||1|0|S
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E
411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2874|lyfalmen|V0994|2874|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||1000||1000|2874||2|0|G
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|3120|5792|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3120||3120|5792||1|H|S
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|CES|1|0|0|100|DKK|4489|8687|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4489||4489|8687||2|0|
412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4986|9630|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4986||4986|9630||2|0|
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|91212|118639|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||91212||91212|118639||2|0|S
412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|47854|63799|lyfalmen|V0711|12509|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||47854||47854|63799||1|0|G
412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|0|G|0|TVA|0|0|0|100|DKK|7912|12388|lyfalmen|V0254|12388|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||7912||7912|12388||2|0|G
412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|48068|64070|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||48068||48068|64070||1|0|E
412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|6597|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3068|5721|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3068||3068|5721||2|0|G
413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4379|7525|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4379||4379|7525||2|0|G
413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0|
413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|OVE|0|0|1|100|DKK|34059|46351|lyfsjukr|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||34059||34059|46351||2|0|S
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0|
414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|1271|3247|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1271||1271|3247||2|0|G
414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TGH|0|0|0|100|NOK|93072|120991|lyfsjukr|||1|12|0|24,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Glatíramer acetat||93072||93072|120991||1|0|ES
414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|42127|56556|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||42127||42127|56556||2|H|S
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1292|3276|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1292||1292|3276||2|0|G
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1180|3122|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1180||1180|3122||1|0|G
415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|199276|254355|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||199276||199276|254355||1|0|L
415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|135815|175427|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||135815||135815|175427||1|0|G
415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|0|G|0|ALO|0|0|0|100|DKK|3211|4783|lyfalmen|V1010|3611|2|30|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||2387||2387|4783||2|0|G
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5818|8351|lyfalmen|V0253|4190|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||4979||4979|8351||2|0|G
416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|37616|50635|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||37446||37446|50635||1|0|G
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|9355|10213|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||6332||6332|10213||1|0|G
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013|31.08.2020|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|4166|7232|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||4166||4166|7232||1|0|G
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2922|5520|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2922||2922|5520||2|0|G
417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|19868|28844|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||19868||19868|28844||1|0|
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|39399|53105|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||39399||39399|53105||1|0|S
417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|100497|131501|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur IX||100497||100497|131501||1|0|L
417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|25853|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||2|0|
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|28697|39570|lyfalmen|V0460|39570|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||28697|39570||1|0|G
418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|30070|40761|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||29639||29639|40761||3|0|S
418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|1|CTH|0|1|0|100|DKK|75044|98189|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||75044||75044|98189||1|H|L
418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|24897|lyfalmen|V0615|24897|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||17000||17000|24897||2|0|
418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991|31.07.2020|R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|5577|9174|lyfalmen|||1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5577||5577|9174||1|0|G
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2529|4979|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2529||2529|4979||1|0|G
419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|1|ROC|0|0|1|100|DKK|2766|5305|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Ceftríaxón||||2766|5305||2|0|S
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|9202|14164|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||9202||9202|14164||1|0|G
419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G
419385|J01FA0901|Klacid|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.03.2017|30.06.2020|R|1|0|0|0|0|0|MDK|0|0|1|100|DKK|4398|3918|lyfalmen|||1|14|0|14,0000|Icepharma hf|Mylan Denmark ApS|Klaritrómýcín||1758||1758|3918||1|0|E
419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|40336|54291|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mercaptamín||40336||40336|54291||3|0|E
419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|13867|20584|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mercaptamín||13867||13867|20584||3|0|E
419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1846|4039|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1846||1846|4039||1|0|G
419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|0|G|0|AGE|0|0|1|100|IKR|2099|4387|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2099||2099|4387||2|0|G
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|12194|18282|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12194||12194|18282||1|0|G
420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|142713|184006|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||142713||142713|184006||2|0|S
420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G
420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|3785|6708|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3785||3785|6708||1|0|G
420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|5395|8924|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||5395||5395|8924||1|0|G
420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RTH|0|0|1|100|DKK|1570|3064|lyfalmen|V0479|3064|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1138||1138|3064||2|0|E
420639|L01XE2701|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|249411|316709|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||249411||249411|316709||1|0|L
420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0|
421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|V0214|4636|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636||2|0|E
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1303|3291|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1303||1303|3291||1|0|G
421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2750|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G
421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|9331|14341|lyfalmen|V1011|14341|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||9331||9331|14341||2|0|E
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|34223|65098|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||34223||34223|65098||1|0|
421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|1791|3428|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1402||1402|3428||2|0|G
422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|613|2342|lyfalmen|V0596|2342|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||613||613|2342||1|0|G
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|2848|5418|lyfalmen|V0049|2884|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2848||2848|5418||1|0|G
422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|0|1|LLS|0|0|0|100|DKK|99272|128833|lyfsjukr|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||99272||99272|128833||2|H|0
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|4682|7942|lyfalmen|V0054|3896|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||4682||4682|7942||1|0|G
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|75391|98628|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||75391||75391|98628||2|H|S
422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|48062|64062|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||48062|64062||3|0|S
422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2996|5622|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2996||2996|5622||3|0|G
422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|11379|17160|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||11379||11379|17160||1|0|G
422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|9662|14797|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||9662||9662|14797||2|0|G
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3103|5164|lyfalm11|V0993|4655|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3103|5164||2|0|
423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0|
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|1|100|XEU|19751|28683|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||19751||19751|28683||2|0|ES
423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|5927|9656|lyfalmen|V0373|4920|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5927||5927|9656||2|0|G
424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|G|0|SSE|0|0|1|100|DKK|72309|94730|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||72309||72309|94730||1|0|G
424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHE|0|0|0|100|DKK|11831|17782|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||11831||11831|17782||1|0|E
424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|0|IRO|0|0|1|100|XEU|5707|9353|lyfalmen|||2|100|0||Artasan ehf|Orifarm Generics A/S|Nýstatín||5707||5707|9353||1|0|0
424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|10414|4159|lyfalmen|V0694|4159|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1933||1933|4159||1|0|G
424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|13518|18448|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||12315||12315|18448||2|0|G
425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|19052|26621|lyfalmen|V0183|20664|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||18253||18253|26621||1|0|G
425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|19838|28803|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||19838||19838|28803||1|0|L
425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|DKK|14537|21507|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||14537||14537|21507||2|0|G
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|619|2350|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||619||619|2350||2|0|E
427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|0|0|1|0|1|SHS|0|0|0|100|DKK|110669|129250|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||99602||99602|129250||1|0|S
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0|
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|8596|13329|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||8596||8596|13329||1|0|
427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0
427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|3242|5165|lyfalmen|V1004|5165|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2664||2664|5165||2|0|E
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2486||1|0|G
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|3431|6220|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3431||3431|6220||2|0|S
429358|R03BB0404|Braltus|innönddu|10|mcg|30|stk|1|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|4510|7299|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||4215||4215|7299||2|0|G
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|82611|107760|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||82611||82611|107760||1|0|ES
429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|6992|5305|lyfalmen|V0812|4224|2|28|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2766||2766|5305||1|0|E
429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6823|10889|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||6823||6823|10889||2|0|G
429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|4642|7887|lyfalmen|||2|200|0|66,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||4642||4642|7887||1|0|E
429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|9897|15120|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9897||9897|15120||3|0|G
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|5777|11131|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5777||5777|11131||1|0|
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|18761|15412|lyfalmen|V0184|13030|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||10109||10109|15412||2|0|G
430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G
430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|DKK|5893|9609|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5893||5893|9609||2|0|G
430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0|
431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|0|1|0|1|HPI|0|0|0|100|DKK|1987322|2478183|lyfsjukr|||1|2|0||Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1987322||1987322|2478183||1|0|0
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1152|3084|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1152||1152|3084||1|0|
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0|
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1430|3466|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1430||1430|3466||1|0|G
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3712|6607|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3712||3712|6607||1|0|G
431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|7004|lyfalmen|V0995|7004|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||4000||4000|7004||2|0|G
431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E
431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|1|TPA|0|1|0|100|DKK|319190|403494|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||319190||319190|403494||1|H|L
431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2097|4384|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2097||2097|4384||1|0|G
432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0|
432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|3494|lyfalmen|V0693|3494|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1450||1450|3494||2|0|E
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|BRO|0|0|0|100|XEU|2930|4422|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2250||2250|4422||2|0|0
433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10189|15522|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10189||10189|15522||1|0|G
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2538|4991|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2538||2538|4991||1|0|G
433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|5577|9174|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5577||5577|9174||1|0|G
433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|0|LHS|1|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0|
433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|416687|524753|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||416687||416687|524753||1|0|ES
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|159907|205391|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||159907||159907|205391||2|H|S
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|QAS|0|0|0|100|NOK|69689|106653|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||66162||66162|106653||1|0|
434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0|
434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|14964|22094|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||14964||14964|22094||1|0|G
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|8162|12732|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||8162||8162|12732||1|0|G
434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G
434601|N07BC0102|Buvidal|stl|128|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|60848|80234|lyfsjukr|||1|1|0|16,0000|Vistor hf|Camurus AB|Búprenorfín||60848||60848|80234||1|H|S
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|794|2591|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||794||794|2591||1|0|E
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|7037|11184|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||7037||7037|11184||2|0|G
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|7021|11162|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||7021||7021|11162||2|0|G
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|10387|15795|lyfalmen|V0315|7189|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10387||10387|15795||2|0|E
434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|0|1|0|1|AMC|0|1|0|100|XEU|2535170|3159553|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2535170||2535170|3159553||1|0|L
435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|13995|20761|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||13995||13995|20761||1|0|L
435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G
435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|0|SSE|0|0|1|100|DKK|13497|20075|lyfalmen|||2|4|0|1,3333|Shire Services BVBA|Shire Services BVBA|Mídazólam||13497||13497|20075||1|0|E
436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|220285|280484|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||220285||220285|280484||2|H|L
436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|305|1918|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||305||305|1918||1|0|E
436199|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|5029|8420|lyfalmen|||2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||5029||5029|8420|31.7.2020|1|0|0
436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|139029|179424|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||139029||139029|179424||2|0|S
436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|45388|60680|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||45388||45388|60680||1|0|ES
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1080|2984|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1080||1080|2984||1|0|
436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|DKK|74334|97291|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||74334||74334|97291||3|0|ES
436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|XEU|550|2099|lyfalmen|V0555|2099|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||437||437|2099||2|0|E
436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|3937|6917|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3937||3937|6917||1|0|G
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|730|2503|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||730||730|2503||1|0|G
437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|4200|4526|lyfalmen|V0813|4526|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E
437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7242|10268|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6372||6372|10268||1|0|G
437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|1|FIN|0|1|0|100|DKK|649499|814306|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||649499||649499|814306||2|H|L
437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|11420|17216|lyfalmen|V0253|4190|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||11420||11420|17216||3|0|G
437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|22163|31305|lyfalmen|V0712|31305|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22163||22163|31305||1|0|G
437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|1191|3137|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1191||1191|3137||1|0|G
437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|58074|76726|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||58074||58074|76726||2|H|L
438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|DEH|1|0|0|100|XEU|24013|45728|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||24013||24013|45728||1|0|0
438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|2104|4394|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2104||2104|4394||1|0|S
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|2223|4558|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2223||2223|4558||1|0|G
438428|N02AE0101|Bupremyl|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018|31.08.2020|R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|1185|2271|lyfalmen|||2|4|0|2,8000|Icepharma hf|Mylan AB|Búprenorfín||562||562|2271||2|0|G
438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|0|G|0|TIL|0|0|0|100|DKK|10768|16319|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||10768||10768|16319|||0|G
438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1729|3878|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1729||1729|3878||1|0|G
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6159|2840|lyfalmen|V0605|2682|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||975||975|2840||2|0|G
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|244555|310669|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafeníb||244555||244555|310669||2|0|L
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|164323|210883|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||164323||164323|210883||1|0|S
438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0|
439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0|
439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|483709|608110|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||483709||483709|608110||2|0|L
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|5222|8685|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||5222||5222|8685||1|0|G
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|21626|30626|lyfalmen|V0615|24399|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||21626||21626|30626||1|0|
439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|16511|24224|lyfalmen|V0818|12544|2|28|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||16511||16511|24224||1|0|E
439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|9196|14155|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||9196||9196|14155||2|0|G
440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|175659|224982|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||175659||175659|224982||1|0|G
440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|1|0|G|0|KAN|0|0|1|100|IKR|4500|6728|lyfalmen|V0224|6728|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3800||3800|6728||2|0|G
440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|1|100|DKK|1424|3458|lyfsjukr|||2|10|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1424||1424|3458||1|0|ES
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|1|100|DKK|2247|4591|lyfsjukr|||2|10|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||2247||2247|4591||1|0|ES
441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1099|3011|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1099||1099|3011||1|0|E
441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1063|2961|lyfalmen|V0046|2483|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1063||1063|2961||1|0|G
441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|6276|10136|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||6276||6276|10136||1|0|G
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|109086|142184|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||109086||109086|142184||2|0|S
442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|6010|9770|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||6010||6010|9770||1|0|0
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2694|5206|lyfalmen|V0283|3931|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2694||2694|5206||2|0|G
442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|TMA|0|1|0|100|DKK|75628|98928|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||75628||75628|98928||3|0|L
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11284|17029|lyfalmen|V0460|13190|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11284|17029||1|0|G
443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1460|3507|lyfalmen|V0560|3466|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1460||1460|3507||2|0|
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3393|6168|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3393||3393|6168||1|0|G
443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|26931|37336|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||26931||26931|37336||1|0|G
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|24857|34713|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||24857||24857|34713||1|0|G
443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|25622|35680|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||25622||25622|35680||3|H|ES
443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|2475|3700|lyfalmen|V0116|3063|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1600||1600|3700||2|0|E
444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2740|5269|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2740||2740|5269||2|0|G
444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|0|1|0|1|NEP|0|0|0|100|DKK|1705591|2127789|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1705591||1705591|2127789||1|0|S
444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|2178|4167|lyfalmen|V0337|4167|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1939||1939|4167||1|0|E
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|3160|5847|lyfalmen|V0061|3637|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3160||3160|5847||2|0|E
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|21952|31038|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||21952||21952|31038||2|H|S
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2179|4497|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2179||2179|4497||2|0|G
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G
444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|5331|8836|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5331||5331|8836||1|0|G
444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|170632|218730|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||170632||170632|218730||2|0|L
445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|19661|28559|lyfalmen|V0705|28559|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||19661||19661|28559||1|0|G
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGP|0|0|0|100|DKK|4966|8333|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||4966||4966|8333||1|0|G
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|2021|4280|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||2021||2021|4280||1|0|G
445169|L01XX1907|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.06.2020||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|43219|57937|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Írinótekan||43219||43219|57937||1|H|S
445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0
445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|7266|3026|lyfalmen|V0684|3026|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|54403|17168|lyfalmen|V0722|17168|2|28|0|42,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||11385||11385|17168||1|0|
445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|6004|9762|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6004||6004|9762||1|0|G
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|16836|24671|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||16836||16836|24671||1|0|G
446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144||2|0|
447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|0|1|0|1|SUG|0|1|0|100|XEU|61652|81251|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||61652||61652|81251||2|0|L
447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|4159|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|11708|17613|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11708||11708|17613||1|0|G
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6554|10519|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6554||6554|10519||1|0|G
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8239|12838|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||8239||8239|12838||1|0|G
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8524|13230|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8524||8524|13230||1|0|G
447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|12009|18027|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||12009||12009|18027||1|0|G
447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3673|lyfalmen|V0948|3563|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1580||1580|3673||2|0|G
447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|24593|34379|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||24593||24593|34379||1|0|L
447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E
448122|A02BA0208|Asýran|filmhtfl|300|mg|90|stk|1|þpakki||A02BA02|01.07.2019||R|1|0|0|0|G|0|TEE|0|0|1|100|XEU|1828|4014|lyfalmen|||2|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||1828||1828|4014||1|0|G
448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3028|5666|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3028||3028|5666||1|0|G
448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0|
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2105|4395|lyfalmen|V0202|3768|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||2105||2105|4395||1|0|G
448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4636|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E
448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|64454|84795|lyfalmen|V0727|84795|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||64454||64454|84795||1|0|E
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1159|3093|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1159||1159|3093||2|H|S
449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|34975|47510|lyfsjukr|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||34975||34975|47510||2|H|S
449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|2033|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1004|2880|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1004||1004|2880||2|0|G
449647|N05AH0414|Quetiapin Hexal|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2017|30.06.2020|R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|4738|7171|lyfalmen|||2|100|0|12,5000|Artasan ehf|Hexal A/S|Quetíapín||4122||4122|7171||1|0|G
449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|0|1|0|1|ZEN|0|1|0|100|SEK|356671|450110|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||356671||356671|450110||1|0|L
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|1|100|DKK|5328|8831|lyfsjukr|||2|10|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||5328||5328|8831||1|0|ES
449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|0|1|LLS|0|0|0|100|DKK|253699|322042|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||253699|322042||2|H|S
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|3498|6313|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3498||3498|6313||2|0|G
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4907|9480|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4907||4907|9480||2|0|
450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1244|3210|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1244||1244|3210||2|0|G
450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|128123|165860|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||128123||128123|165860||1|H|S
450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0814|4224|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|354526|447442|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||354526||354526|447442||1|H|S
450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|0|SSE|0|0|1|100|DKK|13497|20075|lyfalmen|||2|8|0|2,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13497||13497|20075||1|0|E
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|2539|4108|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1896||1896|4108||1|0|
450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|253524|408681|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||253524||253524|408681||1|0|
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NIL|0|0|0|100|XEU|8874|15295|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||8874||8874|15295||2|0|
450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|21610|30606|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21610|30606||5|H|S
451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|44330|59342|lyfalmen|V0980|59341|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||44330||44330|59342||1|0|E
451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|682|2437|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||682||682|2437||1|0|G
451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|316614|400290|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||316614||316614|400290||2|0|L
451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0|
451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3457|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E
451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10541|16007|lyfalmen|V0608|14150|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||10541||10541|16007||1|0|G
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|40448|54432|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||40448||40448|54432||2|0|G
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|Trimb Healthcare AB|Ketókónazól|||||||2|0|
452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0|
452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|7672|12058|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||7672||7672|12058||2|0|G
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0|
452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRG|0|1|0|100|DKK|841667|1053309|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||841667|1053309||2|0|L
452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|8290|12908|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8290||8290|12908||2|0|E
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|8333|12967|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||8333||8333|12967||2|H|S
452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|1404|3430|lyfalmen|V0597|2815|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1404||1404|3430||2|0|G
452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|4213|7297|lyfalmen|V0598|5560|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||4213||4213|7297||2|0|G
452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|2683|5191|lyfalmen|V0584|3702|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2683||2683|5191||2|0|G
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|BOA|0|0|0|100|XEU|1490|2568|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1490||1490|2568||1|0|
453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|8087|12629|lyfalmen|V0585|8149|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||8087||8087|12629||2|0|G
453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|106395|138837|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||106395|138837||2|0|E
453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|MUP|0|0|0|100|DKK|15083|22258|lyfalmen|V0587|13889|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||15083||15083|22258||2|0|G
453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G
454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|5370|10358|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||5370||5370|10358||2|0|
454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|8257|12863|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8257||8257|12863||1|0|G
454659|N05AH0414|Quetiapin Hexal|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2017|30.06.2020|R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|6898|10224|lyfalmen|||2|100|0|37,5000|Artasan ehf|Hexal A/S|Quetíapín||6340||6340|10224||1|0|G
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|36027|44946|lyfalmen|V0342|11424|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32948||32948|44946||1|0|G
454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1|0|
454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|0|1|0|0|BIM|0|0|0|100|SEK|405647|511023|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||405647||405647|511023||2|0|
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1161|2282|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1161||1161|2282||1|0|
454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|1100|2461|lyfalmen|V0174|2461|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||700||700|2461||2|0|E
455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|4903|8246|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4903||4903|8246||1|0|S
455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|0|1|0|1|KNM|0|1|0|100|IKR|50000|66514|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66514||2|0|L
455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7868|12327|lyfalmen|V0713|10538|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7868||7868|12327||1|0|G
455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1121658|1401540|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1121658||1121658|1401540||2|0|L
455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|0|G|0|LVR|0|0|0|100|DKK|29712|40853|lyfalmen|V0653|40853|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||29712||29712|40853||3|0|G
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|823|2631|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||823||823|2631||1|0|E
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|930|2778|lyfalmen|||2|15|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||930||930|2778||1|0|E
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1740|3893|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||1740||1740|3893||1|0|E
456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|4649|7897|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4649||4649|7897||2|0|G
456795|L01XE3501|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01XE35|01.06.2019||R|0|0|0|1|0|1|ZEN|0|1|0|100|SEK|946934|1184232|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||946934||946934|1184232||1|0|L
456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|4926|7004|lyfalmen|V0277|6774|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||4000||4000|7004||2|0|G
457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|6992|5551|lyfalmen|V0816|4224|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2945||2945|5551||1|0|E
457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|ALE|0|0|0|100|SEK|51989|56657|lyfalmen|V0451|56657|2|1|0|83,7200|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||42207||42207|56657||2|0|G
457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3688|6574|lyfalmen|V0326|6438|2|98|0|147,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||3688||3688|6574||1|0|0
457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1599|3699|lyfalmen|V0561|3699|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1599||1599|3699||2|0|
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PEU|0|0|0|100|DKK|6479|10416|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6479||6479|10416||1|0|
457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|3038|5679|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3038||3038|5679||2|0|G
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|2750|2282|lyfalmen|V0003|2276|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||570||570|2282||1|0|E
457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4419|7580|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4419||4419|7580||1|0|G
457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|11282|19446|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11282||11282|19446||2|0|
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1157|3090|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1157||1157|3090||1|0|E
458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|399276|503099|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||399276||399276|503099||2|0|L
458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|0|1|0|1|SUG|0|1|0|100|XEU|61652|81251|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||61652||61652|81251||2|0|L
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|KAR|0|0|1|100|DKK|1256|3227|lyfalmen|V0577|2874|1|20|0|6,6667|Vistor hf|Karo Pharma AB|Pívmecillínam||1256||1256|3227||2|0|E
458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|TMA|0|1|0|100|DKK|115701|150411|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||115701||115701|150411||3|0|L
458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|10215|14838|lyfalmen|V0653|14590|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||9692||9692|14838||1|0|G
458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|0|1|BNB|0|1|0|100|XEU|12160265|15130460|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||12160252||12160252|15130460||2|H|L
459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|886871|1109530|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||886871||886871|1109530||1|0|L
459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|86519|112703|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||86519||86519|112703||2|0|S
459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|22296|31474|lyfsjukr|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||22296|31474||2|H|S
459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|866|2690|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||866||866|2690||1|0|ES
459405|L01XE2701|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|1007920|1260082|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||1007920||1007920|1260082||1|0|L
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|1587|3682|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1587||1587|3682||1|0|ES
459423|N07BC0102|Buvidal|stl|16|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|14228|21081|lyfsjukr|||1|1|0|2,0000|Vistor hf|Camurus AB|Búprenorfín||14228||14228|21081||1|H|S
459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|21461|40886|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||21461||21461|40886||2|0|
459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|2267|2365|lyfalmen|V0284|2365|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||630||630|2365||2|0|G
459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|10500|11546|lyfalmen|V0261|11546|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7300||7300|11546||2|0|0
459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|0|G|0|DSM|0|0|0|100|DKK|6239|10085|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6239||6239|10085||1|0|G
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|1636|3750|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1636||1636|3750||2|0|G
459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír|||||||1|0|0
460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|1|AEE|0|1|0|100|XEU|143997|185603|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||143997||143997|185603||1|H|L
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|9577|14680|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||9577||9577|14680||1|0|G
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|256178|325125|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||256178||256178|325125||2|H|L
460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7620|4321|lyfalmen|V0144|4182|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2051||2051|4321||1|0|E
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|BRO|0|0|0|100|XEU|5203|9347|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4837||4837|9347||2|0|0
461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|4969|8178|lyfalmen|V0585|8149|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4853||4853|8178||1|0|G
461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|462285|581464|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||462285||462285|581464||1|0|L
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E
461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1156343|1444678|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1156343||1156343|1444678||2|0|L
461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|0|MIP|0|0|1|100|DKK|6573|10545|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6573||6573|10545||2|0|E
461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|320306|404882|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||320306||320306|404882||1|H|S
461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|0|G|0|AZE|0|0|0|100|SEK|19225|27959|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||19225||19225|27959||1|0|G
462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|5551|lyfalmen|V0816|4224|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2945||2945|5551||2|0|E
462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|4141|7198|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||4141||4141|7198||1|0|ES
462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|5821|2874|lyfalmen|V0605|2737|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2874||2|0|G
463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2768|5308|lyfalmen|V0325|5149|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||2768||2768|5308||1|0|0
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|52799|70054|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||52799|70054||1|0|S
463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4701|7968|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4701|7968||1|0|G
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0|
463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0|
464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|3548|6115|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3548||3548|6115||1|0|
464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0|
464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0|
464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3425|lyfalmen|V0947|3287|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1400||1400|3425||2|0|G
464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7921|12400|lyfsjukr|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||7921||7921|12400||1|H|S
464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|17022|24927|lyfalmen|V0718|24927|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||17022||17022|24927||1|0|G
464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|6711|10735|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6711||6711|10735||2|0|G
464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|1713|2668|lyfalmen|V0967|2599|2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||850||850|2668||2|0|E
464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0677|2753|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||3121||1|0|G
464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|505|2048|lyfalmen|V0188|2048|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||400||400|2048||2|0|G
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|2749|5282|lyfalmen|V0376|5282|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2749||2749|5282||1|0|G
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1446|2842|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1446||1446|2842||1|0|
465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|MDK|0|0|0|100|DKK|1843|4035|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||1843||1843|4035||2|0|G
465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|3367|6132|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3367||3367|6132||2|0|G
465472|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.04.2019||R|0|1|0|0|0|1|GRP|0|0|0|100|XEU|11562|5836|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3152||3152|5836||1|H|0
465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|79433|103740|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||79433||79433|103740||1|H|L
466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2763|3012|lyfalmen|V0039|3012|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||1100||1100|3012||2|0|G
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|633|2369|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||633||633|2369||1|0|G
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1972|4212|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1972||1972|4212||1|0|G
466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1307|2951|lyfalm11|V0545|1915|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1307|2951||2|0|
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1495|3556|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1495||1495|3556||1|0|G
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|5182|8630|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5182||5182|8630||1|0|G
466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|30634|37970|lyfsjukr|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||27432||27432|37970||2|0|0
466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|267372|339047|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||267372||267372|339047||2|H|L
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|19142|27845|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||19142||19142|27845||1|0|G
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2780|5324|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2780||2780|5324||1|0|G
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7195|11401|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7195||7195|11401||1|0|G
466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0|
466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|0|1|HEL|0|0|0|100|XEU|382639|482407|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||382639||382639|482407||3|0|0
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4574|7794|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4574||4574|7794||1|0|G
466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0|
466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|21485|30448|lyfalmen|V0728|28265|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21485||21485|30448||1|0|E
466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|361|1831|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||242||242|1831||2|0|E
467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|7135|6564|lyfalmen|V0622|6564|2|30|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3681||3681|6564||1|0|E
467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6066|10455|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||6066||6066|10455||2|0|
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|6267|10124|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6267||6267|10124||2|0|S
467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|0|G|0|DIU|0|0|1|100|IKR|28063|38768|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||28063||28063|38768||2|0|G
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|12223|18322|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12223||12223|18322||1|0|G
467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|6284|10147|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||6284||6284|10147||2|0|
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|22940|32288|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||22940||22940|32288||1|0|G
467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|10533|15996|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||10533||10533|15996||1|0|E
467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|PIP|0|0|1|100|DKK|81600|106481|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||81600||81600|106481||1|0|ES
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|417|2072|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||417||417|2072||1|0|S
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6172|7269|lyfalmen|V0317|3150|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4193||4193|7269||1|0|G
468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|14474|8756|lyfalmen|||2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||5273||5273|8756|31.7.2020|2|0|
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7603|7243|lyfalmen|V0318|4359|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4174||4174|7243||1|0|G
468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1001|2876|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1001||1001|2876||1|0|G
468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2376|4095|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2376||2376|4095||2|0|
468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|1|100|XEU|3490|5341|lyfalmen|V0467|4950|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2792||2792|5341||1|0|G
469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7538|11873|lyfalmen|V0712|10435|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7538||7538|11873||1|0|G
469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|1|0|0|0|TVB|0|0|0|100|XEU|6515|6113|lyfalmen|V0960|6040|2|30|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Metýlfenídat||3353||3353|6113||1|0|E
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3290|6026|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3290||3290|6026||1|0|E
469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|AEP|0|0|0|100|DKK|2526|4453|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2526||2526|4453||2|0|
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7031|11175|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7031||7031|11175||1|0|S
469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2542|2938|lyfalmen|V0037|2599|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1046||1046|2938||1|0|G
469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||2|0|
469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|395|2042|lyfalmen|V1025|2042|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||395||395|2042||2|0|G
469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|63301|83337|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||63301||63301|83337||1|0|L
470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|15116|19090|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12781||12781|19090|31.8.2020|2|0|G
470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|0|1|0|1|IPC|0|0|0|100|DKK|49700|59901|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||44772||44772|59901||2|0|S
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4179|7250|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4179||4179|7250||1|0|G
470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|6277|10138|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||6277||6277|10138||2|0|G
470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|64454|84795|lyfalmen|V0728|84795|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||64454||64454|84795||1|0|E
471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|0|G|0|MEC|0|0|0|100|SEK|516|2208|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||516||516|2208||2|0|G
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4816|9307|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4816||4816|9307||1|0|
471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|0|RNU|0|0|1|100|XEU|17365|13228|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||8522||8522|13228||2|0|0
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|RDT|0|0|0|100|DKK|1755|3914|lyfalmen|V0048|2682|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1755||1755|3914||1|0|G
472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3881|6840|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3881||3881|6840||1|0|
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|8704|13478|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8704||8704|13478||1|H|S
472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|5351|5521|lyfalmen|V0811|5492|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2923||2923|5521||2|0|G
472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|22166|31309|lyfalmen|V0516|5902|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||22166||22166|31309||3|0|G
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|3244|5963|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||3244||3244|5963||1|0|G
472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2662|5162|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2662||2662|5162||1|0|G
473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ATN|0|0|1|100|DKK|1467|3517|lyfalmen|||1|5|0|5,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Ketórólak||1467||1467|3517||2|0|G
473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|30188|41455|lyfalmen|V0974|41455|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||30188||30188|41455||2|0|G
473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SUG|0|1|0|100|XEU|89563|116553|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||89563||89563|116553||2|0|L
473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4657|7908|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4657||4657|7908||1|0|G
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2|0|
474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|30753|58515|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||30753||30753|58515||2|0|
475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E
475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0|
475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0|
476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0|
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|62793|82694|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||62793|82694||1|0|S
476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4526|7728|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4526|7728||2|0|S
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|16009|23533|lyfalmen|V0954|6749|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||16009||16009|23533||1|0|E
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|4608|7840|lyfalmen|V0934|5627|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4608||4608|7840||1|0|
477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|AEB|0|1|0|100|XEU|59859|78983|lyfsjukr|||1|27|0||Vistor hf|Amgen Europe B.V.|Apremilast||59859||59859|78983||1|0|L
477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SUG|0|1|0|100|XEU|89563|116553|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||89563||89563|116553||2|0|L
477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0|
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0|
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|541|2102|lyfalmen|V0500|2082|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||439||439|2102||1|0|G
478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|16513|24226|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16513||16513|24226||1|0|G
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|7673|14728|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7673||7673|14728||2|0|
478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|0|EXH|0|0|0|100|DKK|3812|5542|lyfalm11|V0983|5542|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3410||3410|5542||2|0|
478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|178070|227980|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||178070||178070|227980||1|0|L
478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2221|3012|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1100||1100|3012||2|0|G
479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|0|MVX|0|0|0|100|IKR|4900|8105|lyfalmen|V0115|8077|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4800||4800|8105||2|0|E
479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|123782|160461|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||123782||123782|160461||1|0|L
479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|418075|526479|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||418075||418075|526479||1|H|L
479991|L01XX5001|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|854667|1069478|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||854667||854667|1069478||1|0|S
480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|3333|6494|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3333||3333|6494||2|0|
480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|4458|6487|lyfalmen|V0080|6487|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3625||3625|6487||2|0|G
480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|33106|45146|lyfalmen|V0975|45146|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||33106||33106|45146||2|0|G
481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|13262|19752|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||13262||13262|19752||1|0|
481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|722|2492|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||722||722|2492||1|0|G
481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G
481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|6060|7860|lyfalmen|V0681|7860|2|30|0|27,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||4622||4622|7860||1|0|E
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|263|1860|lyfalmen|||1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||263||263|1860||1|0|G
482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|15902|23385|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||15902||15902|23385||2|0|G
482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0|
482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0|
483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|0|0|1|AEB|0|1|0|100|DKK|60426|79700|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||60426||60426|79700||1|H|L
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|32129|43910|lyfalmen|V0977|43585|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||32129|43910||2|0|G
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|6668|10676|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6668||6668|10676||2|H|S
483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48617|64764|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||48617||48617|64764||2|H|S
483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|5158|8597|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5158||5158|8597||2|0|G
483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|2354|4738|lyfalmen|V0368|4738|2|15|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Brímónidín||2354||2354|4738||1|0|G
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6871|10955|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6871||6871|10955||1|0|G
483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|849|2666|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||849||849|2666||1|0|G
484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|356340|449698|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||356340||356340|449698||1|0|E
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|127741|165385|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||127741||127741|165385||1|0|S
484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996|31.08.2020|R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1201|3151|lyfalmen|||1|300|0|50,0000|Icepharma hf|Meda AB|Benzýdamín||1201||1201|3151||2|0|G
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|10494|15942|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||10494||10494|15942||2|0|G
484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|47836|63777|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||47836||47836|63777||1|0|G
484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|8903|13752|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8903||8903|13752||1|0|G
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1319|3313|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1319||1319|3313||2|0|G
485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8799|13609|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8799||8799|13609||2|0|G
485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|398550|502196|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||398550||398550|502196||1|0|L
485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|6386|9100|lyfalmen|V1006|9100|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5523||5523|9100||2|0|E
485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|14754|21805|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||14754||14754|21805||1|0|G
485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|661113|828751|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||661113||661113|828751||2|0|L
485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|0|VEB|0|0|0|100|SEK|6751|12978|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6751||6751|12978||2|0|
485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|4800|4595|lyfalmen|V0116|4595|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2250||2250|4595||2|0|
485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|74097|96991|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||74097||74097|96991||1|0|S
485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6009|9769|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||6009||6009|9769||1|0|G
485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|720263|902317|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||720263||720263|902317||2|0|L
486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0|
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0|
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|333|1956|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||333||333|1956||1|0|G
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|560|2269|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||560||560|2269||1|0|G
487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|846177|1058918|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||846177||846177|1058918||1|0|L
487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|1880|4086|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1880||1880|4086||1|0|G
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|25943|36086|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||25943||25943|36086||1|0|L
487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|1033|2920|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||1033||1033|2920||2|0|G
487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9277|17771|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||9277||9277|17771||1|0|
488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|234270|297878|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||234270||234270|297878||1|0|L
488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|2861|5436|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||2861||2861|5436||1|0|G
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|7935|12420|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||7935||7935|12420||1|0|G
488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|0|G|0|DSM|0|0|0|100|DKK|21651|30658|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||21651||21651|30658||1|0|G
489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|6461|10391|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6461||6461|10391||3|0|G
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|83701|109139|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||83701|109139||1|0|S
489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0|
489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1650|3769|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1650||1650|3769||1|0|G
489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|21035|29879|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||21035||21035|29879||1|0|E
490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999|30.06.2020|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1860|4058|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1860||1860|4058||1|0|G
490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4281|7390|lyfalmen|V0133|7390|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4281||4281|7390||1|0|G
490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|0|G|0|RDT|0|0|0|100|DKK|2474|4903|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2474||2474|4903||1|0|G
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10950|11269|lyfalmen|V0112|2806|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7099||7099|11269||1|0|E
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13368|15101|lyfalmen|V0113|2806|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9883||9883|15101||1|0|E
490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|19760|27014|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||18538||18538|27014||1|0|G
490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|0|1|WEH|0|0|1|100|XEU|15580|19737|lyfsjukr|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||13251||13251|19737||2|0|0
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|15697|18666|lyfalmen|V0114|2806|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12473||12473|18666||1|0|E
491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|21602|30596|lyfalmen|V0665|30596|1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|1446543|1805606|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1446543||1446543|1805606||2|0|S
491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|374373|472126|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||374373||374373|472126||1|0|L
491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21007|29843|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||21007||21007|29843||1|0|G
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|125227|162259|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||125227||125227|162259||1|0|L
491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|46071|61544|lyfsjukr|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||46071||46071|61544||1|H|S
491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|0|SSE|0|0|1|100|DKK|13497|20075|lyfalmen|||2|6|0|2,0000|Shire Services BVBA|Shire Services BVBA|Mídazólam||13497||13497|20075||1|0|E
491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|ASD|0|0|0|100|SEK|2366|3747|lyfalmen|V0693|3261|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1634||1634|3747||2|0|E
491758|H01CB0203|Octreoanne|sts|10|mg|10|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|0|1|TVB|0|0|0|100|NOK|108982|142054|lyfsjukr|||2|10|0|14,2900|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Oktreótíð||108982||108982|142054||1|0|S
492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|0|MYL|0|0|0|100|DKK|882|2712|lyfalmen|||1|0,5|0||Icepharma hf|Mylan AB|Inflúensa, hreinsaðir  mótefnavakar||882||882|2712||2|0|
492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|557015|699282|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||557015||557015|699282||1|0|L
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2612|5093|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2612||2612|5093||2|0|G
492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|0|G|0|TEA|0|0|1|100|SEK|1613|3718|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1613||1613|3718||1|0|G
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0|
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|1|100|SEK|6751|10790|lyfalmen|V0002|6816|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6751||6751|10790||1|0|E
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0|
492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|17646|25786|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||17646||17646|25786||1|0|
492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0|
493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0|
493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|6992|5151|lyfalmen|V0813|4224|2|28|0|6,3000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2654||2654|5151||1|0|E
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|24185|33863|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24185||24185|33863||1|0|G
493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|95182|123660|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||95182||95182|123660||1|0|G
493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|70878|92920|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||70878||70878|92920||1|H|L
493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|0|1|G|0|SHS|0|0|0|100|DKK|30331|41636|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||30331||30331|41636||1|0|G
493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3273|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G
493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2750|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1179|3121|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1179||1179|3121||1|0|G
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3484|6293|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3484||3484|6293||1|0|G
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|79459|103773|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||79459||79459|103773||2|H|L
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|198764|253718|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||198764||198764|253718||2|H|L
494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1250|2007|lyfalmen|V0551|2007|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||370||370|2007||2|0|E
494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|7287|7162|lyfalmen|V0145|4210|2|8|0|16,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||4115||4115|7162||2|0|E
494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2093|4379|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2093||2093|4379||1|0|
494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2284|4642|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2284||2284|4642||1|0|G
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3320|6068|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3320||3320|6068||1|0|G
494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|IKR|3363|6551|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||3363||3363|6551||2|0|
494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|2382|4777|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2382||2382|4777||1|0|G
494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|DKK|929181|1162152|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||929181||929181|1162152||3|0|ES
495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|439331|552916|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||439331||439331|552916||2|H|S
495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|22222|8175|lyfalmen|V0384|5720|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4851||4851|8175||1|0|G
495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ACC|0|0|1|100|XEU|76201|99653|lyfsjukr|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||76201||76201|99653||1|0|ES
495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|5529|9108|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5529||5529|9108||1|0|
495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000|30.06.2020|R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2670|5173|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||2670||2670|5173||1|0|
496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|1|0|0|0|TVB|0|0|0|100|XEU|9912|10310|lyfalmen|V0997|10169|2|30|0|60,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Metýlfenídat||6402||6402|10310||1|0|E
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4628|8951|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4628||4628|8951||2|0|
496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G
496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5640||1|0|
496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|474|2150|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||474||474|2150||1|0|G
496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|856|2676|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||856||856|2676||1|0|G
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|1|100|XEU|228784|291054|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||228784||228784|291054||1|0|S
497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|0|G|0|DIU|0|0|1|100|IKR|14032|20812|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||14032||14032|20812||2|0|G
497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3264|5990|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3264||3264|5990||1|0|G
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|627|2361|lyfalmen|V0448|2361|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||627||627|2361||1|0|G
497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|0|G|0|UNI|0|0|0|100|XEU|4296|7411|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||4296||4296|7411||1|0|G
497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|901|2738|lyfalmen|V0050|2461|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||901||901|2738||1|0|G
497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1981|4225|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1981||1981|4225||2|0|G
498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G
498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|6697|3026|lyfalmen|V0683|3026|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|67500|108810|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||67500||67500|108810||1|0|
498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|7299|5406|lyfalmen|V0234|5406|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2839||2839|5406||1|0|G
498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|4000|4526|lyfalmen|V0812|4526|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E
498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|0|EXH|0|0|0|100|XEU|1562|3057|lyfalm11|V0590|3057|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1393||1393|3057||2|0|
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|25117|35042|lyfalmen|V0718|24927|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25117||25117|35042||1|0|G
499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|0|G|0|SIE|0|0|0|100|SEK|21602|30596|lyfalmen|V0664|30596|1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|9246|14224|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9246|14224||2|0|G
499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|6344|10230|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||6344||6344|10230||2|0|G
499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|10402|15815|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||10402||10402|15815||1|0|
500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|900|2461|lyfalmen|V0050|2461|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||700||700|2461||2|0|G
500476|L01XE3901|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01XE39|01.04.2018||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|2082647|2596741|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||2082647||2082647|2596741||1|0|L
500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|65386|85974|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||65386||65386|85974||2|0|S
501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|1|TVB|0|1|0|100|NOK|17529|25625|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||17529||17529|25625||1|H|L
501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012|31.07.2020|R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4087|4388|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||2100||2100|4388||2|0|G
501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5986|9737|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5986||5986|9737||1|0|G
501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|14747|15371|lyfalmen|V0997|10169|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||10079||10079|15371||1|0|E
501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|28546|39379|lyfalmen|V0974|35533|1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||28546||28546|39379||2|0|G
501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|5707|9353|lyfalmen|V0490|9353|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||5707||5707|9353||2|0|G
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2454|4876|lyfalmen|V0434|4876|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2454||2454|4876||2|0|G
502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|0|1|AZE|0|1|0|100|SEK|112113|145948|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||112113|145948||1|H|L
502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3754|4002|lyfalmen|V0143|3604|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1819||1819|4002||2|0|E
502423|H05BX0106|Cinacalcet ratiopharm|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|62687|19680|lyfalmen|V0722|17168|2|28|0|42,0000|Alvogen|ratiopharm GmbH|Cinacalcet||13210||13210|19680||2|0|0
502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|0|1|FIN|0|1|0|100|DKK|122778|159213|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||122778||122778|159213||2|H|L
502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1774|3940|lyfalmen|V0926|3940|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3940||2|0|G
502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0|
502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|10818|16161|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10653||10653|16161||1|0|G
502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|328080|414551|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||328080||328080|414551||1|0|L
502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|0|G|0|AZE|0|0|0|100|SEK|5950|9688|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5950||5950|9688||1|0|G
503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1|0|0
503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|21602|30596|lyfalmen|V0665|30596|1|28|0|21,0000|Vistor hf|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|5098|8515|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||5098||5098|8515||1|0|G
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|4346|7480|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||4346||4346|7480||2|H|S
504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0|
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1548|2962|lyfalmen|V0494|2815|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||1064||1064|2962||1|0|G
504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGP|0|0|0|100|DKK|6606|10590|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6606||6606|10590||1|0|G
504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|UPJ|0|0|0|100|DKK|38373|51808|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||38373||38373|51808||1|0|ES
504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|579|2295|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||579||579|2295||1|0|G
504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|0|1|GRP|0|0|0|100|XEU|11562|5836|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3152||3152|5836||1|H|0
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|14159|27033|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||14159||14159|27033||1|0|
505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|2611|5092|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2611||2611|5092||1|0|G
505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G
505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|0|1|0|0|MOL|0|0|0|100|IKR|5200|7829|lyfalmen|V0657|7829|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||4600||4600|7829||2|0|E
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3219|5929|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3219||3219|5929||1|H|S
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|8049|12577|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8049||8049|12577||1|H|S
506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|21602|30596|lyfalmen|V0664|30596|1|28|0|14,0000|Vistor hf|Eisai GmbH|Perampanel||21602||21602|30596||1|0|G
506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|RET|0|0|0|100|IKR|7114|11290|lyfalmen|V0968|10556|2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||7114||7114|11290||2|0|
506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G
507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0812|4224|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1973|4214|lyfalmen|V0092|4214|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1973||1973|4214||1|0|G
507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|SEK|908|2748|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||908||908|2748||2|0|G
508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3276|3563|lyfalmen|V0687|2766|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1500||1500|3563||2|0|E
508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|750|2285|lyfalmen|V0555|2099|2|2|0|1,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||572||572|2285||1|0|E
508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|0|MVA|0|0|0|100|DKK|20725|29487|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||20725||20725|29487||1|0|
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5167|9973|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5167|9973||2|0|
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4655|9002|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4655||4655|9002||2|0|
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13792|26337|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13792||13792|26337||2|0|
508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|1|SGB|0|1|0|100|XEU|655702|822021|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||655702||655702|822021||1|H|L
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|9051|13956|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9051||9051|13956||1|0|G
509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|6959|5886|lyfalmen|V0187|5886|2|50|0|12,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||3188||3188|5886||1|0|G
509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0|
509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|0|SPU|0|0|0|100|XEU|1469|3520|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir  mótefnavakar||1469||1469|3520||2|0|
509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0|
509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|2225|4082|lyfalm11|V0134|3444|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2225||2225|4082||2|0|
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|45725|61107|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||45725||45725|61107||1|0|S
509776|A02BC0513|Esomeprazole Jubilant|sþ-tfl|40|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|0|JUB|0|0|1|100|IKR|3164|4113|lyfalmen|V0012|3266|2|56|0|74,6700|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|23859|33450|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche Registration GmbH|Epóetín||23859||23859|33450||2|0|S
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|63851|84032|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche Registration GmbH|Epóetín||63851||63851|84032||2|0|S
510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|1|WEH|0|0|1|100|XEU|25223|25972|lyfsjukr|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||17781||17781|25972||2|0|S
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|487|2168|lyfalmen|V0601|2168|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||487||487|2168||1|0|G
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|151994|195549|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||151994|195549||1|0|S
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4212|3930|lyfalmen|V0445|3492|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Fínasteríð||1767||1767|3930||1|0|G
510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|4149|4939|lyfalmen|V0687|4939|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2500||2500|4939||2|0|E
511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|822|2629|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||822||822|2629||1|0|E
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2722|5244|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2722||2722|5244||1|0|G
511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|0|G|0|DSM|0|0|0|100|DKK|21651|30658|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||21651||21651|30658||1|0|G
511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|2673|5177|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2673|5177||2|H|S
511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|44893|60054|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||44893||44893|60054||1|0|G
511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|17487|25567|lyfsjukr|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||17487||17487|25567||2|H|S
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|16416|21567|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||16416||16416|21567||2|0|E
512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|0|1|0|1|ASD|0|1|0|100|DKK|53799|71319|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||53799||53799|71319||2|0|L
512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|0|G|0|SHS|0|0|1|100|DKK|2830|2355|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||623||623|2355||1|0|G
512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5313|8811|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||5313||5313|8811||1|0|S
512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|0|G|0|DIU|0|0|1|100|IKR|7016|11155|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7016||7016|11155||2|0|G
512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G
513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015|30.06.2020|R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2279|2635|lyfalmen|||2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||826||826|2635||1|0|G
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1080|2424|lyfalmen|V0109|2403|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||673||673|2424||1|0|G
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0|
513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0
513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2721|5333|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2721||2721|5333||2|0|
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|BRO|0|0|0|100|XEU|2142|3880|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||1974||1974|3880||2|0|0
513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|0|1|MUP|0|0|0|100|DKK|5194|8647|lyfsjukr|||1|3|0||Icepharma hf|Mundipharma A/S|Methoxyflurane||5194||5194|8647||2|H|0
514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9764|6040|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3300||3300|6040|31.7.2020|2|0|
514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G
514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G
514280|J07BB0207|Influvac Tetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|0|YLA|0|0|0|100|IKR|13179|19637|lyfalmen|||1|5|0||Icepharma hf|Mylan ApS|Inflúensa, hreinsaðir  mótefnavakar||13179||13179|19637||2|0|
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|18466|26915|lyfalmen|V0818|12544|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||18466|26915||2|0|E
514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2486|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4260|5463|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2881||2881|5463||1|0|G
515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0|
515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|13004|19397|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13004||13004|19397||3|0|G
515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|1624|2680|lyfalmen|V0056|2680|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||859||859|2680||2|0|G
516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|126992|164454|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||126992|164454||2|0|L
516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1800|3136|lyfalmen|V0069|2750|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1190||1190|3136||2|0|G
516803|L01XE0105|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|0|1|0|1|RTH|0|1|0|100|XEU|105702|70424|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatiníb||53092||53092|70424||2|0|L
516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|7223|11440|lyfalmen|V0384|11440|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||7223||7223|11440||1|0|G
517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|9000|7004|lyfalmen|V0273|6990|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||4000||4000|7004||2|0|G
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2248|4592|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2248||2248|4592||1|0|G
517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|31853|43561|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||31853||31853|43561||1|0|G
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2627|5114|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2627||2627|5114||1|0|G
517803|H02AB0208|Dexavit|stl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|0|VIT|0|0|1|100|DKK|3748|6657|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3748||3748|6657||1|0|0
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2817|5375|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2817||2817|5375||1|0|G
517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|30475|41818|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||30475||30475|41818||2|H|S
517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|10404|17932|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||10404||10404|17932||2|0|
518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|12509|lyfalmen|V0711|12509|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||8000||8000|12509||2|0|G
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|1130|3053|lyfalmen|||1|20|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||1130||1130|3053||1|0|G
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|4665|7919|lyfalmen|||1|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||4665||4665|7919||1|0|G
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|2108|3938|lyfalm11|V0590|3057|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||2108||2108|3938||1|0|
518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1280|3260|lyfalmen|V0004|2839|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1280||1280|3260||1|0|E
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|16531|24251|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||16531||16531|24251||1|0|G
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1015|2895|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1015||1015|2895||2|0|E
519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|2728|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8739||2|0|G
519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|PIL|0|0|1|100|IKR|792|2113|lyfalmen|V0564|2113|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||447||447|2113||2|0|G
519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0|
519172|L01XE0303|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|0|1|0|1|WEH|0|1|0|100|XEU|274863|304350|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||239474||239474|304350||2|0|L
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEP|0|0|1|100|DKK|1106|3020|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1106||1106|3020||2|0|E
519722|N07BC0102|Buvidal|stl|64|mg|1|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|1|0|0|1|CMS|0|0|0|100|SEK|60848|80234|lyfsjukr|||1|1|0|8,0000|Vistor hf|Camurus AB|Búprenorfín||60848||60848|80234||1|H|S
519755|L01XE3901|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01XE39|01.03.2020||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|1006848|1258748|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1006848||1006848|1258748||1|0|L
520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3180|4432|lyfalmen|V0515|4432|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2132||2132|4432||1|0|G
520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1629|3740|lyfalmen|V0213|3740|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1629||1629|3740||2|0|G
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22768|32071|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||22768|32071||1|0|G
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|18115|26431|lyfalmen|V0143|3604|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||18115||18115|26431||1|0|E
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|5894|9610|lyfalmen|V0144|1394|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||5894||5894|9610||1|0|E
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|UPJ|0|0|0|100|DKK|16309|23946|lyfalmen|V0144|4182|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||16309||16309|23946||1|0|E
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1483|2764|lyfalmen|V0056|2393|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||920||920|2764||1|0|G
520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|12353|18501|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||12353||12353|18501||1|0|ES
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2398|2764|lyfalmen|V0057|2317|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||920||920|2764||1|0|G
520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9292|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G
520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|0|G|0|MYL|0|0|0|100|DKK|12327|10216|lyfalmen|V0440|9648|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||6334||6334|10216||2|0|G
520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|676|2428|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||676||676|2428||2|0|G
520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0|
521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|1687|3820|lyfalmen|||2|100|0|40,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Warfarín||1687||1687|3820||1|0|G
521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|213355|271865|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||213355||213355|271865||1|H|L
522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0
522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|0|1|0|0|ASR|0|0|0|100|IKR|12900|19253|lyfalmen|V1027|19253|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||12900||12900|19253||2|0|E
522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|91212|118639|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||91212||91212|118639||2|0|S
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|154894|199156|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||154894||154894|199156||1|H|S
522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0|
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5091|3635|lyfalmen|V0285|3287|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1553||1553|3635||1|0|G
523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G
523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|0|1|SUN|0|1|0|100|DKK|85982|112024|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||85982||85982|112024||1|H|L
523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|178716|228784|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||178716||178716|228784||1|H|S
523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1726|2672|lyfalmen|V0144|1394|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||853||853|2672||1|0|E
523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|365480|461066|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||365480||365480|461066||1|0|L
523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0|
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1001|2876|lyfalmen|V0903|2600|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1001||1001|2876||1|0|G
523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6887|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E
523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1601|3702|lyfalmen|V0584|3702|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1601||1601|3702||1|0|G
524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|TOG|0|0|0|100|SEK|359|1992|lyfalmen|||1|28|0|21,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||359||359|1992||1|0|G
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E
524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|V0039|2952|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G
524551|L01XE0106|Imatinib Teva|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.02.2019|30.06.2020|R|1|0|0|1|0|1|TVA|0|1|0|100|XEU|169148|187254|lyfsjukr|||2|30|0||Alvogen|Teva B.V.|Imatiníb||145324||145324|187254||2|0|L
524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|2900|3824|lyfalmen|V0689|3824|2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1690||1690|3824||2|0|E
524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|7227|11445|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||7227||7227|11445||2|0|E
525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|1352|3359|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1352||1352|3359||2|0|G
525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|0|G|0|GLZ|0|0|0|100|DKK|4163|6658|lyfalmen|V0437|6658|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||3749||3749|6658||2|0|G
525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|4795|8098|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4795||4795|8098||2|0|S
525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|0|1|0|0|TGH|0|0|0|100|XEU|81078|98762|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||75497||75497|98762||1|0|E
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|32575|44474|lyfalmen|V0977|44474|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||32575|44474||2|0|G
525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|5130|8559|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||5130||5130|8559||2|H|S
525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4670|7926|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||4670||4670|7926||2|H|S
525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|1|100|DKK|2608|5088|lyfsjukr|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2608|5088||2|0|ES
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0|
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0|
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|6283|10146|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||6283||6283|10146||1|0|G
526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|9168|5902|lyfalmen|V0516|5902|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3200||3200|5902||2|0|G
526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|11133|lyfalmen|V0423|11133|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||7000||7000|11133||2|0|G
526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15481|6856|lyfalmen|V0111|6701|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3893||3893|6856||2|0|E
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3982|6979|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3982||3982|6979||1|0|G
527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|6740|10775|lyfalmen|V0621|8000|1|18|0|18,0000|Vistor hf|M.S.D.|Rizatriptan||6740||6740|10775||1|0|G
527412|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.11.2019||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4104|6761|lyfalmen|V0054|3975|2|100|0|133,3333|Artasan ehf|Hexal A/S|Metóprólól||3824||3824|6761||1|0|G
527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|11184|6986|lyfalmen|V0516|5902|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3987||3987|6986||1|0|G
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1495|3556|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1495||1495|3556||1|0|G
527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5467|9023|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5467||5467|9023||1|0|G
527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2273|3150|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1200||1200|3150||2|0|G
527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|256808|325908|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||256808||256808|325908||1|0|G
527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1843|3622|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1843||1843|3622||2|0|
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1014|2483|lyfalmen|V0046|2483|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||716||716|2483||1|0|G
528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0|
528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G
528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3223||1|0|
528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|GRH|0|0|1|100|DKK|9874|6540|lyfalmen|V0011|5010|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3663||3663|6540||1|0|G
528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|PIL|0|0|1|100|IKR|668|2349|lyfalmen|V0562|2349|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||618||618|2349||2|0|G
528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2073|4351|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2073||2073|4351||1|0|G
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|5691|9331|lyfalmen|||3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5691||5691|9331|31.7.2020|3|0|G
528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6672|10681|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6672||6672|10681||1|0|G
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|4724|8000|lyfalmen|V0621|8000|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||4724||4724|8000||2|0|G
529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|5604|8943|lyfalmen|V1003|8943|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5409||5409|8943||2|0|E
529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|65638|86293|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||65638||65638|86293||1|H|S
529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|0|1|0|1|KAN|0|0|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|S
530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0|
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7462||1|0|E
530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2488|3081|lyfalmen|V0824|3081|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1647|3237|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1647||1647|3237||2|0|
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2885|5469|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2885||2885|5469||1|0|G
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6424|10340|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6424||6424|10340||1|0|S
531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|7096|6731|lyfalmen|V0622|6564|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3802||3802|6731||1|0|E
531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21030|29872|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||21030||21030|29872||1|0|G
531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|0|RNU|0|0|1|100|XEU|7074|6190|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||3409||3409|6190||2|0|0
531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|2032|4295|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2032||2032|4295|30.6.2020|3|H|S
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|652|2395|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||652||652|2395||1|0|
532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|46818|12703|lyfalmen|V0711|11169|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||8141||8141|12703||2|0|G
532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|0|0|1|WEH|0|1|0|100|XEU|118975|154483|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||118975||118975|154483||2|H|L
532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|26873|46318|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||26873||26873|46318||2|0|
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2006|4259|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2006||2006|4259||2|0|S
532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1367|3379|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1367||1367|3379||1|0|E
533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2186|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G
533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|255948|324839|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||255948||255948|324839||2|0|L
533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|817699|1023500|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||817699|1023500||2|H|L
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|22855|32181|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||22855||22855|32181||1|0|G
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PEU|0|0|0|100|DKK|59306|78284|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||59306||59306|78284||1|0|G
534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|3034|5927|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||3034||3034|5927||2|0|
534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|5481|5283|lyfalmen|V0117|5283|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2750||2750|5283||2|0|E
534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2480|4911|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2480||2480|4911||2|0|G
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5378|8900|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5378||5378|8900||2|H|S
534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|3185|5882|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||3185||3185|5882||2|0|G
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2269|4621|lyfalmen|V0092|4214|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2269||2269|4621||1|0|G
535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|2534|4368|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2534||2534|4368||1|0|
535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2378|2984|lyfalmen|V0826|2870|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1080||1080|2984||2|0|G
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0|
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|378|2018|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||378||378|2018||1|0|G
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|394|2040|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||394||394|2040||1|0|G
536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|6306|10177|lyfsjukr|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||6306||6306|10177||1|H|S
536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2750|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G
536429|A02BA0208|Asýran|filmhtfl|150|mg|30|stk|1|þpakki||A02BA02|01.07.2019||L|1|0|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0|
536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|90218|117381|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||90218||90218|117381||1|0|E
536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|10582|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2689|5199|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2689||2689|5199||2|H|S
536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9698|14846|lyfalmen|||2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||9698||9698|14846||1|0|G
536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0
537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|65386|85974|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||65386||65386|85974||2|0|S
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|5571|9166|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5571||5571|9166||1|0|S
537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|9017|13909|lyfalmen|V0492|13909|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||9017||9017|13909||2|0|G
537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G
537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2470||1|0|G
537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0|
538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|7737|12147|lyfalmen|||2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7737||7737|12147||1|0|E
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0|
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0|
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0|
538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3013|5645|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3013||3013|5645||2|0|G
538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGP|0|0|0|100|DKK|4693|7957|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4693||4693|7957||1|0|G
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNP|0|0|0|100|XEU|9119|14049|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||9119||9119|14049||1|0|G
539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5182|8630|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5182||5182|8630||1|0|G
539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|68861|90369|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||68861||68861|90369||1|H|L
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|792|2588|lyfalmen|||2|25|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||792||792|2588||1|0|
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|886|2717|lyfalmen|||2|100|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||886||886|2717||1|0|
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0|
539793|L01XE4201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|521449|655048|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||521449||521449|655048||1|0|L
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1814|3995|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1814||1814|3995||1|0|G
539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|DKK|9900|6921|lyfalmen|V0954|6749|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||3940||3940|6921||2|0|
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19451|28270|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||19451||19451|28270||1|0|S
540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|44175|12381|lyfalmen|V0721|7689|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7907||7907|12381||2|0|
540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019||R|1|0|0|0|G|0|TVA|0|0|0|100|DKK|13715|18571|lyfalmen|V0256|18571|2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12404||12404|18571||2|0|G
540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|22965|32320|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||22965||22965|32320||1|H|S
540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|0|1|BAM|0|0|1|100|DKK|7820|12261|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7820||7820|12261||2|0|S
540752|H01CB0203|Octreoanne|sts|30|mg|30|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|0|1|TVB|0|0|0|100|NOK|174101|196803|lyfsjukr|||2|30|0|42,8600|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Oktreótíð||153002||153002|196803||1|0|S
540854|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|2075|3631|lyfalmen|V0686|3631|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1550||1550|3631||2|0|E
540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|511358|642497|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||511358||511358|642497||2|H|L
540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0813|4224|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|679672|851833|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||||679672|851833||2|0|L
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0|
541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|2409|4814|lyfalmen|V0685|2190|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2409||2409|4814||3|0|E
541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|199276|254355|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||199276||199276|254355||1|0|L
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|1|100|XEU|5473|9031|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5473||5473|9031||2|0|ES
542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|0|1|0|1|KAN|0|0|0|100|IKR|4301|7418|lyfsjukr|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|S
542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|5597|3026|lyfalmen|V0682|3026|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1110||1110|3026||2|0|G
542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|0|G|0|BES|0|0|0|100|DKK|1146|3075|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1146||1146|3075||1|0|G
542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4159|7222|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||4159||4159|7222||2|0|S
542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|18600|6743|lyfalmen|V0720|6743|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||3811||3811|6743||2|0|
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|15997|23516|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||15997|23516||1|0|G
543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G
543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1632|3744|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1632||1632|3744||2|0|G
543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|94300|122544|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||94300||94300|122544||2|H|S
543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999|30.06.2020|L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|250|0|21,7857|Icepharma hf|Meda AB|Semen psyllii (ispaghula)|||||||2|0|
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0|
544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|574051|720470|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||574051||574051|720470||2|0|S
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|392364|494502|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||392364||392364|494502||2|H|L
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12251|18360|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12251||12251|18360||1|0|G
544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|8827|10805|lyfalmen|V0145|4210|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||6762||6762|10805||1|0|E
545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G
545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|280250|355064|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||280250||280250|355064||2|H|L
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RTH|0|0|0|100|XEU|1707|3444|lyfalm11|V0134|3444|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1707||1707|3444||2|0|
545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0|
545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|3533|3865|lyfalmen|V0438|3787|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||1720||1720|3865||2|0|G
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|931|2779|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||931||931|2779||1|0|
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|884|2715|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||884||884|2715||1|0|G
545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|0|G|0|VBA|0|0|1|100|XEU|1251|2600|lyfalmen|V0903|2600|2|100|0|100,0000|Actavis Group PTC ehf|Actavis BV|Prómetazín||801||801|2600||1|0|G
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2033|4296|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2033||2033|4296||1|0|G
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|30545|41907|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||30545||30545|41907||1|0|G
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24627|34422|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||24627||24627|34422||1|0|G
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|30725|42135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||30725||30725|42135||1|0|G
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26102|36287|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||26102||26102|36287||1|0|G
546319|A02BA0208|Asýran|filmhtfl|150|mg|10|stk|1|þpakki||A02BA02|01.07.2019||L|1|0|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0|
546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|570|2282|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||570||570|2282||2|0|G
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|1|100|XEU|4378|4292|lyfalmen|V0010|3916|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2030||2030|4292||1|0|G
547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|16110|23672|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16110||16110|23672||1|0|G
547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|1|RAU|0|0|1|100|XEU|3206|5911|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||3206||3206|5911||2|0|S
547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|IKR|4100|6866|lyfalmen|V0581|6597|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3900||3900|6866||2|0|G
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0|
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGP|0|0|0|100|DKK|9764|14937|lyfsjukr|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||9764||9764|14937||1|H|S
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGP|0|0|0|100|DKK|3139|5818|lyfsjukr|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||3139||3139|5818||1|H|S
547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6806|10866|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6806|10866||2|0|S
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|FIN|0|0|0|100|DKK|107857|140655|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||107857||107857|140655||2|0|S
548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|2257|4604|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2257||2257|4604||2|0|G
548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|9331|14341|lyfalmen|V1011|14341|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||9331||9331|14341||2|0|E
548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|471|2146|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||471||471|2146||1|0|G
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2204||1|0|G
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|154091|198157|lyfsjukr|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||154091||154091|198157||2|H|S
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|7132|11314|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||7132||7132|11314||1|0|G
549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|5283|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E
549476|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|10169|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|32129|43910|lyfalmen|V0976|43585|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||32129|43910||2|0|G
550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|0|G|0|SAO|0|0|1|100|XEU|850|2668|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||850||850|2668||2|0|G
550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|1350|2653|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1350||1350|2653||2|0|
550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1574|2150|lyfalmen|V0551|2007|2|7|0|1,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||474||474|2150||1|0|E
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0|
550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0|
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G
551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1743|3897|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1743||1743|3897||1|0|G
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0|
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7891|12359|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7891||7891|12359||2|H|S
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1662|3785|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1662||1662|3785|30.6.2020|2|0|G
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|5099|8516|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||5099||5099|8516||2|0|G
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1138|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E
551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|1|HSS|0|1|0|100|DKK|55809|73861|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||55809||55809|73861||1|H|L
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2276|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|1692|3827|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1692||1692|3827||2|0|S
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1|0|
552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018||L|1|0|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||1|20|0|10,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0|0
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|QAS|0|0|0|100|GBP|16330|26324|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||16330||16330|26324||1|0|
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3251|5973|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3251||3251|5973||1|0|G
552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0|
553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|173191|221912|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||173191||173191|221912||2|H|S
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6494|10436|lyfalmen|V0237|10436|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||6494|10436||1|0|G
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2452|4873|lyfalmen|V0237|3479|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2452||2452|4873||1|0|G
553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6666|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G
553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2530|lyfalmen|V0169|2530|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||750||750|2530||2|0|
553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0|
553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|462285|581464|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||462285||462285|581464||1|0|L
554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|1|PEU|0|1|0|100|DKK|89086|115950|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||89086||89086|115950||1|H|L
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|9748|18664|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9748||9748|18664||1|0|
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6711|6033|lyfalmen|V0029|6033|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3295||3295|6033||1|0|G
554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1309842|1635588|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1309842||1309842|1635588||2|0|L
555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|174169|223129|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||174169||174169|223129||1|0|L
555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1685|3817|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1685||1685|3817||1|0|G
555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|2345|4726|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2345||2345|4726||1|0|G
555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1198|3147|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1198||1198|3147||1|0|G
556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|2011|3012|lyfalmen|V0461|3012|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1100||1100|3012||2|0|E
556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0|
556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0
556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|74156|97066|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||74156||74156|97066||1|0|E
556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|DKK|11963|6887|lyfalmen|V0954|6887|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3915||3915|6887||2|0|E
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|19815|28771|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||19815||19815|28771||2|0|L
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4927|8279|lyfalmen|V0972|7261|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4927||4927|8279||1|0|G
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|9605|14718|lyfalmen|V0973|12727|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9605||9605|14718||1|0|G
557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|10788|4281|lyfalmen|V0814|4224|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2022||2022|4281||2|0|E
557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0|
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|1447|3490|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1447||1447|3490||2|0|G
558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|0|MAR|0|0|1|100|DKK|||lyfalmen|V1024|9305|1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||9305||2|0|
558417|L01XE1401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01XE14|01.03.2019||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|524273|658560|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||524273||524273|658560||1|0|L
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|233783|297272|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||233783|297272||1|0|L
558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0|
559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0|
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0|
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0|
559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4719|7993|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4719||4719|7993||1|0|G
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1948||1|0|G
560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|1|CBV|0|1|0|100|XEU|41898|56266|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe B.V.|Paklítaxel||41898||41898|56266||2|H|L
560293|L01XX4601|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|0|1|0|1|AZA|0|1|0|100|SEK|384680|484945|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||384680||384680|484945||1|0|L
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0|
560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0|
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|1|COR|0|0|0|100|DKK|111552|145251|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||111552||111552|145251||1|H|S
560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|173448|123889|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||95363||95363|123889||1|0|L
561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
561239|L01XE2701|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|749646|938861|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||749646||749646|938861||1|0|L
561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6504|10450|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6504||6504|10450||1|0|G
561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|199276|254355|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||199276||199276|254355||1|0|L
562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1680|3112|lyfalmen|V0098|2488|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1173||1173|3112||1|0|G
562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|50321|66920|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur IX||50321||50321|66920||1|0|S
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4327|7454|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4327||4327|7454||1|0|G
562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|963492|1204826|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||963492||963492|1204826||2|H|S
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGP|0|1|0|100|DKK|85749|111729|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||85749||85749|111729||1|H|L
562774|H01CB0203|Octreoanne|sts|20|mg|20|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|0|1|TVB|0|0|0|100|NOK|136519|155659|lyfsjukr|||2|20|0|28,5700|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Oktreótíð||119921||119921|155659||1|0|S
563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6414|10326|lyfalmen|V0705|9520|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||6414||6414|10326||1|0|G
563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|34638|47084|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||34638||34638|47084||2|H|S
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1396|3419|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1396||1396|3419||1|0|G
563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|24137|8657|lyfalmen|V0720|6743|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||5201||5201|8657||2|0|
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3485|6295|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3485|6295||2|0|G
563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0|
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|RRD|0|0|0|100|DKK|464756|584538|lyfalmen|||1|60|0|15,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||464756||464756|584538||1|0|E
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0|
563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0|
563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013|31.07.2020|R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|672|2423|lyfalmen|||2|28|0|1,8600|Alvogen|ratiopharm GmbH|Oxýcódon||672||672|2423||2|0|G
564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3744|6651|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3744||3744|6651||1|0|
564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G
564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|TMA|0|1|0|100|DKK|20355|29019|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||20355||20355|29019||3|0|L
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|898|2734|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||898||898|2734||1|0|G
564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1489|2677|lyfalmen|V0056|2393|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||857||857|2677||1|0|G
564607|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4870|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E
564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|BIV|0|0|0|100|XEU|2417|4166|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2417||2417|4166||1|0|
564892|H05BX0106|Cinacalcet ratiopharm|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|42184|8299|lyfalmen|V0721|7689|2|28|0|28,0000|Alvogen|ratiopharm GmbH|Cinacalcet||4941||4941|8299||2|0|0
565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|1|100|DKK|2668|5170|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2668||2668|5170||1|0|S
565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|0|1|LNA|0|0|0|100|XEU|281483|304082|lyfsjukr|||2|1000|0||Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||239259||239259|304082||2|H|0
565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|8855|6109|lyfalmen|V0286|5627|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G
565423|A02BA0208|Asýran|filmhtfl|150|mg|60|stk|1|þpakki||A02BA02|01.07.2019||R|1|0|0|0|G|0|TEE|0|0|1|100|XEU|935|2785|lyfalmen|||2|60|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||935||935|2785||1|0|G
565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8748|16767|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8748|16767||2|0|
565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2306|4304|lyfalmen|V0049|2943|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||2039||2039|4304||1|0|G
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|24174|33849|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||24174||24174|33849||1|H|S
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1547|3627|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1547||1547|3627||1|0|G
566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|14965|22096|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||14965||14965|22096||1|0|G
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|189758|242517|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||189758||189758|242517||1|0|S
567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2806|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G
567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16219|23822|lyfalmen|V0651|23819|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16219||16219|23822||1|0|G
567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|6255|10107|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6255||6255|10107||1|H|S
567372|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|0|JUB|0|0|1|100|IKR|2000|4113|lyfalmen|V0011|2806|2|56|0|37,3300|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E
567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3371||2|0|G
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|5865|9571|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5865|9571||1|0|G
567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2095|4381|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2095||2095|4381||1|0|G
567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2649|5144|lyfalmen|V0291|2461|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2649||2649|5144||1|0|G
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|2784|5330|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||2784||2784|5330||2|0|G
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0|
567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|358416|452280|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||358416|452280||2|0|E
567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0|
567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|10004|15267|lyfalmen|||2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||10004||10004|15267|31.8.2020|1|0|E
567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|0|1|0|0|NEL|0|0|0|100|DKK|70005|91816|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||70005||70005|91816||1|0|E
568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6545|11281|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6545||6545|11281||2|0|0
568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2446|2870|lyfalmen|V0826|2870|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||997||997|2870||2|0|G
568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1040|2929|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||1040||1040|2929||1|0|
568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|0|IVS|0|0|1|100|IKR|||lyflausa|||2|28|0|18,6700|Actavis Group PTC hf|Actavis ehf|Esómeprazól|||||||1|0|0
568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015|30.06.2020|R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|5145|8579|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai GmbH|Perampanel||5145||5145|8579||1|0|G
568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2606|2945|lyfalmen|V0058|2786|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1051||1051|2945||1|0|G
568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3953|3447|lyfalmen|V0059|3235|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1416||1416|3447||1|0|G
569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G
569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G
569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|0|1|0|1|VIC|0|0|0|100|DKK|132002|170685|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||132002||132002|170685||1|0|S
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10789|16348|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10789||10789|16348||2|H|S
569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13645|20279|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13645||13645|20279||1|0|S
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|15691|23095|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||15691||15691|23095||1|0|S
569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5604|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G
570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|1|0|0|0|GOV|0|0|0|100|DKK|10653|14444|lyfalmen|V1005|14444|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||9406||9406|14444||2|0|E
570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|3870|2830|lyfalmen|V0110|2730|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||968||968|2830||2|0|G
570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2577|5045|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2577||2577|5045||2|0|G
570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2100|4388|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2100||2100|4388||1|0|G
570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|3584|5627|lyfalmen|V0196|5627|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3000||3000|5627||2|0|G
571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3427|6672|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3427||3427|6672||1|0|
571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G
571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|3578|6423|lyfalmen|V0384|5720|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||3578||3578|6423||2|0|G
571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|73442|96163|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||73442||73442|96163||1|H|S
571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|551529|692459|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||551529||551529|692459||2|H|L
571526|J05AB1402|Valganciclovir Teva|filmhtfl|450|mg|60|stk|1|þpakki||J05AB14|01.12.2018|31.07.2020|R|1|0|0|0|0|1|TAB|0|0|1|100|DKK|57930|76543|lyfsjukr|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Valgancíklóvír||57930||57930|76543||2|0|S
571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|16743|24543|lyfalmen|V0687|4939|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||16743||16743|24543||3|0|E
571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|57809|76390|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||57809||57809|76390||2|0|0
571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0
572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|CLU|0|1|0|100|XEU|38855|52417|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||38855||38855|52417||1|0|L
572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|90676|102105|lyfsjukr|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||78140||78140|102105||2|0|0
572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|74780|97855|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||74780||74780|97855||1|0|G
572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G
572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|7079|3026|lyfalmen|V0684|3026|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3222|5933|lyfalmen|V0994|2874|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||3222||3222|5933||1|0|G
573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|2169832|2705175|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2169832|2705175||2|0|S
573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|89716|116746|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||89716||89716|116746||2|H|L
573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|0|G|0|VAL|0|0|0|100|XEU|6524|3026|lyfalmen|V0683|3026|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1110||1110|3026||2|0|G
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|14997|18101|lyfsjukr|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||12063||12063|18101||1|0|ES
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|1|100|DKK|24416|28771|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||19815||19815|28771||1|0|ES
573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|0|1|SER|0|0|0|100|XEU|97656|126789|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||97656||97656|126789||3|H|S
574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0|
574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|925|2771|lyfsjukr|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||925||925|2771||1|H|S
574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|429656|540883|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||429656||429656|540883||2|H|L
574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|9254|14235|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||9254||9254|14235||1|0|G
574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|7788|7551|lyfalmen|V0322|2858|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4398||4398|7551||1|0|G
575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|14688|4560|lyfalmen|V0817|4560|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2225||2225|4560||2|0|E
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|13278|7551|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4398||4398|7551||1|0|G
575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|25252|35212|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||25252||25252|35212||1|0|E
575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|40370|54334|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||40370||40370|54334||2|H|L
575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|781683|978706|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||781683||781683|978706||1|H|S
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1379|2369|lyfalmen|V0159|2369|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||633||633|2369||2|0|E
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1690|3173|lyfalmen|V0160|2914|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1217||1217|3173||2|0|E
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1537|2829|lyfalmen|V0158|2829|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||967||967|2829||2|0|E
575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|89786|116835|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||89786||89786|116835||1|0|G
575959|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7898|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E
576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1269954|1585978|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1269954||1269954|1585978||2|0|L
576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0806|10445|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G
576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0|
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|8937|13799|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||8937||8937|13799||2|0|G
576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|13500|16914|lyfalmen|V0680|16914|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||11200||11200|16914||2|0|
577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|481|2160|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||481||481|2160||1|0|E
577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|21485|30448|lyfalmen|V0727|28265|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21485||21485|30448||1|0|E
577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|148131|190745|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||148131||148131|190745||2|0|L
577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|0|LYF|0|0|0|100|IKR|4500|4526|lyfalmen|V0816|4526|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||2200||2200|4526||2|0|E
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11619|17490|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11619||11619|17490||2|H|S
578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|4671|7927|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4671||4671|7927||1|0|
578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|346383|437315|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||346383||346383|437315||2|H|S
578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|107280|139938|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||107280||107280|139938||1|0|0
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|7081|12205|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||7081||7081|12205||2|0|
578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|694|2453|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||694||694|2453||1|0|E
579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|11133|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G
579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|MDK|0|0|0|100|DKK|2586|5057|lyfalmen|||1|98|0|98,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||2586||2586|5057||2|0|G
579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|0|1|CLU|0|0|0|100|XEU|35857|48626|lyfsjukr|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||35857||35857|48626||1|H|S
579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|172069|220517|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||172069||172069|220517||1|H|L
579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|7952|12443|lyfsjukr|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||7952||7952|12443||2|H|S
579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|19364|27817|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||19122||19122|27817||1|0|G
579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E
579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|0|1|0|1|NED|0|1|0|100|XEU|126684|164071|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||126684||126684|164071||2|0|L
579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|10398|15810|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10398||10398|15810||1|0|G
579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2461|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E
579972|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|14906|10385|lyfalmen|V0111|6701|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||6457||6457|10385||2|0|E
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8657|13413|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8657||8657|13413||1|0|
580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|1|FKD|0|0|0|100|DKK|7023|11164|lyfsjukr|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||7023||7023|11164||1|H|S
580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4072|7103|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4072||4072|7103||1|0|G
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|1|100|SEK|1601|3702|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1601||1601|3702||2|0|S
581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|2863|2595|lyfalmen|V0057|2595|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||797||797|2595||2|0|G
581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3287|6022|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3287||3287|6022||2|0|G
581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0|
581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|3604|6458|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3604||3604|6458||2|0|G
581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|20768|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||14000||14000|20768||2|0|G
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|14537|27750|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14537||14537|27750||2|0|
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2440|4856|lyfalmen|V0669|4108|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2440||2440|4856||1|0|G
582004|L01XE2901|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|0|1|0|1|SIE|0|0|0|100|SEK|246583|313191|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||246583||246583|313191||1|0|S
582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0|
582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|DKK|4305|7261|lyfalmen|V0972|7261|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||4187||4187|7261||2|0|G
582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|17698|25857|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||17698||17698|25857||3|0|G
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22951|32302|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||22951||22951|32302||2|H|S
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18693|27227|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||18693||18693|27227||2|H|S
582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|19868|28844|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||19868||19868|28844||1|0|
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|56078|74201|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||56078||56078|74201||2|H|S
582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|0|G|0|DIU|0|0|1|100|IKR|70157|92008|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||70157||70157|92008||2|0|G
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23338|32792|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23338||23338|32792||2|H|S
582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|0|EXH|0|0|0|100|DKK|3812|5542|lyfalm11|V0983|5542|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3410||3410|5542||2|0|
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|33640|45821|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||33640||33640|45821||2|0|L
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2063|4337|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2063||2063|4337||1|0|G
583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|47678|63577|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||47678||47678|63577||2|H|S
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|957|2815|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||957||957|2815||2|0|G
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|80517|105112|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||80517||80517|105112||2|H|S
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25509|35537|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||25509||25509|35537||2|H|S
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40814|54895|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||40814||40814|54895||2|H|S
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|76527|100065|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||76527||76527|100065||2|H|S
583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|4061|5792|lyfalmen|V0985|5792|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||3120||3120|5792||2|0|G
583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|1|RAU|0|0|1|100|XEU|1732|3882|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1732||1732|3882||2|0|S
584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|0|0|1|VAL|0|0|1|100|XEU|8368|10010|lyfsjukr|||2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||6184||6184|10010||2|0|S
584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|2874|lyfalmen|V0250|2874|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1000||1000|2874||2|0|G
584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|627|2361|lyfalmen|V0448|2361|2|100|0|50,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Enalapríl||627||627|2361||1|0|G
585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|7699|12095|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7699||7699|12095||1|0|G
585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|64454|84795|lyfalmen|V0727|84795|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||64454||64454|84795||1|0|E
585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|1|MBV|0|1|0|100|DKK|537087|674497|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||537087||537087|674497||1|H|L
585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0|
585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|18875|27477|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18875||18875|27477||1|0|G
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5826|9517|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5826||5826|9517||1|0|
585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G
585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|12490|18689|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||12490||12490|18689||2|0|G
585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4215|7299|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4215||4215|7299||1|0|
585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|10720|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G
585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|1|HSS|0|1|0|100|DKK|139703|180263|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||139703||139703|180263||1|H|L
586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|0|G|0|ASR|0|0|0|100|IKR|1833|4021|lyfalmen|V0251|3218|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1833||1833|4021||2|0|G
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|28293|39059|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28293||28293|39059||1|0|G
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|1|100|XEU|13168|19622|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||13168||13168|19622||2|0|ES
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|0|1|MLT|0|1|1|100|DKK|299923|379531|lyfsjukr|||1|224|0|56,0000|BGP Products AsP|Mylan Ireland Limited|Tobramýcín||299923||299923|379531||2|0|L
586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|70632|92609|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||70632||70632|92609||1|0|E
586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2861|lyfalmen|V0335|2861|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G
586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0
586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|6992|5514|lyfalmen|V0815|4224|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2918||2918|5514||1|0|E
586939|N05AH0415|Quetiapin Krka|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.07.2019||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|12500|12234|lyfalmen|V0261|11546|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||7800||7800|12234||2|0|0
586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|0|1|AEE|0|0|0|100|XEU|4664|7917|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4664||4664|7917||1|H|0
586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|29767|40923|lyfalmen|V0652|40920|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||29767|40923||1|0|G
587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|4515|6606|lyfalmen|V0196|5627|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3711||3711|6606||1|0|G
587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0|
587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|163082|209340|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||163082||163082|209340||1|0|L
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6537|10495|lyfalmen|V0095|10495|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||6537||6537|10495||1|0|E
587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|V0957|16820|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E
587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|4354|6697|lyfalmen|V0081|6697|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3777||3777|6697||2|0|G
588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|0|1|0|1|OEL|0|1|0|100|DKK|171998|220429|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||171998||171998|220429||1|0|L
588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|6634|3026|lyfalmen|V0683|3026|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1110||1110|3026||2|0|G
588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|702939|880771|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||702939||702939|880771||1|0|ES
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1961|4197|lyfalmen|V0461|2869|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1961||1961|4197||1|0|E
588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015|30.06.2020|R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|20581|29304|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai GmbH|Perampanel||20581||20581|29304||1|0|G
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|18090|14497|lyfalmen|V0282|12854|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||9444||9444|14497||1|0|G
589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|659662|826946|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||659662||659662|826946||1|0|L
589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|1|0|G|0|KAN|0|0|1|100|IKR|3500|5352|lyfalmen|V0228|5352|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2800||2800|5352||2|0|G
589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|0|G|0|SIE|0|0|0|100|SEK|26510|36803|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||26510||26510|36803||1|0|G
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10976|16605|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10976||10976|16605||2|H|S
589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4480|6017|lyfalmen|V0691|5952|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3283||3283|6017||1|0|E
590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|1|0|1|CLU|0|0|0|100|XEU|42063|56475|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||42063||42063|56475||1|0|ES
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0|
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|3092|5027|lyfalmen|V0041|4002|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||2564||2564|5027||1|0|G
590825|L01XX5001|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|854667|1069478|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||854667||854667|1069478||1|0|S
590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1600|3150|lyfalmen|V0317|3150|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1200||1200|3150||2|0|G
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|149430|192360|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||149430||149430|192360||1|H|S
590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|36617|9046|lyfalmen|V0721|7689|2|28|0|28,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||5484||5484|9046||1|0|
591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|0|G|0|LVR|0|0|0|100|DKK|9576|14678|lyfalmen|V0347|14678|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9576||9576|14678||3|0|G
591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|123099|159612|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||123099||123099|159612||1|0|L
591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2088|4372|lyfalmen|V0561|3699|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||2088||2088|4372||2|0|
591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1173|3112|lyfalmen|V0168|2872|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1173||1173|3112||1|0|E
591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|1|HSS|0|1|0|100|DKK|139703|180263|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||139703||139703|180263||1|H|L
592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|2456|4878|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2456||2456|4878||2|0|ES
592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G
592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3835|7446|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3835||3835|7446||1|0|
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|730835|912775|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||728672||728672|912775||1|0|S
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|853|2672|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||853||853|2672||2|0|G
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1146|3075|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1146||1146|3075||2|0|G
593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|7800|4105|lyfalmen|V0694|4076|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1894||1894|4105||2|0|G
593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2542|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|17970|26232|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||17970||17970|26232|31.8.2020|2|0|G
594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|6262|2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||3504||3504|6321||2|0|G
594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|10293|13734|lyfalmen|V0969|12927|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||8890||8890|13734||2|0|E
595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16584|24324|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16584||16584|24324||1|0|G
595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G
595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|20685|29436|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||20685||20685|29436||1|0|L
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|52400|69549|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||52400|69549||1|0|S
596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0|
596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1337|2304|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Febantel, Pyrantelembonat,Prazikvantel||1337||1337|2304||2|0|
597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|1|LNA|0|0|1|100|XEU|98424|110549|lyfsjukr|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||84816||84816|110549||2|0|0
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1784|3953|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1784||1784|3953||1|0|E
597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|573483|719764|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||573483||573483|719764||1|H|L
597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|104893|136969|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||104893||104893|136969||2|0|S
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Trimb Healthcare AB|Ekónazól|||||||2|0|
598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|ADI|0|0|0|100|SEK|2431|4844|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2431||2431|4844||2|0|G
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNP|0|0|1|100|XEU|376|2015|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||376||376|2015||1|0|
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0|
598843|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|tfílát||A07EC03|01.04.2018||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4317|7440|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4317||4317|7440||2|0|G
598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|5534|9115|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5534||5534|9115||1|H|S
598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0|
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2271||1|0|
599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|535150|672088|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||535150||535150|672088||1|0|L
599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|8029|12549|lyfsjukr|||2|20|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Oxalíplatín||8029||8029|12549||1|H|S
599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3651|7097|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3651||3651|7097||1|0|
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4564|8829|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4564||4564|8829||2|0|
599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2588||1|0|G
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|29516|40605|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||29516|40605||1|0|G
599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|19808|7264|lyfalmen|V0720|6743|2|28|0|14,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||4189||4189|7264||1|0|
599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|1335|3335|lyfalmen|||2|100|0|13,3333|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Warfarín||1335||1335|3335||1|0|G
599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3693|3810|lyfalmen|V0334|2601|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1680||1680|3810||1|0|G
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|1|EAG|0|0|0|100|NOK|115099|149662|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||115099||115099|149662||2|H|S
957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0|
957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0|
968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0|
968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0|
968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7280|11518|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7280||7280|11518||2|0|
968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0|
968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0|
970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0|
970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0|
970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E
974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0|
974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0|
974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0|
974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0
974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0
980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0|
980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0|